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(1) 
ABSTRACT 
Natural and induced factors inhibiting foot and mouth disease 
virus were investigated in bovine secretions, especially in those from 
the upper respiratory and oro pharyngeal areas. Techniques were 
devised to collect lachrymal, nasal, buccal and pharyngeal fluids from 
normal, convalescent and passively or actively immunised steers. 
The pH and total protein content of secretions were established 
in normal cattle. Immunoglobulin types IgA and IgGl predominated. 
Interferon was not detected. Normal tears exhibited no antiviral 
activity but nasal secretion, oral saliva and p~al fluid were 
inhibitory due to their alkaline pH and, in the case of salivary 
fluids, to the presence of an additional anti viral factor which was 
partially characterised. Virus lost infectivity in vitro due to 
natural, non specific factors at rates which varied with the strain of 
virus to a maximum of 1.25 log units per hour. 
Clinical disease, viral excretion, interferon and antibody were 
studied following infection with virus of types 0, A and C. Interferon 
was detected for up to 4 days at the period of maximum viral excretion. 
Secretory neutralising antibody developed , - 5 days after exposure, 
reached a peak within 21 - 28 days and was associated principally with 
IgA and IgGl. Serum levels were consistently greater than those in 
secretions. Passive immunisation studies showed that some secretory 
antibody was derived from serum. 
years after infection. 
Antibody persisted for at least ~ 
Secretory antibody levels increased with successive subcutaneous 
doses of inactivated vaccine. A single dose elicited good humoral but 
(2) 
poor secretory responses. Levels in serum and secretions rose after 
a second dose and approached convalescent levels after a third. 
Secretory antibody was principally IgGl but after a third vaccination 
IgA was also detected. 
The relation between secretory antibody and the outcome of exposure 
to infection was studied. In steers vaccinated once or twice and 
exposed 14 days after the last vaccination, no lesions were observed 
and little virus was recovered from their secretions excepting pharyngeal 
fluid. After three vaccinations much less pharyngeal virus was 
recovered following exposure. Convalescent animals reexposed 5t years 
after primary infection were immune and did not become carriers, 
pharyngeal samples remaining negative. These observations correlated 
well with the presence of neutralising IgA in the secretions. 
OBJECT OF THE RESEARCH 
Little is known about the local defence mechanisms of the bovine 
species against foot and mouth disease (FMO) and an investigation was 
considered desirable for the following reasons: 
1. The main portal of entr,y of foot and mouth disease virus (FMDV) is 
thought to be via the infection of superficial epidermal and mucosal 
surfaces particularly those of the naso and oro pharynx. 
2. The clinical lesions of FMD are found mainly in external locations. 
3. FMDV is excreted in quantity in secretions and excretions before, 
during and after the development of clinical lesions. 
4. FMDV spreads via the agency of infected secretions which come into 
contact, directly or indirectly, with susceptible animals. 
5. The carrier state is regarded as a normal sequel to exposure to 
FMDV in cattle and is equally readily established in fully susceptible 
animals or in vaccinated animals immune to the development of clinical 
, 
lesions. Virus is perpetuated by multiplication in the superficial 
tissues of the oro and naso pharynx and is recoverable in secretions 
from this area for months or years after infection. 
6. Recent studies on a number of diseases of man and animals have 
indicated the protective importance of local immunity. 
A study of the local defence mechanisms conducted in normal, infected 
and immunised cattle could therefore be expected to provide fundamental 
information on the factors which determine host resistance or susceptib-
ility, the pathogenesis of the disease, the maintenance and spread of 
the disease in nature and the protection of animals against FMD. 
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5. LITERATURE REVIEW 
5.1. Foot and Mouth Disease 
The literature is reviewed with particular reference to cattle 
under four headings:-
5.1.1. General Information 
5.1.2. Patho~nesis of Foot and Mouth Disease 
The Carrier State 
Host Defences 
5.1.1. General Information 
Foot and mouth disease is at once a condition of great antiquity 
and a major problem of modern livestock production. General reviews 
of the subject have been contributed by Brooksby (1958), Henderson 
(1960), Shahan (1962), Bachrach (1968) and Hyslop (1970). 
The typical clinical disease is acute, febrile and characterised 
by painful vesiculation of the mouth, feet and udder. The resulting 
annorexia, lameness and mastitis leads to lOBS of weight and milk yield. 
Sequellae ~ include abortion, sterility, chronic lameness and mastitis 
and metabolic disorders. 
The condition is perhaps the most infectious of all animal diseases 
and morbidity may attain 100% in susceptible cattle, sheep, goats and 
pigs. Mortality is general~ less than 5% and the importance of the 
disease lies in the suffering which it causes and the resultant loss ot 
productivity which has been estimated at 25%. 
F.MD has a world wide distribution with only the Australian, Central 
(11) 
and North Ame~can continents remaining free of infection for long 
periods of time. The striking clinical signs were probab~ first des-
cribed by the Italian author Fracastorius in 1546 and the filterable 
nature of the aetiological agent was demonstrated by Loeffler and Frosch 
in 1897 when it became the earliest identified animal virus and only the 
second viral agent to be discovered, lvanowslq having shown the filtera-
bility of Tobacco Mosaic Virus in 1892. 
The epizootiological complexity of the disease became somewhat less 
baffling in 1922 when Vallee and Carre showed the plurality of FJID 
viruses, a phenomenon hitherto unknown in virology, and by .1954 the 
disease was known to exist in seven clinically identical but immuno-
logically distinct types. Work on subtypes began with the cross 
immuni ty studies of Waldmann and Trautwein (1926) and was extended by 
the application of serum neutralisation and complement fixation tech-
niques. The World Reference Laboratory for F.MD currently recognises 
some 65 subtypes comprising 11 subtyPes of type 0, ;2 of type A, 5 of 
type C, 7 of type SAT1, 3 of type SAT2, 4 of type SAT3 and 3 of type 
Asial (Arrowsmith 1974 ,personal communication.) 
Types 0, A, and C are most widely prevalent having been found in 
Europe, South and Central America, Africa and Asia. The distribution 
of the South African Territories (SAT) ani Asia types is broad~ as 
suggested by the names but movement of virus types from endemic to non 
endemic areas poses a continual threat to livestock as does the emergence 
of new virus strains. Thus the spread of exotic virus into ths Middle 
East threatened Europe in 1962 when a serious epizootic of type SATI ' 
occurred and again in 1973 when type Asial appeared in Turkey for the 
first time. The A22 subtype also emerged in this sector in 1965·and 
spread to become the dominant type A strain. in the Middle East and Russia. 
(12) 
The existence of multiple antigenic types, the occurence of anti-
genic drift and the extreme infec~iousness of the agent make control 
complex and expensive. Nevertheless the development of efficient 
vaccines and the careful prosecution of prophylactic vaccination schemes 
has been attended by dramatic reduction in outbreaks in ~ parts of 
the world. The scale of the problem is indicated by the fact that over 
a thousand million doses of vaccine were administered in 1913. 
FMDV was one of the first for which estimation of size was made by 
ultrafiltration (Galloway and Elford 1931) and by ultracentrifugation 
(Elford and Galloway 1931). Since then a wealth of biop~sical and 
biochemical information has accumulated and the virus has been studied 
to the level of its component polypeptides and amino acids. These 
aspects have been extensively reviewed by Brown (1962, 1913) and 
Bachrach (1968). 
+ . 
FMDV has a naked capsid with icosahedral symmetry measuring 23- 2 
nanometres and containing 31% single stranded ribonucleic acid with a 
6 mOlecular weight of 2.6 x 10 daltons. These features, together with 
the fact that the virus is resistant to a variety of organic solvents 
including ether and that viral synthesis and maturation takes place in 
the cytoplasm of infected cells, serve to classify the virus as a member 
of the family Picornaviridae while its acid sensitivity places it in the 
Rhinovirus genus. 
5.1.2. Pathogenesis of FMD 
The pathogenesis of FMD has been studied at the level of the cell, 
the organ and the individual animal. 
When virus randomly encounters a susceptible cell the particle 
attaches to a receptor aite and is engulfed. Experiments in tissue 
culture systems have shown that adsorption and penetration of FMDV are 
temperature and calcium ion dependent and that, given optimum conditions, 
the half time of penetration at 37°C is 30 seconds (Thorne and 
Cartwright 1961, Thorne 1962, Brown et al 1962). The exact mechanism 
by which FMDV attains the interior of the cell is unknown but studies 
with poliovirus, a fellow member of the picornavirus froup, have shown 
that an irreversible eclipse occurs at the surface of Busceptible cells 
(Holland 1962) and that viropexis (Mandel 1962,1967a and b, Dales 1973) 
or direct penetration of the plasma membrane (Dunnebacke et al 1969) 
are involved. 
Once within the cell the virus eclipses and the redirection of 
cellular biosynthesis proceeds. In BHK - 21 cells the rate of cellular 
protein synthesis decreases by 5~ ~ithin the first half hour of 
infection and then showed three periods of accelerated activity, the 
first occurred an hour after infection and was assqciated with the syn-
thesis of FMDV specific RNA polymerase, the second was of an unidentified 
nature while the third, at two hours post infection, was associated with 
the maturation of proge~ virus (Brown et al 1966). In calf kidney 
cells new intracellular virus was detected 100 minutes after infection 
and the rate of viral synthesis increased logarithmically for the next 
50 minutes when virus began to be released from the cell. The rate of 
production of new virus tben decreased but persisted at a lower level 
for up to 5 hours post infection at which time cell death ensued 
(Polatnick and Bachrach 1960, Pled~r 1961). 
The isolated FMDV speoific RNA polymerase has been used in the syn-
thesis of RNA in a cell free system and the reaction has been extensively 
studied (Ar1inghaus et a1 1966, Po1atnick and Arlinghaus 1967). At 
least 10 different FMDV speoific proteins are synthesised in the infected 
cell (Ascione et al 1911) only some of which are found in the mature 
virion. A replicative mechanism has been proposed based on a circular 
minus strand of viral tiNA on which the plus strand grows as a tail being 
cleaved at various points ~o yield different molecular species of RNA 
(Brown and Martin 1965) but the exact mechanism of viral replication 
remains unknown. 
The virus replicates in a wide variety of dedifferentiated tissues 
in vitro and growth is usually accompanied by the development of typical 
enterovirus cytopathic effect, the rounding up and shrinkage of refractile 
cells, pyknosis of nuclei, fragmentation of chromatin, loss of structure 
and ultimately cell death. Some infected cells may survive and chronio-
ally infected cultures have been serially passaged through many genera-
tions (Seibold 1966). The Fluorescent antibody technique has been used 
to show that replication and maturation of virus are restricted to the 
cytoplasm of infected cells (Mussgay 1958). 
In vivo the virus shows a high degree of tissue tropism with pre-
dilection for superficial mucosae and epithelia, particular~ that of 
the mouth and phar,ynx and the ooronar,r band and interdigital space of 
the foot. Other superficial areas such as the udder (Burrows et a1 1971), 
the teats (Gailiunas et a1 1964), the pillars of the rumen (Geiger and 
Otte 1958) or the traumatised skin of the pig hook ~ show symptoms and 
microscopical lesions can be found even in hair,r akin at cattle (Gailiunas 
and Cottral 1966), an area whioh very rarely exhibits clinioal lesions. 
The virus may also replicate in musculature, especially in immature 
animals where the damage to cardiac muscle can prove fatal (Patel 1958), 
and oooasionally in parts of the oentral nervous system - partioularly 
the pituitary body (Scott et al 1965) - where its effeots have been 
blamed for subsequent endocrine disturbances. 
Clinical observations suggest that the distribution and severity of 
clinical lesions is related to mechanical stress and trauma. This 
effect was investigated in the guinea pig by Skinner and Knight (1964) 
who found that foot lesions following intramuscular inoculation of virus 
were more severe in animals kept on wire grid floors than in animals kept 
on solid floors with sawdust bedding and that prior injury of the plantar 
pads was associated with greater lesion severity even in pigs maintained 
on solid floors. Using the same species Jones (1968) demonstrated that 
mild mechanical injury of the pinna of one ear inflicted up to 4 days 
before or 2 days after metatarsal pad inoculation of virus resulted in 
higher concentrations of virus in the tissues of the damaged ear than 
in those of the normal control ear. Cottral et al (1965) showed that 
exposure of the dorsal surface of the bovine tongue to l07.SID of FMDV 50 
for 7 minutes was not followed by the development of clinical disease 
whereas lesions did ensue if the epithelium was lightly scratched before 
exposure to virus. The intact integument can therefore protect a pre-
dilection site while any defect in the barrier may predispose to 
infection. 
Platt (1961, 1963a and b) has postulated that phagocytosis is an 
important factor in determining the penetration of virus into susceptible 
cells and that the distribution of lesions in F.MD is partly attributable 
to enhanced phagocytosis and cell membrane activity at predilection sites 
due to continual low grade trauma. In addition, injury leads to tn-
creased vascular permeability which might allow the extravasation of 
virus during the viraemic phase of the disease and to other complex 
cellular changes (Platt 1966) which affect the epidermal susceptibility 
to FJIDV in ways which are not yet clear. The general increase in 
(16) 
cellular metabolism following injury may provide a favourable milieu for 
viral infection and multiplication since it is known that trauma is 
rapidly followed by an increase in DNA synthesis (Hell and Cruikshank 
196,), by bursts of mitotic activity (Sullivan and Epstein 1963) and by 
an increase in RNA and protein synthesis (Baden and Pearlman 1964). 
The histopathology of superficial vesicles has been intensively 
studied by light and electron microscopy in cattle, pigs and guinea pigs 
(Kablov 1958, Platt 1961, Seibold 1963, Gai1iunas et al 1964, Vetterlein 
1967, Krasinkov 1968 etc.) as has the damage to cardiac muscle (Potel 
1958, Lubke 1960) and the skeletal muscle and pancreas of the mouse 
(Platt 1956, Krasnikov 1966 etc.). The basic epithelial lesion has 
been described as 'Balloon degeneration' and it commences with swelling 
of the nucleus and cytoplasm of infected cells in the stratum spino sum 
of the epidermis, especially in the prickle cells. Vacuolation, separa-
tion, necrosis and disintegration ensue with the liberation of virus and 
, 
the development of intercellular oedema and granulocytic infiltration. 
Pathological changes also occur in the endothelial cells of dermal blood 
vessels and probably account for the leakage of lymph into damaged tissues 
during the inflamatory process. The separation of tissue and the 
accumulation of fluid progresses with the formation of macroscopic veaic-
lese In some areas the degenerative process is of a more necrotio 
character and epithelia or mucosa may die and strip away without vesicu-
1ation. 
The primary sites of FMDV infection have not been exhaustively 
studied but much evidence has accumulated to incriminate the pharyngeal 
area as an important predilection site in cattle (Burrows 1966a, 19688 
and 1972, Burrows et al 1971, Sellers et a1 196aband 1969, Sutmoller 1970, 
Mohantyand Cottral 1970, McVicar et al1970 and 1971). There are also 
. indications that the lower respiratory tract constitutes an important 
portal of entry (Eskildsen 1969), while local inoculation of the nasal 
passages (Korn 1957), the udder (Burrows et al 1971) and the foot may 
also provide routes for infection. A number of experiments have 
indicated that exposure of the alimentary tract to virus in food and 
water is a relatively inefficient and variable method of infection for 
pigs (Henderson and Brooksby 1948, Nathans 1965) or for cattle (Burrows 
1972). Terpstra (1972) has shown that pigs may be infected with low 
doses of aerosolised virus, when primar,y multiplication occurs in the 
lung, or with larger doses by the oral instillation of virus when 
multiplication occurs primarily in the tonsils and cervical ~ph nodes. 
Burrows (1968) has also presented data to support the early involvement 
of the phar,yngeal area in pigs. 
The establishment of infection depends upon a number of interrelating 
variables, one of which is the amount of virus which is required to 
initiate disease. In FMD this amount may show considerable differences 
between types and strains of virus. A second variable, the innate 
resistance or the animal, may also exhibit wide differences between 
individuals which in turn creates difficulties of a practically insur-
mountable nature in attempts to establish minimum infective dose levels 
for any particular species, virus or route. Nevertheless, within these 
limitations, much useful data has accumulated and Sellers (1~71) has 
prepared an extensive review of the amounts of FMDV required to infect 
cattle, sheep and pigs by various routes. 
In cattle the lowest reported amounts of virus required to initiate 
infection is 101.OID50 for the intramuscular (Cottral et a1 1966) or 
intranasal (Eskildsen1969) route, 101•4 for subcutaneous (Henderson 1952), 
101.; for intratracheal (Eskildsen 1969) and 102•0 for tonsillar sinus 
routes (Sutmoller et al 1968). The intraperitoneal route required 
102.2ID ( 2 8 50 Gailiun&a and Cottra1 1970), the intravenous route 10 • 
(18) 
(Henderson 1952), artificial insemination 103•4 (Cottra1 et a1 1968) and 
retropharyngea1 spray 105•0 (Mowat and Sellers 1967). The oral adminis-
tration of 105•8 - 106•SID50 resulted in the infection of less than half 
the animals exposed within 72 hours (Burrows 1972). 
Exposure to virus, even in high concentrations, does not necessarily 
result in the production of the disease. This effect ~ be explained 
in part by the existence of vi~s strains which show a high degree of 
natural adaptation to a particular species and many workers have reported 
on strains which were extremely virulent for pigs but avirulent or only 
mildly virulent for cattle (Andrews et a1 1937, Henderson et al 1948, 
Brooksby 1950, Graves and Cunliffe 1960). 
Once infection has been established in superficial areas the disease 
typically progresses with the development of viraemia, the distribution 
of virus throughout the body, the onset of pyrexia and the appearance of 
generalised disease. There have been many studies of the disease process 
in animals but an important distinction must be made between experiments 
performed before and after 1968. Those from the earlier era used direct 
inoculation (of the tongue or musculature) as the main method of in-
fection while latter~ infection has more often been established by means 
of direct or indirect contact with infected donor animals. The earlier 
approach haa the advantaSe of allowing more precise timing and quantit -
ation of the virus dose but the present shift in emphasis has provided 
information which is more directly applicable to the disease situation in 
the field and has increasingly focussed infection Qn the prodromal phase 
of pathogenesis, an area which is virtually bypassed by the method of 
direct inoculation. 
When virus is introduced by intradermo1ingual inoculation, the first 
detection of infectivity in tongue tissue may be as early as 6 hours 
after infection with increasing activity to a peak at 12 hours when the 
vesicles are still immature (Brooksby 1952). Tongue vesicles develop 
at the inoculation site within 18 - 30 hours, viraemia within 5 - 15 
hours and generalised disease within 36 - 96 hours (Burrows 1972). 
Intravenous inoculation of virus in cattle effectively anticipates the 
earlier events of pathogenesis and can result in generalised disease with-
in 24 hours of inoculation~(Mann and Garland unpublished data). The 
intranasal instillation of 108~Op.f.U. of FMDV resulted in the pharyngeal 
production of new virus within 2 hours of infection with the titre rising 
to a maximum at ten hours and persisting at a fairly uniform level for at 
least 24 hours. Viraemia ensued at 24 hours and lesions were detected 
at 72 hours post instillation (Graves et al 1971a). Exposure to lower 
intranasal doses (103.0p•f •u.) gave variable results and while one steer 
so infected developed lesions within 96 hours, three others failed to 
develop clinical disease or show any serological response to the virus 
(Graves et al 1971b). 
McVicar et al (1971) also followed the development of viral infect-
ivity in bovine pharyngeal fluid by sequential sampling after the intra~ 
nasal instillation of FMDV. The titre increased sharply after 2 to 6 
hours, depending on the strain of virus used, until about 12 hours after 
infection when the production of virus levelled out at a titre determined 
by the initial dose. Viraemia was detected at 24 hours and a second 
rise in the viral content of pharyngeal fluid preceded the appearance of 
tongue lesions at 48 hours after infection. One animal showed a much 
slower pathogenesis with low levels of pharyngeal virus which persisted 
for 3 days before the titre rose on the 4th day, when viraemia was 
detected. Lesions appeared on the 6th day. 
Attempts to simulate natural infection by direct and indirect contact 
have shown that virus may be recovered from external situations, espec-
(20) 
ially the mouth and pharynx, prior to the development of clinical lesions 
for up to 9 days in cattle and sheep and up to 10 days in pigs (Burrows 
1968a and 1972, Sellers et a1 1968band 1969, Graves et al 1971~). The 
average time for which pharyngeal virus could be recovered before the 
onset of clinical disease following indirect contact infection was 2.5 
days in cattle and sheep (range 0 - 5 days) and 5 days in pigs (range 
2 - 10 days) (Burrows 1972). 
In an extensive study involving all seven types of FMD Cottral and 
Bachrach (1968) found that viraemia was detectable in cattle following 
tongue inoculation as early as two hours and as late as 120 hours post 
inoculation, the rapidity of development being proportional to the 
amount of virus introduced. Intramuscular inoculation or aerosol in-
fection delayed the onset of viraemia by 24 - 48 hours. The development, 
duration and amount of virus in the blood varied with the individual 
animal but the pea~ concentration of virus was found on average at 40 -
42 hours after tongue inoculation while individuals showed peaks between 
24 and 72 hours post inoculation. In another report viraemia persisted 
for up to 4 days in cattle following intramuscular or tongue inoculation 
(Scott et al 1966). Cottra1 and Bachrach (1968) summarised earlier 
work on FMD viraemia, most of it conducted in animals infected by direct 
inoculation, and quoted the following times for the duration of viraemia: 
cattle 18 - 103 hours, pigs 12 - 96 hours, sheep 12 - 72 hours, and goats 
16 - 92 hours. An early report of the intermittent recover,y of virus 
from the blood of steers 7 - 58 days convalescent to FMD (Waldmann et a1 
1931) has not been confirmed. Viraemia developed in steers within 24 
hours of the intranasal instillation of 108.0p•f •u• of virus or within 1 
to 3 days after the demonstration of virus in pharyngeal fluid following 
contact infection. Lesions invariably appeared within three days of the 
first detection of virus in the blood (Graves et al 1911a). Viraemia 
was detected in cattle following contact infection 1 - 2 daya (Burrows 
(21) 
1968a) or 1 - 6 days (Sellers et al 1968f before the onset of lesions. 
The minor discrepancies which exist between authors are explainable 
by their use of different virus strains, dose rates and methods of infect-
ion but the general pattern is clear; viraemia is rarely detectable for 
more than 6 days and has almost invariably subsided wi thin 2 to 3 days 
of the development of clinical leSions, the clearance of virus from the 
blood coinciding with the rise ,in serum neutralising antibody. 
Attempts have been made to determine the distribution of virus 
throughout the body during the course of disease. The methods used have 
included the sampling of the natural secretions and excretions following 
infection and the 'routine titration' approach of Mi~ (1964) whereby 
animals are slaughtered at intervals a:ter exposure to infection and the 
amount of virus present in their tissues at the time of death is deter-
mined. During the prodromal phase in cattle following contact infection 
virus has been most consistently recovered from the pharyngeal area 
(Burrows 1968a and bland 1912, Sellers et al 196at. 
Predictably, once virus has attained the blood stream it can be 
recovered from the majority of tissues and its presence in ~ particular 
location is then of dubious significance. Conclusions m&J be safe1J 
drawn however, where the infectivity of tissues exceeds that found at 
the same time in blood. Using these criteria a number of internal organs 
and tissues have been shown to support the growth of virus in vivo and to 
retain their infectivity after the viraemic phase. In cattle the lymph 
nodes may contain virus for up to 15 days post infection (Cottral et al 
1963). Internal sites of viral multiplication include the rumen, thryoid, 
adrenal, pineal body and pancreas which BI81' harbour virus for at least 
8 days and the kidney and bone marrow in which virus ma,y persist for up 
to 6 days after tongue inoculation (Hess et al 1960, Cottral 1969). 
(22) 
Using fluorocarbon purification and polyethylene glycol concentration, 
Tsetkova and Sobko (1912) were able to recover virus from the bone marrow, 
thyroid and lung of a steer slaughtered 8 days after infection. Skin 
contains persistent virus for up to 1 days (Gailiunas and Cottral 1966) 
and Cottral and co-workers (1968) found that testes could contain virus 
for up to 10 days. Waldmann's claim in 1931 to have recovered virus 
from the kidneys and urinary bladder of cattle for up to 94 days after 
infection has not been confirmed. 
Virus has been found in other internal, non vascular tissues and 
fluids, possibly as a result of transcapillar.y escape during viraemia. 
Thus FMDV has been recovered from parts of the bfain (Kunter 1958) 
and the brain, spinal chord and cerebro spinal fluid (Scott et al 1965). 
Similarly synovial fluid may contain virus for as long as 5 days after 
tongue infeotion (Gailiunas and Cottral 1904) and fluid from the pleural 
and peritoneal cavities may be infeotive for up to 6 days (Cottral and 
Gailiunas quoted by Cottral 1969). 
Following contaot infection most seoretions and exoretions oontain 
virus for several days prior to the 'development of olinical disease. 
In cattle, pharyngeal fluid may be infective for 0 to 9 days, saliva for 
1 - 1 days, semen and milk for 1 - 4 days, vaginal swabs for 0 - 1 day, 
reo tal swabs for 1 - 6 days and preputial swabs for 2 - 4 days betore 
the first recognition of clinical signs (Burrows 1968a and 1912, Sellers 
et al 1968~. Virus is therefore disseminated in the seoretions well 
before the eruption of vesicles. 
The wide spectrum of clinical FMD is well known (Graham 1959) as is 
the faot that the incubation period and extent of lesions in the experi-
mental disease is related to the virus strain, dose and route of infect-
ion employed. In the most severe bovine case there may be extensive 
(23) 
vesiculation of the tongue, gums, hard palate, dental pad, lips, muzzle, 
nares, teats, udder, prepuce/vagina, coronary bands and interdigital 
space. Milder cases may show only small lesions, possibly of an erosive 
character, on less than four feet and at a few sites in the nose and 
mouth, often without tongue involvement. In some instances sub clinical 
infection occurs as demonstrated by the recover.y of virus from blood and 
pharyngeal fluid and by the rise of antibody (Sutmoller et al 1968). 
In others pharyngeal virus may be recovered in the absenoe of oirculating 
antibody (Hedger 1968, Auge de Mello et al 1966). Yet another form has 
been described in oattle concurrently infected with bovine enterovirus. 
(Graves et a1 1970, 1971b) in which a transient pyrexia and viraemia was 
seen in 1 of 8 animals as the only clinical sign following the intra-
nasal instillation of FUDV and neither symptoms nor antibody could be 
detected until 40 - 120 days after infection when generalised disease 
suddenly developed. These observations were explained on the basis of 
a) Competition between FMDV and tbe preexisting bovine enterovirus and 
b) phenotypic transencapsidation. In this phenomenon the FMDV ribo-
nucleic acid core is enclosed in an enterovirus coat in which form it 
persists until, by means as yet unknown, F.MD is. able to develop 
(Sutmoller et al 1970). Independent confirmation and irrefutable proof 
of the existence of this latent form bas yet to be provided. 
Several natural secretions are altered during the clinical course of 
FMD. In particular the stomatitis often results in increased salivation 
in cattle and the saliva may assume a viscid, mucoid nature. Bilateral 
nasal discharge, initially serous but often becoming muco-purulent, is 
also a common feature while conjunctivitis with occular disoharge may 
occasionally complicate the syndrome. Early reports recognised that 
lymph and epithelium from vesioles of the mouth or feet were particularly 
dangerous sources of virus as was saliva during the clinical disease 
(Waldmann and Reppin 1927, 01itB~ 1927, Olits~ et a1 1928, British Foot 
and Mouth Disease Research Committee 4th Progress Report 1931). 
Saliva collected from cattle following tongue inoculation contained 
104•0 Mouse ID50 per m1 at 16 hours post infection before the development 
of vesicles and the amount of virus increased to a maximum of 108•5 ID50 
at-38 hours when ripe vesicles were rupturing (Hyslop 196~. Waldmann 
and Reppin (1927) found virus in saliva between 9 hours and 11 days after 
infection while Wittmann and E~ssner (1966) stated that virus could be 
recovered from bovine saliva between the 4th and 7th day from cattle 
infected by virus rubbed over the oral mucosa. Scott et a1 (1966) 
found virus for up to 9 days after infection with peak titres of 108•0 
p.f.u. per ml of saliva occurring on the day after tongue inoculation. 
Many reports therefore chronicle the disappearance of FMDV from bovine 
saliva 1 to 11 days after infection. However it is important to differ-
entiate between saliva which has been derived from the mouth and saliva 
which has been obtained from the pharynx since oral saliva loses infect-
ivit.y within a few days of infection but pharyngeal fluid may retain 
infectivity for months or years. The chronic residence and excretion 
of virus in the bovine carrier state is reviewed in section 5.1.3. 
Virus may also be present in nasal discharge for up to 6 days post 
inoculation to a maximum titre of 107•7p.f.u. per m1 at the time of 
rupture of nasal vesicles (Scott et a1 1966). 
The highest titres of virus have been found in vesicle epithelium 
which may contain up to 1010 p.f.u. per g. Virus has been recovered 
from tongue epithelium for as long as 8 days, from palate lesions for up 
to 11 days and intermittently from foot epithelium for up to 11 days post 
infection (Scott et a1 1966). Eurrows (1966a) was able to recover 
type A virus at low titre from the tongue of one or two steers sampled at 
post mortem 23 days after infection. Olitsky et al (1928) found virus 
(25) 
in hoof scrapings from only 1 of 2; convalescent cattle sampled between 
20 to ISO d~s after infection and then only on one occasion on the 34th 
day. Bran4t(192S) carried out a similar search in cattle but ·was 
unable to recover virus between the 5th and 159th day. In this area, 
as in others, the work carried out between 1920 and 1950 is remarkable 
in its scale and thoroughness but it suffers from the lack of sensitive 
assay systems, much of it having been carried out in guinea pigs, and 
consequently quantitative results are scarce in studies made during this 
period. 
It is not surprising that most secretions and excretions contain 
virus, particularly at the height of clinical disease. Bovine urine 
may be contaminated by the overspill of virus during viraemia or by the 
shedding of virus during growth in the kidney or urinary bladder. Hess 
et al (1960) studied the renal multiplication of FMDV in calves and 
showed that virus was present in kidney tissue for up to 6 days after 
tongue inoculation whereas viraemia 'lasted for only 2 days. Virus was 
recovered from 17 of III urine samples derived from cattle 7 to 103 
hours after infection by tongue scarification (Trautwein et al 1928). 
Voinov (1955) detected virus in urine for only up to 15 hours after 
tongue infection. Cottral et al (1968) reported intermittent reoovery 
of virus from the urine of cattle from 12 hours to 7 days post tongue 
inoculation although all but 1 of 10 animals were free of detectable 
urinary virus after 3 days. Maximum titres of 104•9 Mouse ID50 per ml 
of urine were recorded 78 hours after infection. Waldmann et al (1931) 
used absorption and concentration teohniques to study the excretion of 
virus in cattle successively exposed to several types of FMDV and claimed 
that virus could be recovered from urine for as long as 246 days and from 
tissues of the urinary bladder for up to 94 days post infection. Burrows 
(1966a) failed to recover virus from the urinary bladder of 2 steers at 
post mortem 9 ~o 11 weeks after infection. Swabs taken from the bovine 
(26) 
prepuce following contact infection may contain virus for 2 to 4 days 
before the appearance of lesions (Burrows 1968a, Sellers et al 196~. 
The origin of this virus may have been local multiplication in the pre-
puce or contamination during the passage of infected urine. 
Although virus derived from swallowed saliva and oral lesions, 
rumenal vesicles, viraemic blood and bile must contaminate the contents 
of the alimentar,y tract during clinical FMD, the faecal excretion of 
virus is minimal. The acid pH of the gut contents (Kay 1966) is one 
factor which presumably contributes to the low levels of virus found in 
faeces. Since the original report by Bielang (1923) many workers have 
recorded the inconsistent recovery of low levels of FMDV from the faeces 
of infected animals. Voinov (1955) was unable to demonstrate infectiv-
ity in faecal samples derived from cattle infected by tongue inoculation. 
Wittmann and Eissner (1966) produced clinical disease in cattle by 
rubbing a suspension of virus over the tongue, oral cavity and nostrils 
I 
and recovered virus from the faeces on the 1st but not on the 4th day 
after infection. Trautwein et al (1928) recovered virus from 7 out of 
III faecal samples taken from cattle during the first 5 days after tongue 
inoculation. Guinea pig inoculation was used to detect virus and no 
quantitative determinations were made. 
Parker (1971) showed that faeces which were allowed to acoumulate 
on the floor of a loose box housing 2 steers infected with FMD could 
attain levels of up to 105•5 Mouse ID50 per g. b~ the 6th day after 
tongue inoculation. Virus was recovered in considerable quantity be~ 
tween the 1st and 12th day but the levels were considered to be a re-
flection of the total excretion of virus by all routes rather than of 
excretion by the rectal route alone. Following contact infection 
Burrows (1968a) found virus in rectal swabs from 2 of 4 cows one day 
before lesions were detected while Sellers et a1 (l968~ made intermittent 
recoveries of virus from the faeces of 3 of 4 bulls on the bth, 4th and 
3rd days before vesicles were observed. Sellers et al (1969) also 
recovered virus from 8 of 48 rectal swabs when 4 steers were sampled 
daily for 12 days following contact infection, clinical disease being 
first detected on ~he 5th, bth and 7tn days. 
Lactating cattle infected with FMD excrete virus abundantly in the 
milk. Lebail1y (1920) first drew attention to the presence of virus 
in milk during the viraemic stage of the disease prior to the development 
of lesions and German workers amply confirmed his observations, finding 
virus as early as 13 hours and as late as 5 days after the recognition 
of clinical disease (Trautwein et al 1928, Terbruggen 1932). Fluckiger 
(1940) also observed that the virus may be exoreted in the milk before 
the disease becomes clinically obvious. The epidemiological studies 
of Hedger and Dawson (1910) showed the massive dissemination of virus 
in milk and indicated that virus was excreted for at least 33 hours 
before the onset of clinical disease. Burrows and co-workers (1971) 
studied the pathogenesis of F.MD in the mammar.y gland and recorded virus 
concentrations of up to 107•0 p.f.u. per ml of milk within 6 - 32 hours 
of the instillation of virus in one quarter. Virus was recovered from 
other distant sites such as the pharynx, mouth, nose and vagina within 
4 - 24 hours of instillation and although signs of mastitis were often 
detected during the early multiplication of Virus, the olassioal signs 
of F.MD did not appear for 52 - 117 hours. Following oontact infection, 
virus was present in the milk for 0 - 4 days (type A) or 1 - 4 days 
(type 0) before the appearance of clinical lesions and persisted for as 
long as 3 weeks (typ.~A) or 7 weeks ,(type 0). The extreme susoeptibil-
ity of mammar,y tissue was shown by the rapid multiplication of virus 
following primary infection and by the fact that attempts to reinfect 
convalescent cows by the intramammsry instillation of homologous virus 
resulted in at least one oycle of viral replication in the udder, despite 
(28) 
the presence of high levels of neutralising antibody in serum and milk. 
The infected cow ~ also excrete virus in the vaginal secretions 
and Burrows (1968) was able to find virus in the order of 103•0 p.f.u. 
per sample in vaginal swabs on the day before clinical lesions appeared. 
FMDV multiplies in the testes of the infected bull and may be pres-
ent within 12 - 20 hours of p~enteral injection, before lesions have 
developed, and for up to ten days afterwards (Cottral et al 1968). 
Sellers et a1 (1968~ found virus in semen for 1 - 4 days before clinical 
lesions appeared in cattle infected by indirect contact. Maximum 
amounts of virus were found at the height of clinical infection with 
titres of up to 106•2 ID50 per ml of semen. 
Another means, of crucial importance, by which FMDV is disseminated 
from the infected animal is by the creation of infective aerosols. The 
airborne spread of virus has been suspected for many years (5th Progress 
Report of the FMD Research Committee 1931) and several authors have 
reviewed epidemiological incidents which pointed to the excretion and 
transmission of virus by this route (Michelsen 1968, Sellers and Parker 
1969, ayslop 1910). 
The initial experiments in this field brought controversy since some 
workers succeeded in transmitting infection by the airborne route 
(Fogedby et al 1960, McKercher et al 1966) while others were unable to 
do so (Moosbrugger 1948, Traub and Wittmann 1957). The subject remained 
obscure until HYslop (1965c) commenced the quantitative study of excret-
ion and was able to recover virus from the air before the appearance of 
clinical lesions and for up to 14 days after tongue inoculation. 
Kiryukin and Pasechnikov (1966) recovered 6.3 to 630 ID50 of virus per 
litre of exhaled air from infected calves. Sellers and Parker (1969) 
found that airborne virus was released in the greatest amounts by pigs 
(up to 104•7 ID50 per animal per hOur) and in lesser quantity by cattle 
and sheep (up to 103•2 ID50 per animal per hour). The excretion total-
led 106•0 ID50 per pig over 5 days and 104•5 1D50 per steer or sheep 
over 4 days following tongue inoculation. Peak recoveries occurred at 
41 hours post inoculation in cattle and pigs, when disease had general-
ised, and at 17 hours in sheep, prior to the development of lesions. 
Further work showed the considerable influence of virus type and strain 
on the amount of airborne virus which could be recovered (Donaldson et 
al 1970) and provided some explanation for the conflicting results 
obtained by other workers. 
Sellers and Parker (1969) measured the distribution of viral infect-
ivity in droplets of various sizes in the aerosol from infected pigs. 
They showed that 65 - 71% of virus was reo overed at an aerosol size of 
larger than 6p, 19 - 24% at 3 - 6p and 10 - 11% at smaller than 3p. 
By analogy with man these droplets 'might be expeoted to be deposited 
principally in the mouth, nose and paar,ynx (6p), the bronchi (3 - 6p) 
and the alveoli (3p) (Hatch 1961). Droplets of greater than 5~ sedi-
ment fairly rapidly but particles of a smaller size may remain in aerial 
suspension for long periods and, given favourable atmospheric conditions, 
can remain viable during dissemination over long distances (B¥slop 1970, 
1972). 
To summarise, virus is disseminated in large amounts for several 
days before and after clinical FMD with maximum excretion occurring by 
most routes at the height of the syndrome. Virus can rarely be re-
covered from tissue, secretions or excretions later than a few days after 
the acute phase except from milk, the soft palate, the pharynx and sec-
retions from this area in cattle and sheep. With regard to natural 
contact infection Graves'et 81 (1971a) have shown that a steer infected 
by the intranasal instillation of 10S.Op.f.u. of FMDV remained infectious 
for susceptible animals for 7 to S days after the instillation of virus. 
The most efficient transmission occurred 72 - 96 hours after infection 
of the donor when clinical disease was at its peak. 
Immunit,y, both natural and acquired, can greatly modify the patho-
genesis of FMD. Vaccination can effectively prevent the development 
of clinical disease in animals challenged with homologous virus but will 
not prevent the acquisition of the carrier state (see section 5.1.3.). 
Potent inactivated vaccines can however markedly reduce the excretion 
of virus by all other routes, thus Sellers et al (1969) exposed two 
groups of cattle to indirect contact infection; one group vaccinated 
19 days previously and the other,not vaccinated, and compared the daily 
recovery of virus from'each group between the 7th and 10th day after 
exposure. Viraemia and lesions were detected only in the control ,~,' 
animals. Viral recoveries were made from pharyngeal secretion, oral 
saliva and swabs from the prepuce and rectum in 38, 7.3, 5.5 and 1.~ 
respectively of samples from vaccinated cattle and in 71, 41, 33 and 
16% of samples from non vaccinated cattle. Immune animals also 
excreted Virus at much lower titre. Weihe (1966) examined the milk 
and saliva of vaccinated,oattle challenged by oral swabbing or contact 
infection. The animals remained clinically normal and virus was 
recovered in the saliva of 40 out of 156 cattle and in the milk of 2 out 
of 8 cows. In saliva, FMDV was found most frequently between 4 and 6 
days after exposure and could not be detected beyond the 13th day. 
Milk contained virus only on the 6th and 9th day after challenge. 
Wittmann and Eissner (1966) were unable to recover virus from the saliva, 
urine or faeoes of convalescent cattle after reexposure to homologous 
virus, even when samples were concentrated 10 - 30 times prior to assay. 
Cottral et al (1963) found virus in the regional lymph nodes of cattle 
for·up to 15 days after tongue inoculation. In contrast, virus could 
(31) 
not be recovered from the lymph nodes of convalescent cattle slaughtered 
2 days after reinoculation of the tongue with the same virus type. 
It will be seen from the foregoing that, despite the existence of 
a vast body of information, no single systematic study has been made of 
the excretion of FMDV in normal and vaccinated cattle before, during 
and after clinical disease following contact infection. 
5.1.,. The Carrier State 
The carrier state in FMD had been suspected on epidemiological 
grounds since the turn of the century but proof of its existence eluded 
investigators for over 50 years. Attempts to recover virus from the 
natural secretions and excretions after the acute disease had subsided 
were generally unsuccessful (see section 5.1.2.). Then in 1959, 
Van Bekkum and his colleagues published their account of the intermittent 
recovery of virus from the pharyngeal fluid of convalescent cattle which 
they sampled by means of a special probang cup (Plate 3). Other lab-
oratories confirmed their findings and a new chapter opened in F.MD 
research. Reviews of this tQpic have been collated by Sutmoller eD al 
1967bt Henderson 1966/61, Singh 1969, Hyslop 1910 and Sutmoller 1910. 
It is now recognised that a high proportion of cattle will become 
carriers as a sequel to infection with FMD. In the original observat-
ions of Van £ekkum et al (1959), 10 of 13 convalescent cattle carried 
type A virus for up to 5 months after infection. Sutmoller and Gagg~ro 
(1965) found 14 out of 25 animals positive six months after infection 
in the field. £arrows (1966a), working with 3 types and 4 strains of 
F.MDV, recovered virus from 23 of 30 steers following experimental infect-
ion. Virus was detected in 68.~ (208/302) of phar,f.ngeal fluid samples 
taken between 2 and 26 weeks after tongue inoculation. Van Bekkum et 
(32) 
a1 (1966) demonstrated persistence for periods of 7 weeks (type A), a 
weeks (type 0) and 14 weeks (type C) in cattle following intradermo-
lingual infection. McVicar and Sutmoller (196a) reported that 19 of 
32 steers became carriers after intranasal or contact infection. In 
Africa Hedger (196a) surveyed an enzootic area and was able to isolate 
type SAT3 virus from 20% of the animals sampled between 7 and 12 months 
after natural infection. Virus persisted for up to 2t years after 
infection (Hedger and Stubbins.197l). 
Not all cattle exposed to a similar challenge become carriers 
at al (Burrows 1966a and b, Sutmoller 1970, Kaadenl1970 etc.) indeed, consid-
erable variation exists between individual animals in the establishment 
and course of the carrier state. 
The amount of virus and the ro~te by which it is presented influence 
the acquisition of chronic phar,yngea1 infection. At low virus dose 
rates (100 p.f.u.), more carriers were produced by the instillation of 
virus into the tonsillar sinus and pharyngeal region (a/lO) than were 
by intranasal instillation (4/1a). A dose of 10,000 p,ftu" however, 
established the carrier state in 5/6 and 6/6 animals following pharyngeal 
and nasal infection respectively. (Sutmol1er at al 1968). 
Some evidence exists to suggest that virus type and strain may be 
an important determinant in the carrier state. Thus Burrows (1966a and 
b) found that the bovine carrier state was less frequently detected and 
of shorter duration following infection with types SATI and SAT3 than 
with type A Turkey or Al19 while the titre of pharyngeal virus was much 
lower after infection with types A Turkey or SAT3 than after type Al19. 
The significance of these results should not be overemphasised since 
they were derived from small numbers of cattle. Kaaden et a1 (1970) 
were able to recover type 0 virus quite frequently from 8 cattle sampled 
between 1 and 9 months after infection whereas type A virus could not 
be recovered from a similar group sampled one month after infection. 
The effect must be related to strain rather than type since persistent 
excretion has been reported for strains of type A, e.g. Al19 and A4691 
(Van Bekkum et al 1959, Burrows 1966~ Sutmoller and McVicar 1972). It 
is possible that prefeeential adaptation of strains of FMDV to particular 
species may have a bearing on the carrier state. Young et al (1912) 
described an outbreak of FMD in African buffalo following natural infect-
ion with type SAT2 and showed that disease could be transmitted to cattle 
held in an adjoining pen. Both species developed clinical lesions but 
only the buffalo became carriers. 
Species which can be infected with FMD differ in their susceptibil-
ity to the carrier state. Cattle readily become carriers as does the 
African buffalo (Hedger et al 1969, Hedger 1911, Young et al 1912 etc.). 
Sheep and goats commonly harbour virus in the phar,yngeal area, especially 
in tonsillar tissue, for as long as 5 months (Burrows 1966b, 1968) or 
12 months (McVicar and Sutmoller 1968) after infection. In contrast, 
all attempts to demonstrate the carrier state in the pig (Burrows 1966b, 
1968a, Sutmoller 1910) or guinea pig (Burrows 1968b) have been unsuccess-
ful. 
In one study there was no correlation between the sex and age of 
cattle and their carrier status (Hedger 1968). 
Several factors may therefore contribute to the carrier state but 
our knowledge of the determinants of susceptibility or resistance is : 
still rudimentary in this, as in other areas. 
The recovery of virus in pharyngeal fluid is often intermittent 
and the titre may fluotuate quite widely. In 28 weekly samples from 
10 carrier animals, the frequency of viral recovery varied between 1/28 
and 21/28, moreover, on occasions virus could be recovered from only 1 
of 2 samples taken i"rom the same anima.l within a 5 minute period 
(Van Bekkum .t al 1959). However, the frequency of recovery and the 
amount of virus generally decreases with time after infection. Ten 
steers had a mean infectivity of 102.4p•f •u• per ml of pharyngeal fluid 
(range 101•1 - 103•0) 3 weeks after infection with type A119 but 24 
weeks later virus was detectable in only 5 animals at a mean level of 
101.0p•f •u • per ml (range 100•3 - 102.°) (Burrows 1966a). Straver et 
al (1910) repeatedly sampled 66 cattle in 8 carrier herds ·after a type C 
epizootic; 38 animals were positive at least once, more than half of 
these became negative within 4 months of infection and the last animal 
became negative 24 months after the first sampling. 
The development of clinical disease is not a prerequisite of the 
carrier state. A number of authors have reported on susceptible animals 
which did not develop lesions after infection but which did, nevertheless, 
show a chronio asymptomatio infection of the pharynx (Van Bekkum 1959, 
Sutmoller 1910, McVioar and Sutmoller 1969). Such animals usually 
develop circulating antibodies. Several workers have recorded an 
association between high serum antibody titre and the carrier state 
(Sutmoller and G88gero 1965. Burrows 1966a, Van Bekkum 1966). Hedger 
(1910) was of the opinion that the presence of high levels of serum 
antibody in some members of the population after an outbreak of F.MD was 
usually associated with the presence of carrier virus in the group and 
that, conversely, carrier virus was unlikely to be recovered from a popu-
lation in which significant antibody levels could not be demonstrated. 
However, the same author (Hedger 1968) was able to show that while anti-
bodies were found in the sera of 46 out of 50 carriers following a type 
SAT, epizootic, antibo~ could not be demonstrated in the sera of the 
4 remaL~tng carriers. 
Cattle vaccinated using inactivated FMD vaccines, with high levels 
of humoral antibody and fully immune to the development of clinical 
disease, can acquire persistent subclinical infection as readily as non 
vaccinated animals (Van Bekkum et al 1959 and 1966, Burrows 1966a, 
Sutmoller et al 1967a and b and 1968, Hedger 1969, McVicar and Sutmoller 
1969, Kaaden et al 1970 and Pustiglione Netto et al 1972). These 
authors are in agreement on the lack of correlation between a) pre-
existing antibody levels and the development of the carrier state and 
b) the presence or absence of clinical lesions and the development of 
the carrier state. In the light of these findings it is not surprising 
that the asymptomatic carrier state can also follow the application of 
attenuated strain FMD vaccines (Burrows 1966a and b, Auge de Mello et 
al 1966 and 1970). 
Claims have been made that pharyngeal virus was recovered more 
consistently,~for longer periods and at a higher titre from cattle which 
were protected by inactivated vaccine and remained clinically immune on 
exposure to FUn than from non vaccinated cattle which developed clinical 
disease after exposure (Sutmoller et a1 1968, McVicar and Sutm011er 1969, 
Sutmoller 1970). Passively immunised animals appeared to occupy an 
intermediate position (Sutmoller et al 1968). These authors postulated 
that the persistent infection which follows the exposure of vaccinated 
cattle to F.MD may represent a more stable virus - host relationship than 
that which follows when susceptible cattle are exposed to the disease. 
Burrows (1966a) investigated the specific localisation of virus in 
the carrier state by titration of suspensions of mucosae and epithelia 
taken from the pharyngeal and associated areas of convalescent carriers 
at post mortem. The dorsal surface of the soft palate and the walls 
of the pharynx were most often infected to highest titre in cattle follow-
ing infection with wild strains while the tonsillar region figured mo?e 
prominently when attenuated strains were studied. Virus was recovered . 
less frequently from the ventral surface of the soft palate and the 
glosso-epiglottic space and only occasionally from the tonsillar sinuses, 
tonsils, tongue, trachea and oesophagus. No virus was detected in the 
nasal turbinates. Van Bekk~m et al (1966) also concluded that the cells 
lining the phar,ynx appeared to be the main sites of viral production in 
carrier cattle. Henderson (1966/61) recovered virus most consistently 
from the tonsillar region. Mohanty and Cottral (1911) studied cultures 
from the tissues of carrier cattle by fluorescent antibo~ techniques 
and infectivity assay and reported that the pharyngeal and oesophagal 
mucosae were important sites of persistence. The exact nature of the 
cells which support the carrier state is unknown. 
Although the pharyngeal fluid of carrier cattle may contain quite 
large amounts of virus and infected droplets can be expelled by steers 
during coughing (Sutmoller et al 1961a), the significance of the carrier 
state in the maintenance and spread of FMD remains problematical. Many 
attempts have been made to demonstrate the experimental transmission of 
infection from carrier cattle to normal cattle but to date all have 
failed (Van Bekkum ~959, Burrows 1966~ Brooksby 1967, Sutmoller et al 
1961a and 1970, Straver 1970). The application of stress has also 
failed to influence the excretion of virus by carriers or its acquisition 
by recipient animals. Carrier and recipient cattle have been stressed 
by the injection of steroid hormones (Sutmoller and McVicar 1912), the 
simulation of prolonged trekking (Hedger, personal communication) and 
food and water deprivation (Garland unpublished observations). Recip-
ient pigs have been stressed by the abrasion of their feet or by inject-
ion with embr.yonated ascaris eggs (Sutmo1ler and McVicar 1912). 
Limited evidence does exist for the infection of normal animals by 
carriers in the field. Van Bekkum et al (1959) reported a rise in anti-
body in the absence of clinical disease in 1 of 30 calves born in a 
carrier herd 4 months after a type C outbreak. Hedger (1968) demon-
strated type SAT, pharyngeal virus and serum antibody in one calf born 
some months after the last known outbreak of FMD in an enzootic area of 
Botswana. Sutmoller and McVicar (1972) recorded the development of low 
levels of serum antibody to type A in some animals among a group of pigs 
following contact with carrier cattle. No signs of FMD were observed 
and the animals were fully susceptible to the subsequent inoculation of 
type A virus. 
A somewhat different situation exists when certain attenuated strains 
of FMD are employed. Virus was readily recovered from normal cattle in 
contact with animals vaccinated with type C (Resende) attenuated virus 
although se~ antibody did not develop in the recipients. Such trans-
mission was extremely rare when type A (Cruzeiro) attenuated virus was 
used (Auge de Mello et al 1966, 1970). 
The allliost total failure of transmission experiments between carriers 
and susceptible cattle has not been satisfactorily explained. However 
as discussed below (Section 5.1.4.) contributory factors ~ include: 
the presence of neutraliaing antibody in bovine saliva (Hyslop 1965a, 
Burrows 1966a, Van Bekkum 1966, Sutmoller et al 1961a, Kaaden and 
Matthaeus 1970); the periodicity of viral excretion in the carrier state 
(Van Bekkum et al 1959, Burrows 1966a, Sutmoller 1970 etc.); the low 
level of virus normal~ encountered in phar,yngeal fluid (Burrows 1966a, 
Sutmoller and Cottral 1967, Sutmoller 1970 etc.); the production of 
interferon in the oropharynx and the fact that the main volume of upper 
alimentary and respiratory tract secretion is destined to be swallowed, 
disinfected and reabsorbed in the gut rather than be excreted from the 
mouth and nose. 
(38) 
Workers at Pirbright were the first to show that antigenic variation 
could be induced in FMDV by the serial passage of virus in the presence 
of immune bovine serum in tissue culture (Hyslop 1965b) and by serial 
passage in partially immune cattle (Hjslop and Fagg 1965, Fagg and 
Hyslop 1966). Burrows (1966b) extended these observations and showed, 
using serological techniques, that chronic residence of FMDV in the 
bovine phar,ynx could be associated with chamges in ~he antigenic nature 
of the virus. Fellowes and Sutmoller (1970) and Sutmoller (1970) also 
demonstra~ed serological dirferences between the original virus and 
some subsequent carrier isolates from cattle and described additional 
differences between them in such characteristics as growth at various 
temperatures, resistanAe~to heat, acid and ultraviolet energy and stabil-
isation by metallic salts. Strains of carrier virus have been isolated 
with reduced virulence for cattle (Burrows 1966b, Sutmoller et al 1967d, 
Straver et al 1970) and for pigs (Straver et al 1970). Such strains 
may recover full virulence for cattle after a single bovine passage 
(Sutmoller et al 1967d). Hedger used complement fixation tests to 
compare the antigenic characteristics of original virus and later carrier 
isolates from outbreaks of FMD in Africa. He found little variation 
after a type SATl epidemic (Hedger 1970) but detected marked differences 
after a type SAT3 outbreak (Hedger 1968). In Germany, Kaaden and co-
workers (1970) also compared original and progeny virus strains and 
concluded that certain carrier isolates of type 0 virus behaved like 
modified strains of FMDV since they showed decreased virulence for mice 
and cattle, full virulence for pigs, slow development of cytopathic ef-
fect and reduced plaque size in tissue culture and an increased capacity 
for the stimulation of interferon. StraYer et a1 (1970) made similar 
comparisons following an outbreak of type C in the Netherlands and found 
that some carrier isolates were of reduced pathogenicity for cattle and 
pigs, produced smaller plaques in some cell systems and showed an in-
creased sensitivity to inactivation by pH and heat. Since the original 
outbreak virus was composed of a heterogeneous population, some part of 
which exhibited the characteristics of subsequent carrier isolates, the 
authors suggested that selection was in operation during the course of 
the carrier state. 
Other mechanisms of viral variation may operate during chronic 
residence of FMD in the bovine phar,ynx. The phenomenon of genetiC re-
combination has been demonstrated experimentally in vitro between FMDV 
strains of distinct subtype (Pringle 1965, 1968, 1969, Pringle and Slade 
1966, 1968) and the rate of mutation of some strains of the virus to 
thermal resistance can be as high as 10-4 (Pringle 1964). Recombination 
between types of FMDV has not been reported and in this context a number 
of workers have shown that reinfection of convalescent carrier cattle 
with virus of a different type results in the displacement of the first 
virus type in the pharynx in favour of the second type (Fellowes and 
Sutmoller 1970, Sutmoller 1970, Cottral and Gailiunas 1971 and unpublished 
work at Pirbright). Similarly, in superinfection experiments a second 
subtype of FMDV can readily supercede the original subtype in the bovine 
pharynx (Cottral and Gailiunas 1971). 
Although pharyngeal infection is apparently restricted to one virus 
type or subtype at any one time, Sutmoller and Gaggero (1965) recovered 
type C and type A virus in one sampling from different cattle on the 
same farm and different types 9f FMDV have also been recovered from 
individual buffalo within a herd (Hedger 1971, Hedgeret al 1969, 1973). 
Fe1lowes and Sutmoller (1970) presented data which suggests that re-
combination may occur between types of FMDV during mixed infection. 
They examined carrier virus derived from cattle convalescent to type 0 
and reinfected with type A in cross neutralisation tests using antiserum 
prepared against the original and later isolates of type 0 and~A virus. 
The results showed that at least 9Q% of the infectivity of Bome later 
type A isolates could be neutralised by antiserum to both virus types. 
Simple mixed infection was considered unlikely since only type A virus 
could be detected by complement fixation and growth of the isolate in 
type 0 or type A antiserum failed to reveal the presence of more than 
one component. 
The carrier state is a common sequel to acute F.MD in cattle and 
considerable evidence exists to incriminate the carrier as a source of 
infection for other animals. Nevertheless, direct proof of such trans-
mission is lacking and it is clear that spread of virus between carriers 
and susceptible animals occurs only rarely and is likely to involve 
special predisposing factors, such as antigenic variation. We know 
that FMDV can undergo such alteration during the course of the carrier 
state but we rem&in ignorant of the mechanisms involved in effective 
transmission. Rare though the event may be, however, the consequences 
can be extremely grave and the existence of an infected reservoir of 
such dangerous potential is clearly undesirable. 
5.1.4. Host Defences. 
Host d&fences against FMD include both natural, non specific defences 
and acquired or induced immunity. This section of the review deal. only 
with those local and systemic host defence mechanisms which are known to 
oppose infection with FMDV and a later section (5.2.) is concerned with 
the broader aspects of local immunity including vaccination. 
Non specific host defence mechanisms against FMD include innate 
immunity, physical barriers, pH and dilution effects, natural antibodies, 
interferon and interference between viruses. Acquired or induced 
defences following infection or vaccination include interferon, inflam-
mation, cell mediated immunity and specific neutralising antibody which 
(41) 
may be found in internal and external secretions. 
Many viral agents are species specific and such basic, innate resis-
tance depends to a considerable extent on the presence or absence of 
either cellular receptor sites or intracellular growth mechanisms approp-
riate to particular virus. Both species and tissue susceptibility have 
been conclusively linked with the presence of receptors for some picorna-
viruses, particularly the enteroviruaes polio and coxsackie, and 
susceptibility does not depend on the availability of intracellular path-
ways since cells which are resistant to intact virus can often be 
infected with RNA which has been uncoated (Holland 1961, 1962, 1964~ 
Holland and Hoyer 1962). Alternatively particular cell types may resist 
infection, despite the presence of intracellular virus, because they 
lack the necessary biosynthetic pathw~. Resistence of this type ~ 
occur in macrophages (Mims~ 19b4) exposed to some arboviruses (Goodman 
and Koprowski 1962), to murine hepatitis virus (Bang and Warwiok 1960) 
and to yellow fever virus (Sabin 1952). 
The determinants of natural resistance or susceptibility are multiple 
and complex (see reviews by Smorodintsev 1960, Fenner 1968). The 
correlation between specificity in vivo and in vitro is far from absolute 
(Chaproniere and Andrews 1951) and depends on the dynamic interrelation-
ship between virus and host. Resistant oells propagated in vitro ~ 
acquire receptors and develop susceptibility during culture, perhaps by 
the unmasking of preexisting sites or the derepression of synthetic 
mechanisms normally latent in the intact animal (Holland 196~. Virus 
blind-passaged Ul a resistant host ~ adapt to grow well in that system 
(Sabin and Schlesinger 1945, Fenner and Cairns 1959 etc.). 
untogeny of resistance is a feature of several virus diseases. The 
subject has been reviewed by Siegal (1952) and Burnet (1960) and the 
\42) 
effect has been exper~mentally investigated with polio \Sabin 1~62), 
coxsackie (Kunin 1964) and F.MD virus. At a clinical level transmissible 
gastroenteritis and pseuiorabies viruses can cause mortality of nearly 
lO~1o in piglets of up to 10 days of age but produce only mild transient 
illness in adults. In contrast, yellow fever of man and vesicular 
stomatitis virus of cattle are examples of diseases which produce a much 
more severe syndrome in the adult than in the young (Beveridge 1967). 
The effects may be related to the development of immunological competence 
(Overman 1954, Overman and Kilham 1953), possibly to a better developed 
interferon system in the adult (Heineberg 1964) or to the establishment 
of other defences such as the reticulo-endothelial barrier (Chany et a1 
1966). 
The inheritance of resistance to viruses has been studied, princip-
ally in the mouse, commencing with the work of Webster (1937) using 
St Louis Encephalitis and later by Sabin (1952) with yellow fever, 
Bang and Warwick (1960) with Mouse Hepatitis and Goodman and Koprowski 
(1962) with various arbovirus8s. These and other workers have shown 
that certain aspects of resistence are genetically controlled. Despite 
considerable efforts, little is known about the mechanisms which underlie 
the phenomenon of age resistance. 
F.MDV exhibits a well defined species specificity. For example, it 
will not replicate or produce disease in the horse. Age resistanoe is 
also a factor since the immature Calf or piglet is usually much more 
severely ill than the adult and may well die. The determinants of 
susceptibility have not been investigated in d9mestic animals but several 
factors have been carefully examined in the mouse. Skinner (1951, 1953) 
pioneered the use of suckling mice in F.MD research and later work supports 
his original observation that mice of leas than 7 days of age were 
susceptible to the virus while increasing age was parallelled by increas-
(43) 
ing resistance (Uhlmann and Traub 1958, Campbell 1960 etc.). Subak: 
Sharpe made a particular study of age (1961a and c) and strain (1961b) 
resistance in this system and concluded that the difference in suscept-
ibility between certain strains of mouse was determined by a single 
gene with incomplete dominance (1961a and c) but could also be due to 
an interaction between polygenic systems involving several loci in the 
mouse (controlling the complex character of susceptibility) and in the 
virus (determining the infectivity) (196lb). 
Intact mucosa and epithelium can protect some sites against infect-
ion while mechanical damage to this barrier may predispose to disease. 
The experiments of Cottral et al (1965) in which the dorsum of the normal 
bovine tongue was resistant to infection while the mildly traumatised 
dorsum was susceptible have already been mentioned as has the work of 
Platt (1961, 1963a and b, 1966), Skinner and Knisht (1964) and Jones 
(1968) who showed that mechanical injury to external situations was 
often associated with the development and exacerbation of lesions in the 
guinea pig. Infection of superficial sites via abrasions of the mouth 
or feet due for example to poor quality fodder containing sharp materials 
(e.g. old spiky hay, thorns and thistles) is frequently quoted as a 
portal of entry. Reports have also been made of the attempts to infect 
swine by the feeding of v,irus when infection occurred more often after 
the inclusion of bone fragments in the feed (Cox et al 1964, Stockman 
1927, Andrewes et al 1937). 
The FMD virion is stable over a relatively limited pH range'of about 
7.0 - 8.0 and pH values outside this range are associated with loss of 
viral infectivity which occurs very rapidly at acid values of 6.5 or less 
and more slowly at alkaline values of 8.0 to 10.0 (Bachrach et al 1957). 
The alkaline pH of bovine saliva has been cited as an antiviral factor 
(Donaldson 1972) as has the pH of bovine urine which may reach acid values 
down to pH 5.3. The acid shift is particularly noticeable in bovine 
urine during the clinical phase of FMD when inappetance, fever, cachexia: 
and tissue breakdown combine to cause a metabolic acidosis (5th Progress 
Report, RID Research Committee, Ministry of Agriculture and Fisheries, 
19)7, Cottral and Gailiunas 1969). 
Mucosae and epithelia at the natural orifices of the body are kept 
moist by the continual secretion of physiological fluids. Thus occular, 
nasal, oral" pharyngeal, tracheal, bronchial, oesophageal and other 
surfaces are bathed in a mQving film of secretions which overlies the 
outer aspect of superficial cells. Such secretions may play a double 
role in pathogenesis since on one hand they function to wash away parti-
culate matter and to lubricate and protect surfaces against mechanical 
damage but on the other hand they offer a viscous medium which may serve 
to trap pathogens and bring them into intimate contact with susceptible 
cella. In the ruminant, especially in the bovine and most particularly 
in lactating cattle, salivation exhibits a number of unique features. 
The most remarkable feature is the volume of saliva secreted which may 
attain 190 litres per d~ (Bailey 1961). The secretion of such large 
amounts of saliva is likely to exert an antiviral effect simpl~ by the 
dilution and washing away of pathogens in the oral and pharyngeal .,'i j~. 
cavities. 
The topic of natural antibody has been reviewed by Boyden (1966) 
and Michael (1969). Natural antibod~es to a number of viruses occur 
fairly commonly in bovine serum (Allen et al 1958, Klein 1958) and even 
foetal calf serum may contain antibodies to the viruses of infectious 
bovine rhinotracheitis, bovine parainfluenza type 3 and bOvine virus 
diarrhoea (Kniazeff et al 1967). Patty (1910) tested the serum of 20 
normal steers and reported a high incidence of inhibition of FMDV types 
0, A and C. Ron et a1 (1912) examined 19 foetal calf sere for non 
specific neutralisation against FMDV types 0, A, SATI and Asial and 
found activity in all sera against one or more virus types. Immuno-
globulins were deteoted in 6 sera but no correlation was found between 
neutralising activity and the presence of immunoglobulin. Non specific 
neutralisation of FMDV has also been shown in normal porcine serum 
(Bogel 1966, 1961, Bogel et al 1961). The antiviral effect of some 
normal sera against FMD is thus well established but the exact nature 
of the effect, be it inhibition or neutralisation, and the agent, be it 
immunoglobulin or another serum component, remains unknown. It is 
reasonable to assume that suoh a factor constitutes an additional defence 
meohanism. Natural, non specific antibodies have not been reported in 
other secretions. 
Interferenoe between viruses has long been reoognised as a defensive 
faotor and some of the first experiments in this area concerned the 
ability of vaooinia virus to protect guinea pigs against infection with 
FMDV (Gildmeister and Helm 1932). The subject of interference and 
interferon is more properly considered with induced host defences and 
it is neoessary now only to mention that FMD is susceptible to hetero-
logous interference which might contribute to proteotion in the speoial 
circumstances obtaining when an animal is concurrently infected with 
another virus. Interferenoe of this type has been cited to explain the 
lack of clinical disease which ~ follow the exposure of known bovine 
carriers of enteroviruses or infeotious bovine rhinotracheitis virus to 
virulent FMDV (Graves et al 1970, 1971b, Sutmoller 1970). Preexisting 
infection might also induce interferon to inhibit a superinfeoting virus. 
Proof of these hypotheses is currently lacking. 
Aoquired or induced defences against FMD are of two typesl 
1. those which are brought into pl'sy as an immediate but relatively 
short lived counter to infection, restricting the extent of lesions and 
promoting recovery from primary, acute infection and 
2. those which are brought to bear more slowly to engender a longer 
lasting resistance to infection. The first type embraces those factors 
commonly included in the acute inflammatory response such as interferon 
production, local tissue hypoxia and acidity, cellular infiltration and 
fever. The second type includes cell mediated and antibody related 
immunity. This division is convenient but somewhat arbitrary, since 
factors such as antibody may function in both are~s. 
Interference phenomena have interested virologists since the 1930s 
and Heule (1950) and Schlesinger (1959) have reviewed the early investi-
gations in this field. Despite intensive efforts the underlying 
mechanisms remained unknown and interference remained largely a descrip-
tive term until a new era opened with the discovery of the first 
interferon by Issacs and Lindermann in 1951. An avalanche of research 
followed resulting in much information on the induction, nature and mode 
of action of the interferons, as recently reviewed by, among others, 
Allison (1911), Baron (1963, 1910a and b), Colby and Morgan (1911), 
DeClereq and Merigan (1910), Doshi and Shah (1972), Finter (1970), 
~ . . 
Glasgow (1970, 1911), Lockhart (1961), Vilcek (1969) and Wagner et al 
(196a). 
Present knowledge may be briefly summarised as followsl interferons 
(IF) are a family of proteins of cellular origin capable of initiating 
a non specific intracellular inhibition of virus replication. They may 
be differentiated according to their source, spectrum of activit,y and 
physio-chemical properties. They are of a predominantly protein nature, 
possibly incorporating a carbohydrate moiety, and show a relatively high 
resistance to acid, alkali and heat. Interferons are a heterogeneous 
species differing in molecular weight (approximat.~ 25,000 - 100,000 
daltons), electric charge and stability to heat and acid, these differ-
ences perhaps being a reflection of the inducing agent and the cells of 
origin. 
A wide variety of infectious and non infectious agents, their ex-
tracts and synthetic polynucleotides are capable of inducing the form-
ation of IF and most inducers are characterised by their stable, helical, 
polyanionic structure. 
in vivo than in vitro. 
Many more substances will act as inducers 
Interferons are produced in most cell types 
including epithelial cells, fibroblasts, leucocytes, lymphocytes and 
macrophages although there is evidence to suggest that, in vivo, cells 
of the lymphoreticular series are chiefly involved. The precise 
mechanism of production is unclear but is thought to involve the 
derepression of a DNA interferon cystron leading to the production of 
an interferon messenger RNA which directs the synthesis of IF. Two 
mechanisms are postUlated to explain the early appearance of IF after 
induction, one being rapid de-novo syntheSiS and the other being release 
of preformed IF. There have been attempts to link these mechanisms 
with the known existence of two broad classes of IF: 
a) the stable, low molecular weight type produced in response to most 
viruses and statolon being synthesised following derepression and 
b) the more labile, high molecular weight type produced in response to 
bacterial endotoxins and other non viral inducers being associated with 
the release of preformed IF. In any event, IF is detectable very soon 
after infection and is generally found in greatest amount around the time 
of clinical disease in infected animals. 
Interfero~s exhibit a wide spectrum of non specific activity against 
most RNA and DNA containing viruses (the adenoviruses being relatively 
insensitive) and against other intracellular organisms. They act 
locally to protect the cell in which they were induced and are also re-
leased to protect adjacent or distant cells. The effect is largely 
species specific in that IF produced in one host will protect others of 
the same or closely related species but will act at a much reduced 
level, if at all, in other species. Interferons have no direct action 
on viruses but act intracellularly by inhibition of the translation of 
viral messenger RNA to block the synthesis of new virus. Although 
generally stable in the laboratory at +4°C, they are short lived in the 
animal. A half life of 7 - 11 minutes has been reported for IF in 
serum following intravenous injection in various species and a similar 
rapid clearance follows systemic induction. Claims haye been made for 
the efficacy of endogenous and exogenous IF in the prevention and treat-
ment of many viral infections of man and animals but it is usually 
difficult to disentangle the role of IF from that of other host defences. 
Concentration of research on the interferons has tended to over-
shadow the fact that not all interference phenomena are IF mediated. 
Indeed, direct competitive interference between viruses is well reco~ 
nised. The phenomena include heterologous interference (between un-
related viruses) and homologous interference (between slosely related 
viruses). In circumstances of high virus multiplicity, a special type 
of homologous interference may occur between virions of a single virus 
type and strain which has been called Autointerference. The issue may 
be further complicated by the fact that certain agents such as the rous 
inhibitory factor and herpes viruaes can interfere directly with homo-
lcgous virus (Rubin 1960, Rolzman 1965) and can also induce IF (Bader 
1962, !urelian and Roizman 1965) so that special care is required to 
determine the mechanisms at work in any particular situation. 
Means of direct compet1tive interference include the destruction 
of cytoplasmic membrane receptors (Crowell 1966) and competition for 
intracellular sites of synthesis as in mixed enterovirus infection (Corda 
and Holland 1964). Roizman (1965) showed that infection of non permis-
sive cells with a conditional lethal mutant of herpesvirus resulted in 
the formation of non-functional subunits coded for by the defective 
virus which interfered with the replication of a virulent mutant simul-
taneously introduced. The transmissable interfering component of 
vesicular stomatitis virus which gives rise to autointerference was first 
described in 1959 by Cooper and Bellett and has since been widely investi-
gated., Several workers have shown that the effect is mediated by a 
defective, incomplete form of the virus which interferes with the replic-
ation of the complete virion, possibly by introducing a coding error in 
the order of protein synthesis (Huang and Wagner 1966, Crick et al 1966, 
1969 etc.). 
It seems likely that both direct and interferon mediated interfer-
ence figure among the host defences against FMD. The early work of 
Glldmeister and Helm (19}2) with vaccinia and of Michelsen (1946) and 
Schafer (1946) with strains of FMD in guinea pigs showed that the virus 
was susceptible to both homologous and heterologous interference. The 
virus has been shown to induce IF in a number of tissue cultures of 
bovine origin (Dinter 1960, Dinter and Philileon 1962, Sellers 196}, 
Sellers et al 1968b and c). FMDV is also susceptible in vivo and in 
vitro to the action of a number of interferons (or interferon like sub-
stances) produced in response to viral agents other than F.MD and to 
several non viral inducers. The viruses of Newcastle disease (Giacometti 
et al 1968, Gizatullin and Gumerov 1969) and Sendai (Sellers et al 1972) 
do not replicate in the guinea pig but will interfere with the replicat-
ion of FMDV and a similar effect has been observed in calves treated with 
Semliki forest or Sendai virus (Sellers and Mowat unpublished results, 
Sellers et al 1972). Non viral inducers such as yeast RNA (The1y et 
al 1963), phytohaemagglutinin (Richmond 1969), Freund's complete adjuvant 
(Gorhe 1967) and synthetic anionic polymers (Sellers et al 1912, Richmond 
1971) are also known to induce IF inhibitory to FMD. 
(50) 
Several workers have reported that avirulent strains of virus, 
naturally occurring or artificially produced, often induce higher levels 
of IF than more virulent strains (see Isaacs 1963). This phenomenon 
is by no means universal but in FMD some modified strains did induce 
more IF than their virulent counterparts in several in vitro systems 
(Sellers 1963, 1964, Sellers and Mowat 1968, Sellers et al 1968~ 1968b) 
and the use of this trait has been suggested as a genetic marker of 
attenuation (Sellers et al 1968c). 
The basic mechanism of IF aotion against F.MD has been studied in 
tissue culture by Anl (1970, 1971). He showed that strains of FMD 
could be classified according to an increase or lack of increase in~their 
If sensitivity at infra or supra optimal growth temperatures and that 
IF sensitivity was potentiated by the removal from cells of divalent 
cations. Two independent anti-viral factors were distinguished in IF 
from cattle or tissue culture on the basis of physico-chemical and bio-
logical properties. Factor 1 was relatively acid sensitive and reduced 
the number of infective centres in a Buspension of infected cells. 
Factor 2 was relatively unstable at 56°C and reduced the yield of virus 
per infective centre. 
There are few reports of the occurrence and action of IF in natural 
infections of domestio stock with FMD. Cunha et al (1958) and Cottral 
and Gailiunas (1971) have described simultaneous inoculation of cattle 
with two or more types of F.MD when, with a single exception, one type 
assumed sominance, possibly as a result,.of interference and/or IF pro-
duction. Kubin (1961) described interference between the viruses of 
coital vesicular exanthema and F.MD in cattle. Sellers and Mowat (1968) 
and Sellers et al (1968c) have shown that autointerference can occur 
within strains of modified, avirulent F.MD since diluted preparations gave 
rise to lesions when inoculated into the bovine tongue whereas undiluted 
(51) 
virus gave rise to no lesions or lesions of reduced extent and severity. 
The same authors reported that modified FMDV could interfere with the 
development of tongue lesions in cattle when inoculated with virulent 
virus. They were also able to show that a mixture of virulent FMDV and 
IF showed less viral mul~iplication and cytopathegenicity than virulent 
virus alone in tissue culture, but were unable to demonstrate a similar 
effect when the mixtures were inoculated into the dermis of the bovine 
tongue. This failure ~ well have stemmed from ~echnical problems 
concerning the retention of the inoculum in the lingual tissue and from 
differences between the two systems in the number and type of cells 
involved. 
While it is probable that autointerference and IF act to limit the 
spread and promote the early regression of oral and other lesions in 
FMD, no direct evidence is currently available to this effect. 
Local tissue hypoxia, hyperosmolarity and acidity have been accorded 
a non specific protective function in viral infections (Lwoff 1959, Bang 
and Luttre1 1961, Baron 196; and 1961). These factors often oocur 
together since inflammatory foci are associated with oedema and fibrin 
deposition which tends to impede the inward diffusion of oxygen, the 
outward diffusion of carbon dioxide and the transport of other acid 
metabolites. In addition, leucocyte infiltration tends to increase the 
accumulation of acid products and lowered oxygen tension is reflected in 
a shift to_ards anaerobic glycolysis with increased production of lactic 
acid. None of these effects has been speoifically investigaled in FMD 
but pH values pf 5.5 - 6.5 have been recorded in inflammatory sites 
(Frunder 1953) and such values are likely to have a profound inaotivating 
effect on a virus of extreme acid sensitivity. No stUdies have been 
made of the pH values of secretions from animals suffering from FMD, 
other than those on milk (Burrows et al 1971). 
Cellular infiltration occurs in acute viral vesicular foci (Platt 
1961, 1966, 1967) and involves lymphocytes and macrophages. Their 
function is undefined in FMD but prestunably includes the traditional 
role of phagocytosis followed by intracellular breakdown (Mims 1964, 
Silverstein 1970, Smorodintsev 1960) and their more recently discovered 
role as producers of IF (Glasgow 1970) and processors of antigen as a 
first step in the priming of cells whioh are to play a part in antibody 
or cell mediated immunity (Craddook et al 1971, Maokaness 1910, 1971, 
1972, P1ayfair 1971, Inanue and Cerottini 1970). There is no evidence 
to suggest that FMDV either grows in macrophages or attains distant 
target organs as a passenger in macrophages by the means employed in 
other viral diseases (see reviews by Rowley 1962, Mima 1964, Gresser 
and Lang 1966, Allison 1971). FMD viraemia, like that of other pioorno-
viruses (Fenner 1968) is not cell associated (Burrows et al unpublished 
data). 
Pyrexia is a normal componentiof the host response to.F.MD typically 
occurring during the peak of the clinical syndrome and for one or two 
days before and after it. As in many other diseases, the teleological 
significance of fever in FMD is difficult to assess (Fenner 1968, 
Allison 1971, Mima 1972). Elevation of body temperature ~ be assoc-
iated with decreased virus growth as shown experimentally in animals with 
the viruses of coxsackie type Bl, ~oma, Semliki forest, polio, 
Newcastle disease (Bennet and Nicastri 1960, Baron 1963) and canine 
herpes (Carmichael and Barnes 1969). Lwoff (1959) recorded that strains 
of polio virus of low virulence for monkeys grew poorly in tissue culture 
at febrile temperatures while mice infected intracerebral~ with virulent 
strains survived longer if maintained 2 - 3°C above their normal body 
temperature. The same author (Lwoff 1969) reviewed the extensive studies 
of the effect of temperature on polio virus and proposed the unifying 
concept that fever resulted from increased metabolism duu to viral 
infection together with the release of pyrogenic substances from leuco-
cytes mobilised as part of the inflammatory response. Temperatures' 
above those normally found in the host act against the virus in at least 
two ways. Firstly they may depress viral multiplication by the inhib-·· 
ition of viral replicase and secondly they may increase lysosomal 
lesions so that enzymes, including ribonucleases, are released to destroy 
viral RNA. The correlation between optimal growth temperature and 
severity of disease is by no means absolute for all viruses but Barr 
(1969) has shown that strains of FMDV adapted to grow at 25 and 300 C 
were generally of reduced virulence for cattle, while strains adapted 
to grow at 400 C were often of high virulence. 
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Hyp~thermia may contrib-
ute to host resistance against FMD by the mechanisms discussed but there 
is no direct evidence to support this view. The fact that the febrile 
response corresponds with the period of maximum symptoms does not alone 
enable us to ascribe a protective function and as fever usually occurs 
late in the incubation period of FMD following contact infection, it 
possibly occurs as a response to and a reflection of antigen-antibody 
complex formation or to generalised cell mediated immunity (Mima~ 1912). 
The notion that antibody was an important factor in protection 
against disease gained general acceptance in the period 1880 - 1900 and 
passive immunisation against F.MD was used propnylactically at the turn 
of the century .. (Kitt"l 1692). Resistance to reinfection with FMD is 
thought to be largely attributable to the action of specific neutralising 
antibody. Four lines of evidence adduce its protective ,function, firstly, 
the correlation between the presence of neutralising antibody and 
resistance to challenge, secondly the correlation between the absence 
of neutral ising antibody and susceptibility to challenge, thirdly the 
ability of passively transferred antibody to protect against challenge 
and fourthly, the specificity of antib~ for a given viral antigen. 
Tiselills and Kabat (1939) separated serum by electrophoresis and 
showed that antibodies were principally confined to the gamma globulin 
fraction. Brooksby (1949) and Bradish et al (1954a and b) applied this 
technique to the quantitative investigation of serum from normal and FMD 
infected cattle, showing that p globulin level rose 1 days after tongue 
inoculation and regained the normal level during the following week 
while the Y globulin rose 3 to 4 weeks after infection and remained high 
for several weeks. 
FMDV has at least four associated antigens; the complete virion 
(140s), the 'empty' capsid (758), the capsid subunit (12s) and the virus 
infection associated antigen (V.I.A., 4.5s) (Bachrach 1968, Brown 1972). 
All components react in complement fixation and agar gel precipitation 
tests but only l40s and 756 antigens give rise to neutralising antibody 
and immunity. The 140s and 12s components elicit antibodies of differ-
ent electrophoretic mobility. Antibodies to the intact particle are 
type specific whereas antibodies to the subunit show a considerable 
degree of cross reaction between types in precipitin and complement 
fixation tests (Brown and Crick 1958). Antibody to the three larger 
antigens occurs in animals after disease or vaccination but antibodies 
to the V.I.A. component are found only in convalescent animals (Cowan 
and Graves 1966). 
The serum antibody response after infection or immunisation with 
FMDV is typical for foreign protein. Early antibodies are detectable 
in cattle within 3 - 5 days of tongue infection, reach a peak at 7 - 14 
days and gradually decline below detectable levels within 30 days (Brown 
et al 1964, Cowan 1966). They are macroglobulins of the IsM class (by 
analogy with human immunoglobulins) having a sedimentation coeffioient 
of 19s, a fast 71 or p2 globulin electrophoretic mobility (Brown 1960) 
and are 6!nsitive to reductive cleavage with mercaptoethanO! (Brown et 
et al 1964). Early antibody will neutralise and precipitate FMDV, both 
homologous and heterologous (Brown and Graves 1959, Cowan 1966) but does 
not fix complement to any appreciable extent (Cowan 1966). 
Later in infection, at 10 - 14 days, a second antibody type appears 
(Brown and Graves 1959) reaching a peak at about 28 d~B and persisting 
for months and years after infection (Cunliffe 1964, Cowan 1966, Graves 
et a1 1972). Late antibody belongs to the IgG class having a sediment-
ation ooefficient of7s, both fast and slow Y globulin eleotrophoretic 
mobility (Brown 1960, Cowan 1966) and being resistant to the action of 
mercaptoethanol (Brown et al 1964). The 7s antibody shows neutralising, 
preoipitating (Brown and Crick 1958) and complement fixing (Cowan 1966) 
actin ty of a type specific nature. 
Skinner (1953) reported that bovine serum taken 1 days after infeot-
ion with FMDV would neutralise both homotypic and heterotypic types of 
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virus whereas 21 day serum was type specific in its neutralising activity. 
This effect was further confirmed· and extended to include precipitin 
reaotions between subtypes by early but not by late antibody (Brown and 
Graves 1959, Brown 1960). A mixed population of antibody types is also 
found in the IgG class since neutralising antibody persists for at least 
4* years (Cunliffe 1964, Graves et al 1972) whereas complement fixing 
antibody can no longer be detected after 90 d~8 (Cunliffe 1964) or 
declines more rapidly and persists at a much lower level than neutralis-
ing antibody for up to 9 months after infection (Cowan 1966). 
The antibody response of cattle to inactivated vaccines has also 
been studied and closely resembles that described following infection 
(McKercher and Giordano 1967, Chappuis et 81 1971). A similar, non 
specific neutralising component is found mainly in the IsM fraction 
(Peleg and Madan 1972, Kalmar and Peleg 1972) but antibody to V.I.A. 
is absent (Cowan and Graves 1966). 
The extensive studies on the serum antibody response of the guinea 
pig to FMD are not reviewed here. In general they resemble those 
quoted for cattle although recent work has demonstrated that 19s guinea 
pig antibody was capable of differentiating antigenic variations within 
a strain of FMDV which were not detectable us~.1s guinea pig or 19s 
and 7s cattle antibody (Wagner.and Cowan 1971). Analogies should 
therefore be drawn with caution. 
Passive immunisation has shown the protective nature of serum 
antibody in FMD. Antibody is secreted in the colostrum of convalescent 
or immunised cows (Schneider 1955, Stone and De lay 1959) and calves 
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which suckle an immune dam rapidly acquire serum antibo~ (Graves 196jr, 
Van Bekkum 1966) which will interfere with vaccination for 3 - 4 months 
(Wisniewski and Jankowska 1971, 1972) and protect against homologous 
challenge for at least 6 weeks (Srubar 1966). Passive immunisation 
using whole blood, convalescent plasma or immune and hyperimmune serum 
was extensively used in Europe prior to the advent of FMDV vaccines and 
was relied upon to give 10 - 14 days protection in the field (Galloway 
1954). Brooksby (1949) demonstrated that protection could be passively 
transferred between adult cattle by purified and concentrated convalescent 
serum antibody and suggested that the dose of serum and the degree of 
protection were quantitatively related. Similar experiments were 
reported by Sutmoller et al (1968) who also pointed out that protection 
did not include freedom from pharyngeal infection. Many authors have 
reported that the protective efficacy of FMD vaccines can be estimated 
from the neutralising antibody titre of the serum (Martin and Chapman 
1961, Van Bekkum et al 1963, 1969, Graves et al 1972 etc.) although 
individual variations and discrepancies do'occur following vacoination 
(Borgen et al 1962, Graves et al 1968, Sutmoller and McVioar 1912) and 
passive immunisation (Sutmoller et al 1968). 
Preliminary studies on FUn antibodies in external secretions are 
fully discussed in section 5.2 •• 
Cell Mediated Immunity (CM!) which·resides in specifically sensit-
ised, thymus-derived lymphocytes an~ may act via macrophages, is trans-
ferrable by cells (as opposed ~o serum) and is responsible for delayed 
hypersensitivity and homograft rejection phenomena. It has recently 
been ascribed significance in immunity to a number of viral conditions, 
particularly those caused by pox, herpes, leuko and some ~o and para-
myxo viruses as reviewed by Allison (1971), Allison and Burns (197~) and 
Mi~ (1972). Evidence for the importance of eM! derives from clinical 
and experimental observations. Hypogammaglobulinaemic subjects recover 
normally from a number of viral infections (Good et al 1962). Persons 
with congenital abnormalities of CM! are prone to severe, recurrent and 
often fatal attacks by viruses which produce a much milder syndrome in 
the normal host, for example, thymic dysplasia is often associated wi th·~ 
unusually severe pox virus infection despite a normal antibody response 
(Rossen 1968). Immunosuppressive techniques often exacerbate viral 
infections (Allison 1967) while immunity can often be restored by the 
transfer of sensitised lymphocytes as Blanden (1971) conclusively showed 
with ectromelia infection in mice. 
Suppression of CM! by the use of tAymecto~ or anti-~phocyte serum 
does not appear to potentiate infections due to certain enteroviruses or 
arboviruses. The use of agents which suppress antibody, such as cyclo-
phosphamide, does potentiate them ~d normal immunity can be restored by 
the transfer of antibody (Murphy and Glasgow 1968, Zisman and Allison 
197J, Zisman et al 1971, Zlotnick et al 1970). Some authorities have 
suggested that CM! may be important in generalised diseases and perhaps 
plays no part in superficial infections (Mims 1972). Nevertheless 
use of the Macrophage Migration Inhibition techniques showed the presence 
of antigen sensitive lymphocytes in bronchial washings following immuni-
sation with inactivated influenza virus (Waldman and Henney 1971, Waldman 
et al 1972) or attenuated respiratory syncytial virus (Chanock 1970) so 
that CMI is at least a possibility in these regions. Cell Mediated 
lImnunity has not been investigated in FMD but it is reasonable to assume, 
from the data given above on antibody and the fact that the disease is 
caused by enterovirus, that it may not be of paramount importance. 
Convalescent cattle may show a total clinical immunity to the same 
type of blIDV for 3 - 4 months after infection, resisting even challenge 
by tongue inoculation. Partial susceptibility ~ then ensue since 
localised lesions can develop at the inoculation site on the tongue but 
generalisation is resisted (Trautwein 1929, Galloway 1954, Davies et al 
1963 etc.). Cunliffe (1964) investigated the duration of immunity in 
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steers to homologous challenge following type 0 infection. At 335 -
,6, days post infectio~ 7 animals were challenged by tongue inoculation 
and, although primar,r vesicles developed at several inoculation sites 
in all animals, fever and secondary lesions were absent and disease did 
not spread to convalescent animals in contact. At 1708 days post 
infection 2 of 3 animals similarly challenged developed generalised 
disease but the third steer remained free of detectable lesions. 
Cottral and Gailiunas (1971) confirmed an early observation by 
Trautwein (1927) when they showed that sequential infection of cattle 
with up to 7 types of ~IDV resulted in a cumulative effect towards 
resistance but complete heterotypic resistance was not encountered until 
at least four different types had been applied. Cross neutralisation 
test reactions on serum antibody correlated well with challenge results. 
These observ&tions are of mainly academic interest, however, since 
infection with one type of mlD lends no resistance against heterologous 
challenge and repeated exposure to multiple types is rare, even in areas 
where 2 or 3 types of virus are endemic. 
5.2. Local Immunity 
References to protective substances in secretions are scattered 
through the early literature such as the finding of agglutinins to typhus 
in human faeces (Staubli 1903) and the demonstration of poliovirus 
neutralisation by human nasal washings (Amos and T~lor 1917) but the 
existence of a specialised, independent immune system operating at the 
external surfaces of the host seems to have been conceived by Besredka 
(1919, 1927). His studies of infections of the alimentary tract with 
entero~acteriaceae and the skin with B. anthracis led him to postUlate 
the existence of such a system and to suggest.that it might be manipul-
ated in favour of host immunity. 
Much original and subsequent work concerned infections due to 
bacteria, helminths and protozoa. These extensive studies have been 
reviewed by Pierce (1959), Tomasi and Bienenstock (1968) and Duncan 
(1971) and will only be alluded to in those areas which have pertinence 
for,virology. 
The initial observations of viral neutralising activity in secret-
ions was greatly expanded in the period 1940 - 1954 by the work of two 
research groups under the leadership of Francis and Fazekas de St Groth 
who carried out systematic studies on local immunity in mice and men 
following infection or vaccination with influenza virus. Francis (1940) 
showed that convalescent human nasal washings could neutralise the virus 
and soon afterwards this effect was attributed to the presence of specific 
antibody (mucoantibody) in the secretions of the respirator" tract 
(60) 
(Francis and Brightman 1941, Francis 1943, Francis et 81 1943). Intra-
nasal exposure of mice to influenza was followed by the simultaneous 
appearance of antibody in bronchial mucus and in serum (Fazekas de St 
Groth and Donnelly 1950a, b and c). Similar results followed subcut-
aneous vaccination in man using live or inactivated virus, moreover anti-
bo~ titres in secretion and serum showed parallel fluctuations (Francis 
et al 1943). Resistance to reinfection was thought to be primarily 
mediated by local antibo~ while antibody in serum was relatively in-
effective. The evidence was circumstantial, being based on the fact 
that protection could be more closely correlated with the titre of anti-
body in respiratory secretion than with the titre in serum. Higher 
antibody levels were found in secretions after intranasal instillation 
than after parenteral inoculation of virus (Fazekas de St Groth and 
Donnelly 1950a). However, after passive immunisation a proportion of 
serum antibody could attain the secretions (Fazekas de St Groth and 
Graham 1954) and this proportion could be greatly increased by the intra-
nasal application of heterologous virus, meta-periodate ion or certain 
astringents (Fazekas de St Groth et al 1951b). This latter phenomenon, 
so called 'pathotopic potentiation', was ascribed to mild inflammatory 
change with increased capillar,y permeability allowing the escape of serum 
antibody into secretions (Fazekas de St Groth 1951a). 
In 1959 Heremans and co-workers discovered the IgA class of antibody. 
IgA differs from the other immunoglobulins (IgM, IgG, 19E and IgD) in 
immunolOgical and physicochemical properties and also in distribution 
since it is a minor globulin type of serum but forms the major immuno-
globulin (Ig) of human external secretions (Hanson 1961, Chodirker and 
Tomasi 1963). 19A has since been studied increasingly and the origin, 
structure, properties and function of the class have been reviewed by 
Tomasi and Bienenstock (1968), Heremans (1968, 1970), Tomasi (1970, 1972), 
Brandtzaeg (1973) and Vaerman (1913). IgA exists in two forms, the 1s 
(61) 
monomer with a molecular weig~t of approximately 160,000 daltons being 
found mainly in serum and the lIs dimer, comprising two monomers conjug-
ated with an epithelial glycoprotein (the secretory piece or component) 
with a molecular weight of about 390,000 being found mainly in external 
secretions. The globulin is chiefly synthesised by plasma cells situated 
in the stroma of mucosae and glandular structures, close to the external 
surfaces of the body and, in man, constitutes the predOminant Ig in milk, 
colostrum, saliva, tears, nasal fluid, bronchial fluid, gastrointestinal 
secretions, bile and urine. The exact function of the secretory piece 
is unknown but it does confer additional resistance against proteolytic 
enzymes and may serve as a specialised surface receptor holding 19A 
molecules at epithelial surfaces. In man, 19A predominates in external 
fluids but IgM, IgG and to a lesser extent IgD and IgE may also be found. 
Bovine immunoglobulins analogous in physicochemical and antigenic 
characteristics to human 19O, IgM and 19A have been identified in serum 
and secretions and several recent r~views have been devoted to them 
(Butler 1969, 191;, Sullivan et al 1969, Aalund 1972, Duncan et al 1972, 
Porter 191;). IgG exhibits a partioular1y well defined heterogeneity 
in cattle with two prominent subclasses, IgGl and IgG2 (Milstein and 
Feinstein 1968). ls02 is mainly confined to serum while ls01, with the 
lower isoelectric point, comprises from one half to two thirds of the 
serum IsO and nearly all the IsO in external secretions (Sullivan et a1 
1969, Duncan et al 1912). IgA is a minor globulin of bovine serum exist-
ing mainly as a dimer, unlike the monomeric form encountered in human 
serum (Mach and Pahud 1911, Butler 1971), and it is the main glQbulin 
of most external fluids, where it is found complexed with secretory piece 
(Vaerman 1910). 19A forms a relatively small part of the globulin in 
milk and colostrum where IgGl predominates, in contrast to the dominance 
of 19A in these secretions in man (Murphy et a1 1964, Aalund 1968 etc.). 
Complete immunological cr~ss reactivity has been demonstratod between 
(62) 
the heavy chains of human and bovine immunoglobulins (Murphy et al 1965) 
and free bovine or human secretory piece will combine equally readily 
with IgA from either species (Mach 1970, Mach and Pahud 1971). 
Most bovine secretions have been investigated for immunoglobulin 
type and content and although quantative values differ widely between 
authors, probably as a result of different methods of collection and 
assay, the general pattern is fairly consistent. IgA has been identified 
in all secretions and is the principal globulin type in tears (Mach and 
Pahud 1971, Butler et al 1972, Pedersen and Nansen 1972), nasal fluid 
and saliva (Mach and Pahud 1971, Duncan et a1 1972) and intestinal 
secretions (Porter and Noakes 1970, Mach and Pahud 1971). IgG1 is com-
monly found in secretions and, in addition to its predominance in milk, 
colostrum and serum, it occurs in approximately equal amounts with IgA 
in small intestinal and vaginal mucus, spermatic fluid, bile and urine 
(Mach and Pahud 1971, Duncan et a1 1972). Traces of IgG2 are found in 
most secretions as the minor component although Vaginal mucus, spermatic 
fluid, bile and colostrum contain appreciable amounts (Mach and Pahud 
1971, Duncan et al 1972). IgM attains its highest levels in serum 
(Butler 1973) but also occurs in tears (Pedersen and Nansen 1972) and 
nasal fluid (Duncan et al 1972) in levels intermediate to those of IgA 
and IgG1 as well as being a minor globulin of saliva, bile, milk and 
colostrum. Albumin has the highest concentration of any serum protein 
but only low levels have been recorded in tears, nasal fluid, saliva, 
milk and vaginal mucus (Butler et al 1972, Duncan et a1 1972). Having 
the highest molecular weight of the serum proteins, the molecule is least 
likely to attain the secretions by diffusion and the serum:secretion 
ratio for albumin has been used as an index of serum protein transudation 
(Duncan 1971). 
Immunoglobulins occur in secretions sa a result of Simple transud-
ation or selective transfer from serum, of local synthesis and release 
from superficial sites or by a combination of these. The overspill of 
serum protein has been studied in man using passively transferred, radio-
actively labelled globulin of various classes and, in general, such studies 
indicate that very little 19A is derived from the blood by transudation 
and only up to half the IgG content of secretions is derived in this way 
(Tomasi et a1 1965 ;-But1er et al 1961, Rossen 1971). Studies with 19A 
have not been made in cattle but similar experiments with laGl and 19G2 
indicated some selectivit.y in the transport of IgGl in the gut, respira-
tory system (Curtain 1911), and eye (Sullivan et al 1969, Pedersen and 
Nansen 1912) and a highly developed system of selective transport in the 
mammary gland (Dixon et al 1961, Murpby et al 1964). Sullivan et al 
(1969) sampled the serum and seoretions of a calf before suckling and 
showed them to be devoid of globulin. _ IgGl was detected in serum, teaaa 
and saliva 24 hours after the ingestion of colostrum suggesting the serum 
origin of secretory globulin. In contrast Provost (1910) was unable to 
demonstrate rinderpest antibody in the nasal secretion of calves born of 
immune dams although colostrum-derived serum antibody was plentiful. 
However, unusual membrane permeability is a feature of the neonatal calf 
and additional confirmation of these effects is required. The vast 
majority of 19G1 in all secr~tions other than milk and c910strum is 
thought to be locally synthesised (Curtain et al 1911, Maoh and Pahud 
1911). 
Looal synthesis has been investigated in two ways. Firstly: 
immunohistochemical examination of human tissues using antisera speoifio 
for each class if Ig has usually shown that the majority of plasma cells 
in the lamina propria of the gut, the nasal and bronchial submucosa and 
the interstitial spaces of the salivary gland contain 19A while only a 
minori ty contain IgG or IgM (Brand tzaeg 1968, Tourville et a1 1969a etc.). 
A similar situation obtains in the bovine gut (Vaerman 1910, Yurchak et a1 
1911, Porter et al 1912, 1913). Secondly: the syn.:t;hesis of specific 
Ig types has been studied in vitro using explanted tissues nourished with 
media containing radioactive amino acids. In man, radioactively label-
led IgA was produced by gastro intestinal tissue and by parotid and 
mammary gland. A little labelled 19G1 was sometimes detected but no 
labelling of IgM occurred (Tomasi et al 1965, Rossen et al 1911 etc.). 
In cattle, IgA was the principal immunoglobulin synthesised by the ileum, 
duodenum, colon, lungs, nassl mucosa, oral pharynx and the parotid and 
lachrymal glands (Porter and Noakes 1910, Butler et al 1911, Mach and 
Pahud 1911, Hurliman and Darling 1911). Butler and colleagues (1973) 
confirmed these findings and, in extending them, drew attention to the 
fact that tissues in close anatomical. proximity may synthesise different 
types and amounts of globulin. For example, they scored the production 
of IgA, IgGl' IgG2 and IgM on autorad1ographic intensity as 2, 2, 2 and 
1 in upper nasal mucosa and as 3, 1, 1 and 1 in lower nasal mucosa. 
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Quantitative studies on bovine secretor,y globulins have demonstrated 
wide fluctuations in values between animals, between samples in a 12 
weekly series, before and after calving and even between quarters of the 
mammar,y gland (Butler et al 1972a, Duncan et al 1972). Breed bas been 
considered as a source of differences (Butler et al 1972a). Disease 
can also alter membrane permeability and, in consequence, the distrib-
ution of Ig. Thus in mastitis IgG2' present only in trace amounts in 
normal milk, may achieve levels equal to those of the principal globulin 
type, IgGl (Butler et al 1972a). Similarly, albumin may attain the 
secretions during inflammatory processes (Butler et al 1970, Dunoan et al 
1972). 
The existence of a more or less distinct immunological system in 
external secretions has therefore been adduced from a number of inter-
related observations I 1. the distribution of Ig types varies widely 
and, in most instances, independently in serum and secretions. 2. IgA 
accounts for 60 - 100% of the Ig content of most external secretions but 
only 10 - 20% of the serum !g. 3. IgA exists as different molecular 
species in serum (7s) and in secretions (lIs). 4. Except in the case 
of lacteal secretion, plasma Ig contributes little to the protein content 
of external fluids. 5. The plasma cell population of superficial 
situations chiefly secretes IgA. 6. There is often a dissociation 
between the levels and class of antibody in serum and secretions following 
infection or immunisation. 7. Resistance to certain infections may be 
better correlated with secretory rather than humoral antibody. 
Elucidation of the secretory immune system gave fresh impetus to 
investigations of pathogenesis and protection. Local immunity might 
be expeoted to exert its greatest influence against those diseases which 
are initiated in or which confine their effects to superficial sites in 
the host. It is not surprising therefore that much attention has been 
paid to its role in viral conditions of the respiratory and alimentary 
tracts. Work in the human has oentred on polio (reviewed by Ogra and 
Karzon 1971) and influenza (reviewed by Mills et al 1970 and Rossen et al 
1971), but many diseases have been investigated including those caused 
by parainfluenza virus (Artenstein et al 1964, Smith et a1 1966, 1967, 
Tremonti et al 1968), rhinovirus (Perkins et &1 1969& and b, Cate et al 
1966, Douglas et &1 1967, Butler et al 1970), respiratory syncytial virus 
(Anderson et &1 1962, Kim et a1 1969, Scott et al 1970), adenovirus 
(Artenstein at al 1964, Bel1antini et a1 1969, Chanock 1970), echovirus 
(Artenstein et al 1964, Ogra 1970), coxsackievirus (Rossen et a1 1965, 
Be11antini et a1 1965), measles (Bel1antini et a1 1969), rabies ;. 
(Sirisinha and Charaputana 1970), rubella (Ogra 1971, Craddock et &1 1973). 
and herpes (Centifanto et a1 1973) viruses. 
In the veterinary field, aspects of local immunity have been studied 
(66) 
in respect of influenza in horses (Rouse 1971, Rouse and Ditchfie1d 1970a, 
b and 0, Fontaine 1972) and in ferrets (Potter et a1 1972, Shore et a1 
1972), parainfluenza in calves (Boge1 and Liebelt 1963, 1964, Gutenkunst 
et a1 1969, Gates et a1 1970, Morein 1970, 1972, Provost 1970, Marshall 
and Frank 1971, Frank and Marshall 1971, McKercher et a1 1972, 1973, 
Bernhardt and Bengelsdorff 1973), infectious bovine rhinotracheitis in 
cattle (Provost 1970, MCKercher and Cr~shaw 1971, Todd et a1 1971, 1972), 
rinderpest and mucosal disea~e in cattle (Provost 1970, Provost and 
Borredon 1972) and FMD in cattle (Hyslop 1965a, Scott 1966, Kaaden and 
Matthaeus 1970, Hedger 1970, Sutmo1ler 1970, Burrows et al 1971, Figueroa 
et al 1973) and in pigs (Wittman 1972). 
Studies divide into those concerning infection and those concerning 
immunisation while further subdivisions are possible according to the 
use of inactivated or attenuated vacoines and the use of parenteral or 
topical routes. Secretory antibody usually appears in external secret-
ions, as it does in serum, following infection with all the viruses 
listed above. Exceptions are known e.g. 7 children exposed to para-
influenza or respiratory syncytial virus showed a rise in nasal antibody 
but an equal number showed a fall' and in 3 the level remained unchanged 
(Kim et al 1969). Nasal secretion, saliva and tears have been moat 
commonly examined and specific neutralis~ activity has been shown to 
reside principally in the 19A fraction after infection of man with 
influenza, coxsackie (Butler et a1 1970), parainfluenza (Smith et a1 1967), 
rhino (Rossen et al 1966) and polio (Ogra et al 1968) viruses. Sputum 
(Mann et a1 1968, Waldman et a1 1970a and b, 1972b) and broncho-alveolar 
lavage fluid (Waldman et al 1973) showed a similar pattern after exposure 
to influenza virus. Gaotrointestinal secretions also develop neutral-
ising antibody of the 19A class after polio (Ogra and Karzon 1969a and b) 
and coxsackie virus infection (Ogra 1970). In studies with measles 
(Bellatini et al 1969) and polio (Ogra et a1 1968) an leGl component has 
also been detected. Less classification of globulins has been under-
taken in animals but cattle infected with parainfluenza (Morein 1970, 
1972) or FMD (Kaaden and Matthaeus 1970) develop specific neutralising 
antibody in nasal and saliv8r,1 secretions which is almost exclusively 
19A. Provost (1970) however, found nasal antibody of both IgA and 
IgM classes in calves following rinderpest infeotion. 
Little is known of the temporal development of the secretory anti-
body response. Antibody may be measurable within a few days of infect-
ion with polio (Ogra and Karzon 1971) but several workers have shown that, 
despite an immediate and lasting rise in the 19A concentration of nasal 
secretions, neutralising antibody may only develop 10 - 14 days after 
exposure to respiratory viruses (Alford et al 1967, Rossen et al 1971). 
Wide variations are also reported in the duration of the response. " 
Values of 16 days (Rossen et a1 1965) have been reported in human nasal 
secretion after infeotion with coxsackie type A2l virus, 3 weeks (Alford 
et al 1967) or up to 6 months (Kasel'et al 1969, Waldman et al 1969) 
after influenza, up to 2 months after rhinovirus (Perkins et al 196~ 
and 2 years or 15 years after polio (Ogra and Karzan 1968, 1971). These 
variations probably stem from different methods of collection and assay 
together with the difficulty of precluding reexposure to these agents. 
Few observations have been reported for cattle. Morein (1970) 
detected neutralising activity in the nasal secretion of calves naturally 
infected with parainfluenza type} virus. Neutralisation was demonst-
rated shortly after infection, persisted for at least 2 months and was 
contained in the 19A fraction. Marshall and Frank (1971) also detected 
neutralising activity in nasal seoretions and serum from? calves at 
maximal levels within 6 days of infeotion with an aerosol containing 
108•5 T.eolono 50 of parainfluenza type 3 virus. Serum and secretory 
'antibody levels were followed over a 17 week period. In one calf neither 
(68) 
class of antibody declined wHile in the other calf serum antibody remained 
high but nasal antibody showed a gradual fall. The secretory response 
was dependent upon dose, since a third calf exposed to 103•5 T.e.r.D. 50 
showed only a very slight, transient rise in nasal antibody and also on 
route of administration, since much less secretory antibody was produced 
when the intramuscular route was used. Repeated aerosol exposure also 
gave rise to increased humoral and secretory antibody. 
Hyslop (1965a) showed that the oral saliva of normal steers posses-
sed only slight, non specific antiviral activity whereas saliva collected 
4 weeks after infection with FUn contained specific neutralising activity. 
Sutmoller et a1 (196~ 1970)and Figueroa et a1 (1973) also found that 
type specific neutralising activity developed in the secretions of 
convalescent cattle, sheep and goats. The reports provide few details 
but the activity was said to reach a peak 14 - 21 days post exposure to 
FMDV with parallel titres in pharyngeal, saliva and nasal secretions and 
uniformly higher levels in the latter. The effect was confirmed for 
pharyngeal fluid by Kaaden et al (1970) and Kaaden and Matthaeus (1970) 
went on to show by immunoelectrophoresis, dissociation and ultracentri-
fugation studies that the neutralising activity of 4 - 6 week convales-
cent bovine saliva was associated with a protein analogous to human 
secretory 19A. 
Several workers have examined the relationship between antibo~ 
levels in secretions and recovery from or resistance to infection. Good 
correlation has been demonstrated .in studies on rhinovirus (Cate et al 
1966), parainfluenza virus (Smith e~ al 1966), influenza virus (Waldman 
et al 1969) and polio virus (Ogra and Karzon 1969a). Immunity was 
measured by an assessment of clinical disease and/or by the quantitation 
of viral multiplication and excretion after exposure and could be more 
closely related to the levels of seoretory rather than serum antibody. 
It must be emphasised that the data admit of possible correlation rather 
than proof. In other infections, such as those due adeno (Scott et al 
1969), herpes (Centifanto et al 1970), rubella (Cradock-Watson et al 1973) 
and respiratory syncytial virus (Mills et al 1970) little or no correl-
ation has been found between immunity and secretory antibody. Further-
more, while some persons suffering from selective IgA deficiency also 
suffer recurrent but usually mild infections, particularly of the respir-
atory tract (South et al 1965, Bel1antini et a1 1969), others may remain 
heal thy (Tomasi and Bienenstock 196,8 t Heremans 1970). 
Studies with attenuated viral vaccines produced results whioh closely 
resemble those found following natural infection, provided that the agent 
was applied topically, i.e. by aerosol or intranasal instillation. 
Parenteral vaccination usually stimulates a satisfactory humoral response 
but often elicits a very poor secretory response. Results of this type 
were obtained following vaccination with modified live virus vaccines 
against measles (Bellantini et al 1969) and influenza (Fazekas de St Groth 
1950) viruses in man. Similar results were observed in cattle using 
attenuated viral vaccines of parainfluenza type 3 (Bogel and Liebelt 1963, 
1964, Gutenkunst et al 1969, Gates et al 1970, Morein 1970, 1972, Frank 
and Marshall 1971, Marshall and Frank 1971, McKercher et al 1972, and 
Todd 1971), infectiOUS bovine rhinotrachetis and bovine virus diarrhoea 
(Todd et al 1971, 1972). The reciprooal situation in which vaccination 
by the respiratory route gives rise to both secretory and serum antibody 
whereas parenteral vaccination produces'only serum antibody, was also 
observed in many of the cattle experiments. Yet another response has 
been reported in man following infection with parainfluenza type 1 (Smith 
et al 1967) and influenza (Mann et al 1968) viruses when antibody 
developed in secretions but not in serum. 
An interesting feature of the seoretory immune system was noted by 
Ogra and Karzon (1969b) who showed that the IgA response to poliovirus 
could be strictly localised. Implantation of modified poliovirus in 
different areas of the surgically isolated gut resulted in antibody 
formation only in the area of infeotion and in the serum but not in other 
regions of the intestine or pharynx. Coproantibody was exolusively IgA 
while serum antibody was of the IgM and IgG classes. Conversley, 
Douglas et al (1967) found rhinovirus only in the nasopharynx during 
infection but antibody levels rose in serum, saliva and tears as well as 
in nasal secretions. Duncan et al (197~ reoorded a similar finding 
in cattle following infection by intravaginal or intramusoular infection 
with v. foetus when serum, vaginal and nasal antibo~ achieved high levels 
but lachrymal or salivary levels were very low and variable. 
Attempts to stimulate seoretory immunity using inactivated viral 
vaccines have underlined the oritical effect of dose rate and route as 
mentioned above and have generally produced less consistent results than 
I 
attenuated virus (see reviews by Mills et al 1970 and Todd 1973). Human 
trials with dead influenza vaccines have compared the intranasal and 
subcutaneous or: intramuscular routes. All three ga:le comparable serum 
antibody titres but appreciable levels of nasal or sputum antibody tended 
to develop more often, to higher titre and to persist longer after intra-
nasal administration (Smith et al 1966, Waldman et al 1968, 1969, 1973" 
Alford 1969, Fulk et al 1969, Downie 1970, 1973). Failure to produce 
nasal antibody was often associated with failure to protect against chal-
lenge. In one study similar low levels of antibody were detected in 
saliva after live intranasal or dead subcutaneous influenza vaccination 
(Mann et al 1968) but in most reports live attenuated preparations almost 
alw~s elicited a greater secretory response. Virus serotype may 
influence the response since Kasel et al (1969) recorded that influenza 
A stimulated much more secretory antibody than influenza B when inactivated 
preparatiOns were given intranasally. 
(71) 
Killed rhinovirus vaccine stimulated both nasal and serum antibody 
~ 
formation after intranasal administration (Perkins et al 1969). Fulk 
and colleagues (quoted by Mills 1970) showed that inactivated para-
influenza type , virus stimulated nasal antibody in some persons after 
instillation in the nose. Chanock et al (1967) reported that parenteral 
immunisation with inactivated parainfluenza type 1 virus induced detect-
able levels of nasal antibo~ in only 12% of those vaccinated, as opposed 
to 83% of men infected intranasally with the virus. Similar results 
were quoted by Smith et al (1966). Ogra and co-workers (1968, 1969b) 
compared the effects of poliovirus infection and inactivated vaccination. 
Infection gave rise to antibody in serum and nasal secretions lasting 
for at least a year while intranasal vaccination produced only nasal 
antibody persisting for 2 - 3 months. Parenteral immunisation gave rise 
to serum antibody but no nasal or duodenal antibody was detected. 
Subcutaneous administration of formalin inactivated parainfluenza 
type, virus in cattle failed to eliCit nasal antibo~ after a single 
. 
injection but did evoke such antibody after a second injection given 2 
- , weeks later. (MOrein 1910, 1912). Using the same virus, comparisons 
have also been made between dead vaccine administered as an aerosol and 
live vaccine given as an aerosol or parenterally. Serum antibody 
developed following attenuated vaccine regardless of the route of admin-
istration but nasal antibody was much more consistent and longer lasting 
after intranasal vaccination. The low titre of nasal antibody detected 
in some calves after live parenteral vaccination could be correlated with 
the titre concurrently present in serum. Low serum antibody levels 
developed after a single aerosol exposure to inactivated vaccine but 
nasal antibody was not detected. Calves reexposed in a similar manner 
1 weeks later showed marked increases in serum antibody and developed 
low levels of nasal antibody (Frank and Marshall 1911, 1~sha1l and Frank 
1971). 
In preliminar.y experiments mlD antibodtes have not been detected in 
nasal secretion or saliva after a single application of inactivated 
antigen by the intranasal route in pigs (Wittman 1972) or cattle (Figueroa 
et al 1973). Hyslop (1965a) found low levels of antiviral activity, 
probably due to antibody, in the saliva of steers following subcutaneous 
immunisation with inactivated vaccine but Figueroa et al (1973) were 
unable to confirm this finding in calves. 
Recent investigations of secretor,y immunity have concentrated on 
the IgA system almost to the exclusion of other factors. However, other 
mechanisms are at work. Interferon has been found in external secret-
ions during the course of several viral infections of man (Cate et al 
1969) and animals (Todd 1971, 1972, Rosenquist 197~) and Cell Mediated 
immunity has also been demonstrated in the secretions of the respiratory 
tract (Henney and Waldman 1970, et al 1972, Ruben 1913, Wetherbee 1973). 
These factors have both been associated with recovery from primary viral 
i 
infection and it is possible that other mechanisms, as yet unidentified, 
may also contribute to immunity at the external surfaces of the host. 
6. MATERIALS AND METHODS 
6.1. Tissue Culture 
6.1.1. Primar,r Cultures: Calf Thyroid (CTY) (Snowdon 1966) and Calf 
Kidney (CK) (Sellers et al 1968a) cells were prepared by trypsinisation 
of minced thyroid gland or kidney cortex freshly obtained from looal 
abattoirs. CTY oells were gr~ in equal parts of Eagle's medium and 
Hank's saline - yeast extract (0.01%) - lactalbumin hydrolysate (0.5%) 
medium (LYH) with 10% bovine serum and antibiotics. CK cells were 
grown in LYH medium with lQ% ox serum and antibiotics. Cells were re-
suspended at a rate of 5.0 x 105 viable oells per ml and 1.0 or 2.0 ml 
volumes were dispensed into rubber stoppered 153 mm x 16 mm glass 
tubes. In the oase of CK oells, Roux flasks were also seeded with 
100 ml of oell suspension. Monolayers became confluent after 5 - 1 
days incubation in sloped, static racks at 37°C. 
CTY cultures were used for the assay of FMDV in samples from 
oattle. CK tube cultures were used for the assay of interferon and CK 
Roux oultures for the production of standard IF preparations. 
6.1.2. Continuous Cultures. Baby Hamster Kidney, strain 21, clone 13 
cells (BBK) originated by Macpherson and Stoker (1962) were grown in 
Eagle's medium with l~~ tryptose phosphate broth, 10,% bovine serum and 
antibiotios. Cultures were seeded in Roux flasks (100 ml), 20 oz. 
medical flats (80 ml) or 6 cm glass or plastic petri dishes (5 ml) at a 
conoentration of 5.0 x 105 viable cells per ml and incubated at 37°C 
until confluent 24 - 48 hours later. Petri dishes were held in gassed 
incubators supplied with air containing 5% carbon dioxide. 
The IB-RS-2 oell line, a oontinuous pig kidney cell oulture 
originated by De Castro (1964), was grown in LYH medium with 10% bovine 
serum and antibiotics as descrtbed for BHK cells. 
BHK and IB-RS-2 cultures were used in the production and assay of 
stock and concentrated FMD viruses. IB-RS-2 cultures were also used 
as an assay system in studies on the kinetics of virus inactivation. 
6.1.~. Media: All media were supplied by the Tissue Culture Production 
Department of this Institute whichr~lso provided CTY cell suspension and 
BHK monolayers. Media contained Phenol Red (0.001%) as ~ pH indicator 
and antibiotics were routinely incorporated to a final concentration of: 
penicillin, neomycin and polymixin Beach 100 units/ml, mycostatin 50 
units/ml and streptomycin 400 fg/ml. 
Cell monolayers were washed with 0.01% phosphate buffered saline 
free of calcium and magnesium ions p~ior to harvesting by means of a 
I 
versene (0.01%) - trypsin (0.02%) solution. 
6.2. Animals, (Breed, Management and Infeotion) 
Mice, guinea pigs and rabbits were obtained from the breeding oolony 
of this Institute. Cattle and pigs were supplied by a dealer. 
6.2.1. Mioe: suokling mioe of the albino 'P' (Parkes) strain were kept 
as randomised litters of 10 with one or two lactating females in tins 
with sawdust litter and woodwool bedding. Pelle ted diet was fed from 
hoppers and water was provided ad libitum. Mice were used in virus 
neutralisation studies. 
6.2.2. Guinea pigs: groups of adult guinea pigs of the albino Hartley 
Dunkin stratI1 weighing at least 500 g were kept in cages and fed on 
pelleted diet with cabbage and grass in season and water ad libitum. 
They were used as a source of anti bovine globulin serum. 
6.2.3. Rabbits: Adult rabbits of the New Zealand White or Dutch Half 
Lop breed were kept singly in cages on pelle ted diet with water ad 
libitum, hay and green food in season. Rabbits were employed in the 
production of anti bovine globulin serum. 
Pigs: Large White crossbred pigs weighing 20 - 30 Kg were housed 
in disease secure isolation units and fed on a proprietary balanced meal 
with water freely available. Pigs were infected with FMDV by inoculat-
ion to provide challenge virus for cattle. 
Cattle: Steers of the Devon breed, 12 - 18 months old and 
weighing approximately 400 Kg, were supplied from the south west of 
England. The breed has been used at this Institute as the standard 
bovine animal for FMD research and the management and accommodation has 
been described by Henderson (1952) and Barr (1965). Up to 3 animals 
were housed in each loose box (3.65 m x 3.35 m x 3.05 m) in disease 
secure isolation units from which air was extracted through high effic-
iency filters. The dai17 ration included 4 lb mixed bran, rolled oats 
and concentrated cake together with 2 lb of concentrates fed in the 
morning and 8 lb of long hay fed in the afternoon. Alternatively 6 lb 
of lucerne cobs were given twice daily. Water was available ad libitum. 
Boxes were cleaned out daily. 
6.2.6. Infection of animals with foot and mouth disease virus: 
a) Infection of donor pigs: pigs were infected by the intradermal 
inoculation of stock FMDV into the bulbs of the heels of both fore feet. 
Eight sites were used, two on each claw, and animals received a total 
of approximately 105•0 p.f.u. ol virus as measured in IB-RS-2 cells. 
Pigs usually developed primary lesions within 24 hours of inoculation 
and generalised disease ensued within 72 hours. 
b) Infection of cattle: Cattle were infected by direct or indirect 
contact with FtIDV excreted by donor pigs. Exposure was mainly confined 
to the period 48 - 58 hours after inoculation when donors were developing 
generalised disease and viral excretion is known to be at a high level. 
Direct contact was achieved by introducing 2 donor pigs into a loose box 
containing 2 or 3 cattle and housing the animals together for 2 hours. 
Indirect contact was achieved by holding groups of 3 steers for one hour 
in a loose box immediately after it had been vacated by 6 infected pigs. 
The amount of virus in the box was replenished by returning the donor 
pigs to it for one hour before the infection of the next group of cattle. 
In one experiment only (Section 7.5.2.) cattle were infected by the 
intradermal inoculation of FMDV into the dorsum of the tongue. 
c) Infection of mice: suckling mice were inoculated with 0.03 ml of 
virus dilution by the intraperitoneal route (Skinner 1951). 
6.3. Viruses 
6.3.1. Foot and Mouth Disease Virus 
6.3.1.1. Identity and Histor,y of FMD strains 
Type Subtype Strain Origin Passage History at A.V.R.I.* 
0 1 Swiss 1/66 Swiss field sample C1 P6 C1 1966 
0 1 BFS 1860 British field sample 
°2 1967 
A 12 119 British field sample 
°27 BHKl 01 1932 
0 Noville Swiss field sample C3 1966 
* Passage history: passage in cattle (C), pigs (p) or baby hamSter 
kidney cells (BHK). 
The identity of all stock viruses and of a random sample of virus 
isolates from cattle was checked in complement fixation tests performed 
by the World Reference Laboratory at this Institute. 
Production of FMDV 
a) Production in animals: Stock virus was produced in cattle by 
multiple intradermal inoculation of the tongue. Vesicular epithelium 
was harvested 24 - 48 hours later. After mincing and grinding with sand 
in a pestle and mortar the epithelium was suspended in equal parts 0.04% 
phosphate buffer/Hartley's digest broth and filtered. An equal volume 
of sterile glycerol was added to the filtrate to give a final dilution 
of epithelium of 1:20 and the suspension was stored at _20oC. This 
stock was used for the infection of donor pigs and for tissue culture 
passage. 
b) Production in tissue culture (Mowat and Chapman 1962, De Castro 
1964): glycerinated seitz filtrates of bovine tongue vesicle epithelium 
were used to initiate tissue culture passage series in BHK or IB-RS-2 
cells. Confluent mono layers in Roux flasks or 20 oz medical flats were 
washed with phosphate buffered saline (PBS, Dulbecco and Vogt 1954) at 
37°C and 1.0 ml of a 1:100 dilution of stock virus was inoculated. 
After 30 minutes adsorption at 370 C the cultures were again washed with 
buffer and 60 - 100 ml. of serum free maintenance medium was added. 
Infected mono layers were incubated at 37° C until 90 - 100% cytopathic 
effect (CPE) was observed at which time the culture field was harvested, 
centrifuged at 3000 rpm for 10 minutes and the supernatant collected. 
Viruses were adapted for growth in monolayer by up to 15 serial passages. 
Conditions of maximum virus yield were determined in growth curve exper-
iments using fully adapted virus at multiplicities of 0.1 - 0.01 and 
virus produced under optimal oonditions was filtered, glycerinafed and 
(78) 
o 
stored at -20 C. This virus was used in mouse neutralisation tests and 
for the infection of monolayers in the production of concentrated virus. 
Concentration of FMDV 
a) Salt precipitation (Brown and Cartwright 1963). Tissue culture 
virus harvests were clarified at 3000 rpm for 10 minutes and then mixed 
with an equal volume of saturated amonium sulphate at pH 7.4. After 
o 
at least 1 hour at 4 C, the precipitate was collected by spinning at 
2500 rpm for 30 minutes in a refrigerate. centrifuge and resuspended in 
a reduced volume of PBS to give a physical concentration factor of x50 
to xlOO. On occasions the suspension was further clarified by centri-
fugation at 10,000 rpm for 30 minutes. 
b) Single phase polymer concentration (Fayet 1969, Wagner et al 1970). 
The method of concentration was essentially as described for salt pre-
cipitation except that ammonium sulphate was replaced by an aqueous 
solution of autoclaved polyethylene glycol (~olecular weight 6,000) 
which was added to the clarified virus harvest to a final concentration 
(w/v) of 6%. Precipitation was allowed to proceed for a minimum of 
2 hours and on occasion a second precipitation was carried out. 
c) Ultracentrifugation (Brown and Cartwright 1963). Virus concentrated 
by salt or polymer precipitation was clarified by spinning at 10,000 rpm 
for 30 minutes and then further purified and concentrated by ultracentri-
fugation at 25,000 rpm for 3i hours at 4°C. The pellet was allowed to 
o 
soften overnight at 4 C under a small volume of PBS before being resus-
pended in a reduced amount of buffer. 
Concentrated virus was stored in 1.0 ml volumes in bijoux bottles 
at -700 C and sHrved as antigen in immunodiffusion and immunoelectro-
phoresis experiments. 
6.,.1.4. Assay of Virus Infectivity. 
a) Estimation of 50% End Points in Tissue Culture. Confluent CTY 
monolayers were washed with PBS at 370C and 0.2 ml volumes of tenfold 
dilutions of virus in PBS were inoculated using 2 .. or 4 tubes per dilution. 
After 30 minutes at 370C,2.0 m~ of serum free maintenance medium was 
added and the tubes were incubated at 37°C on a roller apparatus. 
Cultures were examined for CPE ~ low power light microscopy at 24 and 
48 hours post inoculation and 50% end points were calculated by the 
method of Reed and MUench (1938). 
This method was used to estimate the viral infectivity of samples 
from cattle and titres were expressed as log ID50 per ml of nasal secret-
ion, oral saliva, pharyngeal fluid, urine and serum per g of faeces or 
per sample in the case of tears or preputial swabs. 
b) Plaque Assay (Dulbecco 1952, Sellers and Stewart 1969). Confluent 
BBK or IB-RS-2 mono layers in petri dishes were infected by the method 
described for CTY tubes using 2 or 3 plates per dilution. After 60 
minutes adsorption the infected mono layers were overlaid with 5.0 ml of 
Eagle's (BHK) or LYH (IB-RS-2) medium containing l.o-fo (w/v) nutrient agar 
(Difco Bacto) and antibiotics. After 48 hours incubation at 370C the 
monolayers were stained with a 1:10,000 dilution of neutral red in PBS 
or with methylene blue solution and the plaques counted. Results were 
expressed as plaque forming units (p.f.u.) per ml of inoculum. 
The method was used in titrations of stock virus infectivity (BHK) 
and in studies on the kinetics of virus inactivation by various anti-
viral factors (IB-RS-2). 
(eo) 
c) Estimation of 50% End Points in Mice. This method was used in 
virus neutralisation studies and is detailed under section 6.6.2. 
Storage of Virus. 
Glycerinated stocks of vesicular epithelium or tissue culture virus 
o 
were stored at -20 C. Concentrated virus stocks were held at -100 C. 
Samples from cattle were stored at 4°C for up to 48 hours after collect-
ion or at -10°C for longer periods until assayed for infectivity. 
6.3.2. Vesicular Stomatitis Virus. 
The Indiana C strain of vesicular stomatitis virus (VSV) was used 
at the 15th BHK passage level as challenge virus in interferon assays 
and as an inducer in the production of reference stocks of IF. (see 
section 6.5.). Bottles containing VSV were wrapped in silver foil to 
protect the light sensitive virus. 
_20°C in 50.% sterile glycerol. 
Tissue culture virus was stored at 
6.4. Foot and Mouth Disease Vaccine 
Inactivated FMD vaccine was kindly supplied by Burroughs Wel1come 
and Company. The vaccine was prepared from virus of type C (strain 
Novi11e) by the standard production method whereby virus is grown in BHK 
cell suspension cultures, filtered, inactivated with acetylethyleneimine 
and ~~onin is incorporated as an adjuvant. The vaccine contained more 
than six 5~/o Cattle Protective Doses per 2.0 ml dose and was administered 
by subcutaneous injection. 
6.5. Interferon 
(81) 
Interferon Assay 
Samples from cattle were assayed for interferon (IF) by measuring 
their capacity to inhibit CPE in CK tube cultures (Sellers and Fitzpatrick 
1962, Sellers et a1 1968b and c). 
Each 4.0 m1 volume of bovine ~sa1 secretion or dia1ysed pharyngeal 
fluid was acidified to pH 2.0 by the addition of approximately 0.3 m1 
of Nil hydrochloric acid (HCl) in order to inactivate any FMDV in the 
sample. After 24 hours at 4oC:the pH was readjusted by the addition of 
an equivalent amount of Nil sodium hydroxide (NaOH) and final adjustments 
were made to bring the pH of the sample within the range 7.4 - 7.6 by 
the addition of NI10 HCl or iaOH. 
A rive fold dilution series of each sample was prepared in LYE 
medium with antibiotics to cover the range 1:1 to 1:625 and 0.5 m1 was 
inoculated into confluent CK cultures containing fresh growth medium with 
2% heat inactivated bovine serum previously tested to show the absence of 
IF. Three tubes were inoculated for each dilution. After 24 hours 
o . 
rotation at 31 C, 0.2 ml of LYH containing approximately 100 CK TCID50 
of vesicular stomatitis virus (VSV) was added and the cultures were again 
rolled at 37°C. 
Controls included: a) A ~itration of challenge virus, b) a chal-
lenge virus control in which tne sample was replaced by 0.5 ml of growth 
medium, c) a control on sample tOXicity in which the undiluted sample 
was included and the virus was replaced by 0.2 ml of medium, d) a con~ro1 
on the efficiency and reproductibility of the system in which a standard 
preparation of CK interferon replaced the test samples. 
The cultures were examined microscopically and when control tubes 
(8~) 
showed maximum CPE (usually at 24 hours) the degree of CPE was estimated 
in all tubes and the IF titre calculated as the final dilution of the 
sample that protected 50% of the cells. The calculation was made accord-
ing to the method of Reed and Muench (1938) and the titre was expressed 
as log units of IF in 0.5 ml of original sample. 
6.5.2. Production of Standard Interferon Preparation. 
A standard preparation of IF was produced from a 48 hour harvest of 
CK mono layers in Roux flasks infected with VSV by the method described 
for FUDV (see Section 6.3.1.2.). The infected tissue culture fluid 
was centrifuged at 3,000 rpm for 10 minutes and the supernatant acidified 
to pH 2.0 by the addition of Nil BCl. o After 24 hours at 4 C, the pH of 
the harvest was corrected to pH 7.6 by the addition of Nil NaOR. When 
the preparation had been satisfactorily tested for the presence of IF 
and the absence of VSV, it was stored at 4°C. 
Characterisation of Interferon. 
The standard IF preparation and some samples from cattle were part-
ially characterised by the demonstration of a) laok of direct effect on 
FMDV, b) marked loss of aotivity in non bovine assay systems, c) approx-
imately equal effeot on various types of FMDV and on VSV showing the non 
speoifio nature of the inhibition. 
6.6. Antibodies 
6.6.1. Convalescent Bovine Serum. 
6.6.1.1. Preparation of Convalescent Bovine Serum. 
Four steers developed fully generalised disease after infection with 
~JDV type 0, strain BFS 1860 by intradermolingual inoculation. One 
month post infection the jugular vein was catheterised and 5.0 - 6.0 
litres of blood were taken from each animal. Serum was obtained from 
clotted blood in the usual w~ and filtered through pads of a sterilising 
grade. The filtered serum was dialysed against running tap water for 
48 hours to precipitate the euglobulin fraction and the remaining serum 
proteins were precipitated by the addition of an equal volume of 66% 
saturated ammonium sulphate solution. The precipitates were collected 
by centrifugation at 2,500 rpm for 30 minutes at 4°p and resuspended in 
a reduced volume of normal saline. The supernatant was reconcentrated 
and the two precipitates combined in a volume which was about 50 times 
less than that of the original serum. The concentrate was dialysed 
against repeated changes of normal saline until sulphate ions were no 
longer detectable in the dialysate (Campbell et al 19qJ). The protein 
concentration was followed throughout the procedure by direct spectro-
photometry at 280 nm and 72 - 75% w~s retained i~ the final preparation. 
The mouse neutralisation index of the original material averaged 6.8 
and of the concentrate 7.8 per ml. Concentrated serum was stored at 
40C and used within 4 weeks of preparation. 
Concentrated antibo~ preparations were pooled and their 8lobulin 
type was investigated by immunoelectrophoresis, the patterns being devel-
oped with antiserum against bovine immunoglobulin and against concentrated 
homologous FMDV. Aotivity against FMD resided principally in the IgGl 
and IgG2 molecules with some activity in the IgM fraction. 
6.6.1.2. Passive Immunisation. 
Concentrated convalescent bovine serum to FMDV type 0, strain BFS 
1860 was administered to , steers by intravenous injection. Each 
received 200 ml of concentrate administered via a flutter valve. Blood 
samples and secretion samples were taken before immunisation, at 2 hourly 
intervals for 8 hours after immunisation, and then daily for 21 days. 
6.6.2. Measurement of Antibody to FMDV. 
Tho neutralising activity of antibody to lMDv in sera and secretions 
was measured by ~eans of neutralisation tests in mice using a constant 
dilution of serum or secretion and var.ying dilutions of virus (Skinner 
1953, et al 1952). 
Samples were routinely tested at the following dilution: serum 1:10, 
tears approximately 1:2, nasal secretion 1:1, dialysed saliva and 
pharyngeal fluid 1:1 or after concentration by a factor of 10 to 100. 
On occasions, these secretions were also examined at other dilutions and 
additional tests were carried out on lower respiratory and alimentar.y 
tract secretions at a dilution of 1~10 and on faecal suspension (1:10 
or x50) and urine (1:1 or xlOO). 
On the day of testing samples were diluted in PBS and heated at 5600 
for 30 minutes. They were then distributed in 0.25 ml volumes in 
bijoux bottles and an equal amount of the appropriate tenfold dilution 
of virus in PBS was added to each. Viral titrations diluted in an equal 
volume of PBS were also included and the specificity of the neutralisation 
was controlled by tasting samples against both homologous and heterologous 
types of FMDV. The reproductibility of the test was monitored by the 
inclusion of a standard homologous bovine antiserum. When all the re-
agents had been added the caps were replaced, the bottles thoroughly 
shaken and the neutralisation reaction allowed to proceed for 60 minutes 
o 
at 37 0 in a water bath. 
Residual viral infectivity was assayed in mice. Each sample was 
inoculated intraperitoneally in 5 - 7 day old mice using 5 or 10 mice 
per dilution. Litters were examined daily for 7 d~s and the number 
of mice paralysed or dead was recorded. ~ouse 50% infective doses were 
calculated by the method of Reed and Muench (1938) and the neutralisation 
index (NI) was given by the difference in infectivity between the virus 
control and the test sample. Results were expressed as Mouse Neutral-
isation Indices per 0.03 ml of sample at the dilution tested. 
Periodical~ the identity of virus in tissue suspensions f~om infect-
ed mice was checked by complement fixation. Within tests the standard 
error of the NI was 0.184 and the coefficient of variation was 3.640% 
(20 observations). Between tests the values were 0.228 and 6.58~ 
(20 observations). 
6.6.3. Preparation of Bovine Immunoglobulins. 
The immunoglobulins 19M, laG 1 ' 19G2 and secretory 19A were isolated 
and purified from bovine serum, colostrum and saliva by a combination of 
techniques as described by Sul1ivanet al 1969, Porter and Noakes 1970, 
l~ch and Pahud 1971, Porter 1971, Butler 1971, et a1 1972a, b and Ct 
Duncan et a1 1972. 
Colostrum was centrifuged at 2,500 rpm for 60 minutes and the fat 
layer removed with a spatula. Caseins were removed by lowering the pH 
o to 4.6 with 0.1 N HC1, incubating at 37 C for 30 minutes and spinning 
out the precipitate at 2,500 rpm for }O minutes. The pH of the super-
natant was readjusted to 7.4 by the addition of 0.1 N NaOH. 
Serum and colostral whey were dia~Bed against running tap water 
for 6 hours and against 3 daily changes ot distilled water at 40C to 
(86) 
precipitate the euglobulins. After dialysis the precipitate was collected 
by centrifugation as above and resuspended in PBS. The water soluble 
proteins in the supernat.ant were precipitated by the addition of 33% 
saturated ammonium sulphate solution (pH 7.4) at room temperature with 
continuous m1xing.~ After centrifugation the precipitate was resuspended 
in a reduced volume of PBS and dialysed against the same buffer until 
sUlphate ions were no longer detectable in the dialysate. 
Saliva was clarified by low speed centrifugation and the supernatant 
concentrated by positive pressure dialysis at 40 C. 
IgM was isolated from the euglobulin fraction of serum by collecting 
the leading edge of the first peak to emerge after exclusion chromate-
graphy on sephadex gels. The peak was concentrated and twice recycled 
on the same column. Contaminatingc.C 2 macroglobulin was separated by 
pevikon block electrophoresis and the resulting highly purified IgM was 
collected and concentrated. 
leGl was isolated from colostrum. Ai'ter defatting, decaseination 
and salt precipitation as described, the resuspended precipitate was 
dialysed against 2 changes of 0.1 M Tris - 0.05 M Saline buffer at 4°C. 
Once equilibriated the solution was fractionated by anion exchange 
chromatography using gradient elution. The second and largest peale was 
concentrated and applied to a G 200 sephadex column from which 3 peaks 
emerged. The third peak was collected, concentrated and twice recycled 
on G 200 gels to yield highly purified leGl " 
leG2 was isolated from serum. After dialysis, precipitation and 
equilibration as described for 19G1 the protein mixture was spearated by 
anion exchange chromatography on DEAE A50 cellulose. The first peak 
was collected, concentrated and recycled 04 ~ephadex G 200 to yield 
highly purified IgG2. 
Secretor,y 19A was obtained from concentrated saliva. The concen-
trate was equilibrated with the starting buffer for anion exchange and 
chromatographed on a DEAE A50 cellulose cloumn. Secretor,y IgA was 
obtained with a minor IgGl component and the two were separated by running 
the concentrated material through a sephadex G200 column which allowed 
the collection of highly purified secretory IgA. 
The identity and purity of separated immunoglobulins was assessed 
by their pattern of elution from chromatography columns, their electro-
phoretic mobility and precipitation pattern in immunoelectrophoresis 
using (i) polyvalent antisera directed against whole serum or secretions 
and (ii) monospecific antisera directed against particular globulin 
classes. Absolute purity of immunoglobulins is difficult to achieve 
even when ultracentrifugation or iao electric focussing is included in 
the method. The difficulty stems from a) the marked heterogeneity of 
globulin classes, particularly of bovine IgG and b) the existence of 
commom antigenio determinants in different globulin olasses. However, 
contaminating protein reactivity in antisera raised using these Ig pre-
parations could be removed or greatly reduced by reciprocal absorption 
with the appropriate protein as described in sections 6.6.4. and 6.6.5.6 •• 
Production of Antiserum to Bovine Immunoglobulins. 
Antisera to whole bovine serum, tears, nasal secretion, conoentrated 
saliva and purified and concentrated samples of IgM, IgGl and secretory 
IgA were produced in rabbits. A one m1 solution containing I to 5 mg 
of appropriate protein was emulsified in an equal volume of Freund's 
complete adjuvant and two 0.5 ml injections. were given at separate intra-
muscular sites each month for'at least three months. Prior to bleeding, 
(88) 
1 - 5 mg o~ the required protein was injected intravenously and serum 
was prepared from blood collected by cardiac puncture 10 days later. 
Some rabbits were rendered tolerant to IgG prior to immunisation with 
I~I and secretory 19A by the method of Spiegelberg and Weigle (1968j. 
Antiserum to bovine IgG2 was produced in guinea pigs by the method of 
Binaghi et a1 (1961). 
Many antisera showed unwanted cross reactivity in respect of pre-
cipitin formation in gels. Contaminating antibodies were removed or 
minimised by repeated reciprocal absorption with the appropriate hetero-
logous immunog1obulin,to produce monospecific antisera. Thus antisera 
to IgM, IgG2' and secretory 19A was absorbed with IgGl to remove anti 
light-chain reactivity and antisera to IgGl was absorbed with IgG2 (Mach 
and Pahud 191t, Downie 1970). The method of absorption is given in 
section 6.6.5.6. and the specificity of antisera is shown in Plates 5 -
8. 
6.6.5. Methods for the Isolation and Characterisation of Antibody. 
6.6.5.1. Gel filtration (Exclusion chromatograpQy). 
Sephadex G150 or G200 (Pharmacia, Uppsa1a, Sweden) was swollen in 
boiling water for 6 hours and the resultant gel was equilibrated in 5 
daily changes of 0.1M Tris - 0.2M NaCl buffer oontaining 0.02,% sodium 
azide at pH 1.6. Fines were oarefully decanted at each buffer change 
and the gel was poured in 100 cm x 2.5 cm glass columns. Final equilib-
ration was achieved by passing a further 1,000 ml of buffer through the 
column after which the flow characteristics and void volume of the column 
were determined by observing the elution of 3 ml of 0.1% blue dextran 
(mOlecular weight 2.0 x 106) in Tris - Saline buffer. Serum or secret-
ion samples containing 200 - 300 mg of protein were applied to the bottom 
of the column in amounts of up to 3~ of the bed volume and eluted in an 
ascending flow of Tria - saline buffer under a constant hydrostatic head 
adjusted to give a flow rate of 30 ml per hour at room temperature. 
Column effluent passed through a device which allowed automatic 
scanning and recording of ultraviolet light absorption at a wavelength 
of 280 nm.(Isco U - V Absorptiometer Model 4A, Flow Cell Type 4, Recorder 
Type BD7, Shandon Southern Ltd, Camberley, Surrey). Fractions of 2, 
5 or 10 ml were separated by means of a volumetric siphon and collected 
automatically (The Central Fraction Collector, Scientific Supplies Ltd., 
London). 
Anion Exchange Chromatography. 
The method employed was essentially that of Binaghi et al (1967). 
DEAE sephadex type A-50 (Pharmacia, Uppsala, Sweden) was equilibrated 
in 3 daily changes of 0.1M Tris - 0.05M NaCl buffer containing 0.02,% 
azide at pH 8.3 and the gel poured in 45 cm x 2.5 em glass columns. 
Samples of serum or secretion were dialysed to equilibrium with the start-
ing buffer and volumes of up to 3.0 ml were applied to the top of the 
column. Protein was eluted sequentially from the gel by the action of· 
a continuous gradient of increasing ionic strength rising from the start-
ing buffer containing 0.1M Tris and 0.05M NaCl to the final buffer con-
taining 0.1M Tris and 0.22M NaCl. All buffers were at pH 8.3 and con-
tained '0.021~ sodium azide. The gradient was produced using a reservoir 
made up of three cylinders connected in series via tubes at the base of 
each cylinder. The third reservoir which led to the column was stirred 
mechanically and contained 270 ml of starting buffer while the first and 
second reservoirs each contained 270 ml of final buffer. Buffer was 
allowed to run under gravity at an initial flow rate of 25 ml per hour 
at room temperature and fractions were monitored, recorded and collected 
automatically as described for gel filtration in section 6.6.5.1 •• 
Immunodiffusion. 
Double diffusion in agar gel was performed according to the method 
of Oughterlony (1958) with minor modifications. Ion agar number 2 
(OxOid) was dissolved by steaming in veronal buffer ionic strength O~l 
containing 0.1% sodium azide at pH 8.3 •• Ten ml amounts of 1.5% (w/v) 
agar were dispensed in 6 cm plastic petri dishes. Wells of 3 mm diameter 
set 3 mm apart were cut in the agar to a present pattern by means of a 
special punch and filled with 10 Fl of the appropriate antigen or anti-
body solution. Diffusion at room temperatures in a humified chamber 
was followed by the appearance of precipitin lines within 3 days. 
Immunoelectrophoresis. 
I 
Lucro immunoelectrophoresis was carried out according to Scheidegger 
(1955) with minor modifications using Shandon equipment. Glass slides, 
25 mm x 75 mm, held on a levelling table were coated with a 2 mm deep 
layer of 1.()P~ Ionagar No.2 (Oxoid) dissolved b.1 steaming in barbitone 
acetate buffer, ionic strength 0.05, pH 8.6.. Wells and troughs were 
cut in the agar to a preset pattern by means of a special tool. Wells 
were filled with 5 - 10 ?1 of test sample and the slides were arranged 
above the two chambers of an electrophoresis tank each of which contained 
500 ml of barbitone acetate buffer, 0.1M, pH 8.6. Filter paper wicks 
joined the ends of the slide to the buffer solution in each compartment. 
A constant potential difference of 6 vOlts/cm was applied to the slides 
for 2 hours. 
After electrophoresis the separated proteins were precipitated with 
anti globulin serum or concentrated FMDV which was allowed co diffuse 
from troughs running parallel to the direction of migration of the test 
sample. . Diffusion was at room temperature in a humidified chamber. 
Slides were examined daily for 5 days and the results were recorded by 
means of drawing or photography. 
6.6.5.5. Preparative electrophoresis. 
The method of Aalund (1968) was followed. Pevikon C-810 (polyvinyl 
acetate copolymer, Feinbiochemica, Heidelberg, West Germany) was cast in 
a bloek measuring 22 em x 25 cm x 1 cm in 0.125M barbital acetate buffer 
pH 8.6. Samples were prepared as a slurry in Pevikon and applied to a 
slot 1 em x 23 em running the width of the block at a point 5 cm from its 
cathodal side. Electrophoresis was carried out at room temperature for 
18 hours using a constant current of 45 milliamps in the equipment des-
cribed in section 6.6.5.4. Subsequently the block was sectioned at 1 
cm intervals across its width and the protein eluted in PBS. 
6.6.5.6. Absorption of antibody. 
Immunoglobulins were removed from samples by the addition of 2 vol-
umes of polyvalent or class specific antiglobulin serum followed by 
incubation at 4°C for 16 hours. Precipitates were removed by centri-
fugation at 25,000 rpm for 30 minutes. The degree of absorption was 
tested by immunodiffusion and immunoelectrophoresis and if necessary the 
process was repeated using small increments of antiglobulin serum until 
the specific precipitin could no longer be detected (Downie 1910). 
6.6.5.1. Dissociation of antibody. 
Dissociation experiments were performed by mixing equal volumes of 
immunoglobulin solution and 0.2M 2 - merca~toethanol in PBS at pH 1.4. 
Reduction of disulphide bonds was allowed to proceed for 18 hours at 4°C 
and the material was then alkylated by the addition of an equal amount 
of 0.211 iodoacetamide in PBS at the same pH (Fleischman et al 1962). 
Toxic residues were removed by overnight dialysis against PBS at 4°C. 
Control preparations were treated in an identical manner except that PBS 
was added in place of mercaptoethanol and iodoacetamide. The effect 
of dissociation was examined by neutralisation tests in mice. 
6.6.6. Methods of antibody concentration. 
Antibody in volumes of more than 1.0 L was generally concentrated 
by salt or polymer precipitation as described under sections 6.3.1.3. 
Smaller volumes, particularly column chromatography fractions, 
were concentrated by means of negative pressure dialysis (Sartorius 
membranfilter type SM 132, Gottingen, West Germany), positive pressure 
dialysis in stirred cells (Amicon, membrane types XM 50 and CM 50, High 
Wycombe, Bucks), centrifugal dialysis (Amicon, Cone type CF 50 A) or 
polyacrylamide gel absorption ('Lyphogelt, Gelman, Lancing, Sussex). 
6.6.7. Dissociation of FMDV antigen - antibody complexes. 
A modification of the method of fluorocarbon dissociation described 
by Brown and Cartwright (1960) was applied to recover viral infectivity 
from neutral mixtures of FMDV virus and antibody. One volume of tri-
chloro trifluoroethane (tArklone P', ICI Ltd., Runcorn, Cheshire) was 
mixed with one volume of antigen-antibody complex and the mixture blended 
together for 60 seconds at 16,000 rpm. The resultant emulsion was centri-
fuged at 3,000 rpm for 5 minutes and the upper phase containing the virus 
was aspirated. The procedure was repeated on four occasions and bovine 
plasma albumin was added to the final product to a concentration of 0.1%. 
t93) 
6.6.8. Kinetics of antibody neutralisation of FMDV. 
Tissue culture adapted strains of FMDV containing approximately 
106•5 pfu per ml were mixed with an equal volume (2.0 ml) of bovine serum 
(1:10), nasal secretion (1:1) or dialysed saliva (1:1 or xlO). Bio-
logical fluids had been derived at various times from normal and conval-
escent cattle and were heated at 560 C for 1 hour before testing. Mixtures 
were incubated at 37°C for up to 4 hours and 0.2 ml samples removed at 20 
minute intervals were immediately diluted tenfold in PBS containing 0.1% 
bovine plasma albumin (BPA). Loss of viral infectivity due to causes 
other than neutralisation were measured by the inclusion of a virus ti-
tration diluted in PBS containing 0.1% BPA. Residual infectivity was 
measured by the plaque technique in IB-RS-2 monolayers using 3 cultures 
per dilution and results were expressed as the percentage of the original 
virus surviving per Unit time. 
6.7. Bovine Secretions 
6.7.1. Methods of collection and processing. 
Ante mortem collection. 
a) Lachrymal secretion: tears were collected on cotton swabs held in the 
pocket formed by the everted lower eye lid using 10 swabs for each eye. 
On average 4.6 ml of secretion was obtained (range 3.2 - 8.5 ml) and after 
washing in 5.0 ml of PBS, the fluid was oolleoted by centrifugation at 
2,500 rpm for ten minutes. 
b) Nasal secretion: Absorbent cotton tampons were held in the nares by 
means of a muslin mask as shown in plate 1.· After 15 - 20 minutes tampons 
were removed and about 15 m1 of secretion"was harvested by plaoing the 
tampon in the barrel of a disposable 20 ml syringe and squeezing the 
fluid out in a special press incorporating a disposable bacteriological 
nS 
filter, designed and constructed for this purpose at this I;ttitute 
(Plate 2). 
c) Oral saliva: mixed saliva was collected from the floor of the mouth 
and the region between the teeth and the cheek by suction using a 20 ml 
disposable mucus extractor (SterilinILtd., Richmond, Surrey). Debris 
was removed by centrifugation at ;,000 rpm for 10 minutes and concentrat-
ion was achieved by positive pressure dialysis. 
d) Pharyngeal secretion: fluid was collected in 10 ml amounts by means 
of a cup probang passed through the mouth into the pharynx as described 
by Van Bekkum (1959) and Burrows (1966) or by a similar instrument modified 
by the attachment of a 'lid' to facilitate repeated passage through the 
fauces. Amounts of 100 ml were readily obtained by means of a special 
cup probang fitted with a metal tube; and a suction device designed and 
constru~ted for the purpose at this Institute. The three types of 
instrument are shown in plates ; and 4. Pharyngeal fluid was subsequently 
processed as described above for saliva. 
e) Faeces: faeces collected from the rectum were prepared as a 1:10 
suspension by mechanical shaking in PBS with double strength antibiotics 
and the supernatant was collected after spinning at ;,000 rpm for 20 
minutes. Some samples were clarified by centrifugation at 10,000 rpm 
for 30 minutes and filtered prior to concentration by polymer precipit-
ation as in section 6.;.1.;. 
f) Urine: samples obtained during urination were centrifuged at low 
speed and some were concentrated by polymer precipitation as above. 
PLATE 1. Collection of bovine nasal secretion. 
PLATE 2. Laboratory press for the recovery of nasal secretion 
from tampons. 
PLATE 3. 
Cup probang. . Original and ~odified ~er.ions . Overall length of wire 600 Centi~etres . 
(98 ) 
PLATE 4. Cup probang with suction device. 
g) Serum: blood obtained by jugular venupunctuxe was allowed to clot 
and the serum separated after centrifugation. 
6.7.1.2. Post Mortem Collection 
Post mortem secretions were obtained from cattle which had been bled 
out after the lethal intravenous injection of barbiturate solution • 
. . ., . 
a) Respiratory secretions: muous was obtained from the external surfaces 
of the trachea and major bronchi by gently running the blunt end of a 
scalpel handle over the mucosa and collecting the accumulated secretion 
under suction. Mucus was resuspended by vigorous pipetting in PBS at 
a dilution of 1:10. 
Broncho-alveolar washings were taken by introducing 500 ml of PBS 
into the right apical lobe of the lung via the stem bronchus. The ···'.t 
I 
bronchus was clamped off, the lobe gently massaged and the available 
washings poured out of the air passages. Only about 60% of the buffer 
was recoverable. Washings were centrifuged at 3,000 rpm for 15 minutes 
to remove cellular material. 
b) Alimentary secretions: -, the abomasum, small intestine, caecum and 
colon were inCised, emptied and washed under gently running tap water. 
Mucus was collected and processed as described above for respiratory 
secretions. 
Secretions were concentrated by the methods given under sections 
6.;.1.;., 6.6.; and 6.6.6 •• Samples were stored at _20oC or at _70oC 
when infectivity was to be preserved. 
Detection of Haemoglobin. 
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Secretion samples were examined for the presence of haemoglobin 
(as an indication of contamination with blood) by means of proprietary 
reagent strips ('Labstix', Ames Co., Stoke Poges, Bucks.). 
6.7.3. Measurement of pH 
The pH of secretions was measured by means of a portable pH meter 
with a combined glass microelectrode (Meter Type 300, Electrode Type 
9259/81, E.I.L. Ltd., Richmond, Surrey). The instrument was equipped 
with automatic temperature compensation and was accurate to within! U.l 
of a pH unit with discrimination to the level of 0.05 of a pH unit. 
j 
The pH was measured either directly in vivo (tears), immediately 
after collection (saliva, pharyngeal fluid, urine, faeces, blood) or 
immediately after processing (nasal secretion, serum). Thirty seconds 
was the maximum time elapsing between the collection of samples and the 
measurement of pH in all cases except serum where much longer periods 
elapsed. 
6.7.4. Investigation of antiviral factors in secretions. 
6.7.4.1. Interferon and Antibody. 
The methods employed have been described in sections 6.5. and 6.6 
respectively. 
pH and Other effects. 
a) Range of pH stability of b1IDV strains: buffers were prepared to cover 
the range 5.0 - 10.0 in steps of a quarter of a pH unit. A potassium 
phosphate - disodium phosphate buft'er(Sorellson) was used for the rang'! 
· (101) 
5.0 - 8.0, a potassium phosphate - borax buffer for the range 8.25 - 9.0 
and a glycine - sodium hydroxide buffer (Sorenson) for the range 9.25 -
10.0. Buffers were prepared in glass distilled water containing 0.1% 
bovine plasma albumin according to Documenta Geigy (1968) and pH was 
measured using a direct reading electronic meter. Buffer capacities 
were sufficient to hold the pH within 0.1 of a unit throughout the test. 
Stock virus was diluted i~ buffer at various pH values to give 4.0 
ml of test solution containing 106•0 pfu per mI. Two series of each 
were prepared in capped bijoux bottles, one of which was held at room 
temperature while the other was held at 37°C in a water bath. Test 
solutions achieved 37°C within 3 minutes of partial immersion. After 
one hour samples were diluted a hundred fold in PBS containing 0.1% BPA 
and infectivity was measured by plaque ass~ in IB-RS-2 plates using 3 
cultures per dilution. Results are derived from 3 experiments with each 
virus strain. 
b) Kinetics of Inactivation of FMDV strains in secretions at physio-
logical pH values: pools of secretions from normal or convalescent cattle 
were heated to 56°C for 30 minutes and the pH was then adjusted by the 
addition of NllO HOI or NaOH to values of 8.5 (pharyngeal fluid or oral 
saliva), 8.0 (nasal secretion) or 7.5 (tears). FMDV was diluted in the 
secretions and in buffer solutions at corresponding pH values (prepared 
as in section 4.7.4.2.a) to give 106•0 pfu/ml and 4.0 ml volumes were 
o held in capped bijoux bottles at room temperature or at 37 C in a water 
bath. Mixtures were incubated for up to 4 hours and 0.2 ml samples with-
drawn at 20 minute intervals were immediately diluted tenfold in PBS 
containing 0.1% BPA. Infectivity was measured by plaque ass~ in IB-
RS-2 mono layers using 3 cultures per dilution and re~ults were derived 
from 3 experiments with each virus strain. 
(102) 
6.8. Protein Estimation 
Protein concentrations were determined by the method of Lowry et al 
(1951) or by direct measurement of optical density at 280 nm followed by 
comparison with a standard absorbance curve for bovine plasma albumin. 
Optical density was measured in silica cells of 1 em path length using a 
Un1cam Model SP500 Spectrophotometer or the laco Model UA4 Absorbance 
Monitor described in section 6.6.5.1. 
7. INVESTIGATIONS, RESULTS AND CONCLUSIONS 
7.1. Investigations of secretions from the normal animal 
Secretions derived from 61 cattle prior to any experimental pro-
ceedure involving FMDV and from 40 cattle following experimental pro-
cedures were measured to establish several normal parameters including : 
pH, total protein concentration, globulin type, the occurrence of inter-
feron and the presence and amount of other non specific anti viral 
factors. 
7.1.1. Normal pH values 
The pH of secretions might have a bearing on FMDV infection and 
excretion either directly, by inactivation of the pH sensitive virus, or 
indirectly, by influencing other mechanisms such as neutralisation. A 
survey was conducted to establish the mean and range of pH in secretions 
from normal cattle. 
7.1.1.1. Diurnal variations 
The secretions of 3 cattle were sampled at four hourly intervals 
throughout a 24 hour period. The animals were fed once, immediately 
after the first set of samples had been taken. The results are summar-
ised in Table 1. Inactivation of virus by pH would be most likely to 
occur at the alkaline values obtained for pharyngeal fluid, oral saliva 
and nasal secretion and less likely to occur at the pH of the other 
secretions. 
1.1.1.2. Daily variations 
Table 2 shows the mean pH values of secretions derived from 6 cattle 
sampled daily for seven days. 
Seasonal variations 
Table 3 shows the mean pH values of bovine secretions measured at 
monthly intervals throughout one year. The figures are derived from 3 
steers convalescent to FMDV and were used when it had been established 
that FmD infection produced no effect on the pH values of these secretions. 
No seasonal variation was discerned since the values obtained fell at 
random within the range found for weekly variation in pH values. The 
housing and diet of these animals remained constant throughout the period 
so that they were not exposed to the type of seasonal variation encount. 
ered in the field. 
Effect on diet 
Comparisons were made between two groups of 3 steers convalescent to 
FhlDV, one fed on a lucerne cob diet and the other fed on a diet of hay 
and concentrates. The results are shown in Table 4. Weekly measure-
ments of secretion pH over a five week period revealed no significant 
differences between the groups for all secretions excepting urine for 
which the grQuP fed on hay and concentrates gave a consistently lower 
value. The acid pH would tend to inactivate FMDV. 
Collected pH values 
Table 5 and Fig. 3a show the mean value and range of pH of normal 
bovine secretions. Values were derived from 120 observations for each 
secretion taken from various animals over a three year period. All 
measurements were made at the animal as expeditiously as possible. 
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Table 1. Mean pH values of bovine secretions measured at four hourly 
intervals for one day. 
Time of day L/S Ph/F O/S N/S F ,U B 
(hours) 
0800 * 7·43 8.23 8.31 7.72 1·23 6.14 1.46 
1200 1.16 8.10 8.46 1.86 6.52 7.54 
1600 7.40 8.35 8.31 7·82 6.84 7.52** 7.51 
2000 1.42 8.40 8.55 8.00 7·03 1.48 
2400 7.08 8.52 8.56 7.93 6.78 7.63** 7.55 
0400 1.33 8.50 8.42 1.86 6.92 1.51 
0800 7.51 8.36 8.50 1.88 1.11 6.82 1.60 
x 7.33 8.43 8.45 1.86 6.91 1.11 7.52 
S.E. 0.058 0.056 0.034 0.031 0.088 0.231 0.017 
* Sampling of the first animal commenced at the times specified 
** Mean of only two samples 
L/S Lachrymal Secretion 
Ph/F Pharyngeal Fluid 
O/S Oral Saliva 
N/S Nasal Secretion 
F Faeces 
U Urine 
B Blood 
\.lUb) 
Table 2. Mean pH values of bovine secretions measured at daily inter-
vals for one week. 
L/S Ph/F O/S N/S F u B 
Monday 7.42 8.35 8.39 7.90 6.58 8.26 7.60 
Tuesday 7·08 8.62 8.45 7.65 7.11 6.48 7.65 
Wednesday 7.25 8.71 8.36. 7.86 7.06 7.35 7.53 
Thursday 7.36 8.1'3 8.32 8.22 7.20 7.62 7.48 
Friday 7.27 8.33 8.57 8.01 7.04 6.46 7.61 
Saturday 7·44 8.26 8.55 8.05 6.82 6.53 7.58 
Sunday 7·58 8.34 8.46 7·92 6.85 7.05 7.68 
x 7.34 8.47 8.44 7.94 6.95 7.10 7.59 
S.E. 0.060 0.075 0.034 0.066 0.080 0.258 0.244 
Key as for Table 1. 
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Table 3. Mean pH values of bovine secretions measured at monthly 
intervals throughout the year. 
Lis Ph/F ols N/s F u B 
January 1.43 8.61 8.56 1.83 1.10 6.13 7.51 
February 1.60 8.32 8.40 7.56 7.25 7.26 7.64 
March 1.05 8.41 . 8.63 7.91 6.63 6.93 7.64 
April 1.60 8.48 8.52 8.21 6.95 7.50 7·50 
May 7·13 8.13 8.55 8.05 6.73 7.63 7.71 
June 7.42 8.31 8.47 8.l2 7.20 7.28 7.52 
July 7·25 8.65 8.38 7·95 7·14 8.00 7.63 
August 1.33 8.69 8.42 7.73 6.84 6.41 7.44 
S~ptember 1.36 8.54 8.55 8.24 7.00 6.56 7.56 
October 7.21 8.75 8.32 8.02 6.93 6.84 7.42 
November 7.54 8.55 8.47 7·77 6.53 7.62 7.70 
, 
December 1.40 8.63 8.52 7.92 6.68 7.93 7.54 
x 7.36 8.55 8.48 7.94 6.91 7.22 7.56 
S.E. 0.048 0.042 0.024 0.~57 0.067 0.529 0.095 
Key as for Table 1. 
_ (108) 
Table 4. Mean pH values of bovine secretions from steers fed on 
different diets. 
Week 
1 
2 
3 
4 
5 
x 
S.E. 
1 
2 
3 
4 
5 
x 
S.E. 
Lis 
A 
7.43 
7.34 
7.05 
7.28 
7.60 
7.34 
0.090 
N/s 
A 
7.83 
8.21 
8.00 
7.81 
7.56 
7.88 
0.107 
A Lucerne Cob Diet 
B 
7.37 
7.45 
7.31 
7.06 
7.42 
7.32 
0.069 
B 
7.92 
7.85 
7.89 
8.06 
7.94 
Key otherwise as for Table 1. 
Ph/F 
A 
8.61 
8.23 
8.66 
8.37 
8.41 
8.45 
0.078 
F 
A 
7.10 
6.83 
7.10 
6.74 
7.25 
0.094 
B 
8.42 
8.36 
8.45 
8.56 
8.42 
8.44 
0.031 
B 
7.15 
6.90 
6.53 
7.03 
7.11 
6.94 
0.111 
ols 
A 
8.56 
8·32 
8.61 
8.33 
8.63 
8.49 
0.067 
A 
6.73 
7.26 
7.68 
8.08 
7.26 
7.40 
0.226 
u 
B 
8.34 
8.40 
8.45 
8.51 
8.38 
8.41 
0.028 
B 
6.48 
6.50 
6.49 
6.52 
6.70 
B H~ and Concentrate Diet 
The figures agree closely with the results of daily, weekly and 
monthly measurements (Tables 1, 2, 3 and 4), and show that remarkably 
little variation, less than 1 pH unit, occurs in the pH of these secret-
ions with the exception of urine. The results were used to select pH 
values which were employed in further tests on the kinetics of inacti-
vation of F~V by antiviral factors in secretions. 
Table 5. 
1.1.2. 
Collected pH values of bovine secretions measured at the 
animal. 
pH Value 
Sample LIe an Range 
Tears 1.32 1.01 - 1.60 
Pharyngeal Fluid 8.52 8.23 - 8.15 
Oral Saliva 8.48 I 8.30 - 8.58 
Nasal Secretion 8.01 1.61 - 8.40 
Faeces 1.01 6.52 - 1.20 
Urine 6.16 6.41 - 8.08 
Blood 1.56 1.40 - 1.12 
Normal protein values. 
Proteins occurring naturally in secretions might influence FdDV 
infection and secretion by acting as a stabilising agent for viral infect-
ivity or, in contrast, by exerting anti viral effects via mechanisms such 
as neutralisation. For this reason and because normal values were re-
qui red for use in tests on the antiviral activity of secretions, a survey 
of total protein levels was conducted in nO~lal cattle. Sampling was as 
(110) 
described in the corresponding section 7.1.1.1. - 7.1.1.5. 
7.1.2.1. Diurnal variation 
Table 6. Uean protein values of bovine secretions measured at four 
hourly intervals for one day (mg/100 ml). 
Time of Day 
(hours) 
0800* 
1200 
1600 
2000 
2400 
0400 
0800 
x 
S.E. 
L/S 
690 
517 
560 
679 
749 
693 
162 
664 
34.84 
Ph/F· 
127 
150 
155 
270 
306 
310 
264 
226 
29.86 
o/S 
146 
273 
187 
190 
432 
360 
,251 
262 
38.13 
Se Serum Key otherwise as in Table 1. 
H/S U Se 
}80 24.8 6840 
416 6720 
592 18.2** 6420 
463 6680 
458 31.0** 6710 
615 6850 
504 10.3 6840 
22.3 6122 
5.69 5.11 
* Sampling of the first animal commenced at the time specified 
** }lean of only two samples. 
The results in Table 6 show that total protein levels vary widely 
between secretions. Urine had the lowest levels, tears and nasal 
secretions had similar levels as did oral saliva and pharyngeal fluid 
while serum contained levels which were at least 12 times greater than 
the highest concentration found in external secretions. 
1.1.2.2. Daily variations 
~lll) 
The results were similar to those obtained during sampling through-
out a 24 hour period as shown in Table 7. 
Table 7. liean protein values of bovine secretions measured at daily 
intervals for one week (mgflOO ml). 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
x 
S.E. 
417 
563 
489 
563 
605 
587 
521 
535 
24.59 
Key as for ~ables 1 and 6. 
115 
167 
208 
124 
463 
202 
651 
274 
76.62 
7.1.2.,. Seasonal variation 
o/S 
92 
117 
18, 
212 
309 
620 
306 
i 
262 
67.55 
H/S 
470 
545 
490 
305 
580 
557 
720 
523 
47.58 
u Se 
12.5 6490 
13.2 6510 
37.5 6830 
29.0 6810 
60.0 6530 
10.2 6770 
35.6 6560 
28.3 6640 
6.81 5.76 
No seasonal variation was discerned in the protein content of sec-
retions since values fluctuated at random throughout the period as 
shown in Table 8 below. 
7.1.2.4. Effect of diet 
The diets had no influence on the protein content of the secretions 
during the period of investigation as is shown in Table 9. 
(112) 
Table 8. Mean protein values of bovine secretions measured at monthly 
intervals for one year (mg/100 ml). 
January 
February 
March 
April 
May 
June 
July 
August 
September 
October 
November 
December 
x 
S.E. 
L/S 
408 
516 
613 
605 
315 
191 
804 
563 
600 
126 
181 
583 
619 
143.35 
Ph/F O/S 
145 102 
290 196 
168 208 
192 314 
305 266 
613 435 
204 197 
337 250 
562 386 
457 251 
518 520 
213 418 
338 295 
50.25 ·35.14 
Key as for Tables 1 and 6. 
N/S U Se 
108 9.1 6510 
825 3.2 6640 
621 41.6 6690 
900 35.0 6130 
801 25.6 6650 
612 21.0 6820 
442 63.1 6110 
750 45.0 6510 
675/ 11.6 6170 
638 18.0 6550 
800 35.2 6610 
681 14.6 6120 
27.5 6669 
5.03 2.80 
(113) 
Table 9. Mean protein values of bovine secretions from steers fed on 
different diets (ms/IOO ml). 
Week 
1 
2 
3 
4 
5 
x 
S.E. 
1 
2 
3 
4 
5 
x 
S.E. 
A 
407 
533 
345 
417 
390 
418 
31.19 
A 
670 
728 
470 
490 
557 
58~ 
50.34 
T 
N/s 
A Lucerne Cob Diet 
Key as for Table 6. 
B 
516 
401 
563 
~90 
461 
466 
33.11 
B 
695 
862 
545 
580 
720 
680 
56.20 
Ph/F 
A 
210 
163 
180 
227 
158 
187 
13.40 
U 
A 
11.7 
22.1 
32.6 
9·4 
25.2 
20.2 
B 
19~ 
205 
175 
185 
170 
185 
6.27 
B 
20.5 
17.6 
22.8 
15.0 
30.7 
21.2 
2.68 
A 
237 
165 
179 
147 
163 
178 
15.55 
A 
6780 
6510 
6810 
6620 
6850 
6710 
6.42 
ols 
Se 
B ~ and Concentrate Diet 
B 
145 
286 
162 
205 
104 
180 
30.97 
B 
6810 
6770 
6530 
6490 
6780 
6670 
6.83 
1.1.2.5. Collected protein values for bovine secretions (mg/loo ml) 
and comparisons with values from the literature 
Table 10. 
Tears 
Naaal 
Secretion 
Mean 
540 390 - 804 
596 305 - 900 
Pharyngeal 242 
Fluid 
115 - 673 
Saliva 
Urine 
Serum 
Reference 
A 
B 
C 
D 
E 
F 
G 
235 102 - 620 
2; ;.2 - 60 
6682 6420 - 6850 
Duncan et al 
Butler et al 
Pedersen and Nansen 
Rouse and Angulo 
Mach and Pahud 
McKercher et al 
Altman and Dittmer 
Values from the literature.Reference 
Mean 
824 - 896 A. 
896 B 
6;9 .. ;50 - 1210 c 
931 660 - 1360 
224 179 - 244 
201 144 - 2;9 
7;5 ;29 - 1569 
D 
A. 
E 
F 
130 - 144 B 
7600 G 
6120 - 6150 B 
1972 
1972 
1972 
1970 
1971 
1973 
1961 
Breed 
Holstein - Friesian 
Holstein - Friesian 
Danish Red 
Unspecified 
Simmenta1 
Unspecified 
Various. 
There is general agreement between the results of this new survey 
and the values from the literature. Specific discrepancies may reflect 
differences of age, sex, breed, management and techniques (sae section 
7.1.2.6.) • 
7.1.2.6. Effect of collection method on the protein content of nasal 
secretion. 
The levels of total protein in nasal secretion reported by Duncan 
et al (1972) and Mach and Pahud (1971) were below those found by Rouse 
and Angelo (1970), MCKercher et al (1973) or in the current aurvey. 
Since the lower levels were found in fluid collected as washings and 
the higher values in fluid collected on tamp0Da, the method apparently 
influenced the results. To test this possibilit,y and to investigate 
the possible exudation of serum protein caused by the tampon method, 
nasal secretions were obtained from steers on three successive days. 
i 
On D~ 1 seoretion waa collected in a rubber tipped pipette as it 
accumulated in the nares, on Day 2 secretion was colleoted by washing 
with PBS and on D~ 3 by the use of tampons. The resulta in Table 11 
show that a) les8 protein was recovered in waahinga, b) oomparable 
levels were recovered by the slow collection of fluid as secreted or 
by the tampon method and c) the use of tampons did not increase the 
extravasation of serum protein. 
(116) 
Table 11 •. 
Animal Collection Method 
Washing Pipette Tampon 
BR8 237* 463 506 
BR9 190 512 489 
HRlO lee 373 462 
HRll 304 685 613 
-
x 229.7 508 517 
S.E. 27.21 65.57 33.09 
* Protein concentration in mg/1OO ml of nasal secretion 
7.1.3. Normal globulin classes in bovine secretions. 
A number of reoent reports have concerned the identifioation of 
globulin classes in bovine secretions. However, no data is available 
for the Devon breed and no single author has reported on the range of 
secretions investigated in this thesis. Moreover, little information 
is available on the globulin type in secretions following exposure to 
FMDV and none on possible alterations in the type of antib~ found at 
different times after exposure. A survey wsa therefore conducted to 
establish the type of antibody present in normal bovine secretions. 
Samples taken from 15 steers immediately before infection and from 
one normal animal at post mottem were examined by a number of techniques 
including gel filtration, anion exchange chromatography, immunoelectro-
phoresis and immunodiffusion. 
(117) 
Protein elution profiles are shown for secretions following gel 
filtration (Fig. 1) and anion exchange chromatography (Fig. 2). The 
secretions were from one steer but the profiles are representative of 
all the samples examined. Secretions and selected concentrated fract-
ions from column chromatography were examined by immunoelectrophoresis 
(Plates 5 - 9) and immunodiffusion (Plate 10) using antisera directed 
against whole secretions or against single globulin classes. 
Serum showed the characteristic triple peaks after gel filtration. 
IgM, IgG subclasses and albumin accounted for the main precipj,.tat1D;g 
antibody reactions in the first, second and third peaks respectively. 
19A was also detected in serum in concentrated fractions from the trough 
between the first and second peaks. Following anion exchange chroma-
tography, serum proteins separated into a fall-through peak, containing 
principally IgG2' and a second broad peak made up of at least two minor 
peaks containing, in order of elution, IgGl' 19A, IgM and albumin. The 
, 
findings were in accordance with those of other workers and indicated 
that the techniques of separation and identification were functioning 
adequately. 
Lachrymal secretion gave two distinct peaks on gel filtration, the 
first and major peak contained 19A with lesser amounts (as measured by 
the intensity of the precipitin reaction) of IgM. IgGl was detected 
in the trough and the smaller second peak contained albumin. 
could be detected. Anion exchange results showed a small fall-through 
peak followed by a trough with a second distinct peak, composed largely 
of secretory 19A, running into a third ill-defined peak containing sec-
retory 19A, IgM and Albumin. Mach and Pahud (1971) reported similar 
results but were also able to detect low levels of IgG2 in some lachrymal 
secretions from Friesian cattle. 
(118) 
Nasal secretion separated into two peaks on sephadex G200; the 
first sharply defined peak contained chiefly 19A with traces of 19M 
while the trough and second peak were rich in 19G1 with traces of 
albumin occurring at the tail of the pattern. Resul ts of anion exchange. 
chromatography resembled those obtained for tears. 
The elution patterns and precipitin reactions obtained with concen-
trated oral saliva and pharyngeal fluid were indistinguishable. The 
first, well defined peak on gel filtration contained secretory 19A while 
19G1 was detected in the trough and in the second diffuse peak. The 
absence of 19G2 was confirmed on anion exchange chromatography and the 
single broad peak contained principal~ secretory 19A with some leGl • 
The low levels of 19G2 and 19M detected in saliva by Mach and Pahud 
(1971) and Duncan et al (1972) were not confirmed. 
Intestinal mucus and bronchial washings were subjected only to pre-
cipitin tests. Reactions were particularly strong with antiserum to 
secretory 19A and less well defined with antiserum to leGl • No reactions 
were elicited in tests with antiserum to 19G2 and 19M. 
It is to be noted that no attempt was made to distinguish the minor 
protein components of serum and secretions reported by other workers and 
mentioned in the literature review of this .... thesis. The classes 
were named by analogy with human immunoglobulins according to a) the 
elution pattern in chromatography, b) the relative position of precip-
itin lines in immunOdiffusion against specific antisera. The results 
are shown in Table 12. In summary, the predominant globulin class of 
external secretions in steers of the Devon breed was 19A. 
also commonly detected in smaller amounts while IgM was a minor component 
of certain secretions. The secretory globulins of the breed are essent-
ially similar to those reported for other breeds of cattle. 
Fig 1. Gel Filtration Protein Elution Profiles For Bovine Secretions. 
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Fig 2. Anion Exchange Chromatography Protein Elution Profiles 
For Bovine Secretions. 
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(121) 
PLATE 5. Immunoelectrophoretic patterns for bovine immunoglobulins. 
Wells contained: 1, 3 and 4 - bovine serum. 
2 - bovine colostrum. 
Troughs contained: 1. Antiserum to bovine IgM 
2. Antiserum to bovine 19A 
3. Antiserum to bovine IgGl 
4. Antiserum to bovine IgG2 
Cathode on the right. 
1 
2 
3 
4 
5 
(122) 
PLATE 6. Immunoelectrophoretic patterns for bovine serum. 
Wells contained bovine serum. 
Troughs contained: 1. 
2. 
3. 
4. 
5. 
Antiserum to whole bovine serum. 
Antiserum to bovine IgM. 
Antiserum to bovine IgA. 
Antiserum to bovine IgGI' 
Antiserum to bovine IgG2. 
Cathode on the right. 
PLATE 7. 
1 
2 
3 
4 
5 
(123) 
Immunoelectrophoretic patterns for bovine lachrymal 
secretion. 
Wells contained bovine lachrymal secretion xlO. 
Troughs contained: 1. 
2. 
3. 
4. 
5· 
Antiserum to whole bovine lachrymal secretion. 
Antiserum to bovine IgM. 
Antiserum to bovine IgA. 
Antiserum to bovine IgGl 
Antiserum to bovine IgG2. 
Cathode on the right. 
1 
2 
3 
4 
5 
PLATE 8. Immunoelectrophoretic patterns of bovine nasal secretions. 
Wells contained bovine nasal secretion. 
Troughs contained: 1. Antiserum to whole bovine nasal secretion. 
2. Antiserum to bovine IgM. 
3· Antise:r;um to bovine IgA, 
4. Antiserum to bovine IgGl· 
5. Antiserum to bovine IgG2· 
Cathode on the right. 
PLATE 9. 
1 
2 
3 
4 
5 
(125) 
Immunoelectrophoretic patterns for bovine oral saliva/ 
pharyngeal fluid. 
Wells contained oral saliva/pharyngeal fluid xlOO. 
Troughs contained: 1. Antiserum to whole bovine oral sali val 
ph~geal fluid. 
2. Antis~rum to bovine IgM. 
3. Antiserum to bovine 19A. 
4. Antiserum to bovine IgGl· 
5. Antiserum to bovine IgG2· 
Cathode on the right. 
(126) 
Table 12. Distribution of globulin classes in normal bovine secretions. 
Secretion IgM IgA IgGl IgG2 
Lachrymal ++ +++ + 
Nasal + +++ ++ 
Salivary (%20) +++ + 
Pharyngeal (x20) +++ + 
Bronchial +++ + 
Intestinal +++ + 
Serum +++ + ++++ +++ 
Precipitin Reactions: - None, + Faint, ++ Distinct, +++ Strong, 
++++ Very Strong. 
A subjective assessment was made of the maximum intensity of the 
precipitin reaction which occurred during 5 days of observation. 
7.1.4. Antiviral factors in normal secretions. 
7.1.4.1. Interferons. 
No interferon was detected in serum or in lachrymal, nasal, salivary 
or pharyngeal secretion from each of 16 normal cattle or in intestinal 
or lower respiratory secretions from one steer. 
pH and other effects. 
a) The range of pH stability of FMDV strains~ 
Since pH could pl~ a part in the inactivation of FMDV in sec-
retions and since the effect might be compounded with that ~f other ant~ 
viral factors, preliminary studies were carried out to establish the 
range of pH stability of the virus strains in experiments uncomplicated 
by factors other than hydrogen ion concentration. The survival of type 
O,(Swiss 1/66), A and C FMDV for 60 minutes at 37°C in buffers containing 
0.1% BPA and covering the pH range of 5 - 10 is shown in Fig. 3b. 
Under the conditions of the test optimal survival of viral infect-
ivity occurred over the pH ranges 7.0 - 8.25 (type A), 7.0 - 8.0 (type 0) 
and 1.5 - 8.5 (type C). The pH values of pharyngea.l fluid, oral sa.liva 
and nasal secretion may exceed these ranges of pH stabilit.y while those 
of faeces and urine may fall below them. In these circumstances, the 
pH of the secretion might itself serve in a protective capacity. How-
ever, virus inactivation proceeded only slowly through further increments 
of 0.25 - 0.5 pH units on either side of the range of optimal stability 
and traces of viruses persisted below pH 6.5 or above 9.0 for more than 
60 minutes. The intrinsic antiviral effect of pH in secretions is likely 
to be of minor importance. 
b) The kinetics of inactivation of FMDV in secretions at physiological 
pH va1ues.-
Ereliminary studies indicated that the inactivation of virus at 
37°C proceeded more rapidly in certain secretions than in buffers at the 
same pH. Experiments were therefore conducted to examine the kinetics 
of virus inactivation in normal tears, nasal fluid, oral saliva and 
pharyngeal fluid. Virus was suspended in secretion or buffer at the 
appropriate mean physiolOgical pH value and the inactivation of virus 
was measured over a four hour period at 37°C. Results are shown in 
Fig. 4. FMDV in tears or nasal secretion lost titre at a rate which 
was equal to or slightly less than the rate in the corresponding buffer. 
The slight sparing effect may have been due to the extra protein in the 
secretions. However, viruses were inacti:rated much more rapidly in oral 
(128) : 
Fig 3 A. iv1ean And Range Of pH Of Normal Bovine Secretions 
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pH. 
saliva and phar,yngeal fluid than in buffer solution at the same pH. 
A difference of 2 - 3 loglO p.f.u. was apparent for all strain& of virus 
with marginally greater inactivation occurring with types 0 and A than 
with type C. 
Normal bovine saliva and pharyngeal fluid therefore contained two 
non specific antiviral factors: an adverse pH effect and an additional 
unidentified component. 
c) Investigations of the additional, non specific antiviral factor in 
saliva and phar,yngeal fluid. 
Partial characterisation of the additional antiviral factor was 
carried out using a pool of normal bovine saliva and type 0 (Swiss 1/66) 
FMDV to investigate the effect of concentration, pH, heat and dia~sis •. 
The standard assay method was employed using virus at 106•0 p.f.u./ml, 
o 
sampling after 4 hours incubation at 37 C and ass~ing by the plaque 
technique in IB-RS-2 monolayers. 
(i) Effect of concentration. 
Virus was diluted in varying proportions of saliva or glycine -
sodium hydroxide buffer at pH 8.5 and the mixtures were held at 37°C for 
4 hours. The virus titre decreased as the proportion of saliva in-
creased (Table 13) showing the concentration dependancy of the inactiv-
ation. 
(i1) Effect of pH 
Saliva was heated to 56°c for 30 minutes and aliquots were adjusted 
to pH values of 7.5, 8.0 and 9.0 by the addition of NaOH or HC1. Virus 
was suspended in saliva or bUffer at these pH values at 106•0 p.f.u./ml 
(130) 
and the mixtures were held at 37°0 for 4 hours. Although the pH values 
altered during incubation (Table 14) the results showed virus inactiva-
tion by saliva to be independent of pH values over the range 7.5 - 8.5. 
Table 13. Effect of the concentration of saliva on the inactivation 
of FMDV. 
Diluent 
Ratio Buffer/Saliva 
100/0 
75/25 
50/50 
25/75 
0/100 
Virus Titre 
loglO p.f.u./ml 
4.52* 
,.84 
3.25 
2.70 
2.35 
* Virus titre after 4 hours at pH 8.5 and 37°0. 
Initial titre 106•Op.f.u./ml. Mean of 3 experiments. 
Table 14. Effeot of pH on the inaotivation of FMDV by saliva. , 
Diluent pH Virus Titre 
Initial Final loglO p.f.u./ml 
Buffer 7.50 7.55* 5.82** 
8.00 8.10 5.57 
8.50 8.53 5.14 
9.00 9.15 4.63 
Saliva 7.50 7.70 2.50 
8.00 8.22 2.65 
8.50 8.65 2.58 
9.0 9.02 2.14 
* Maximum pH deviation in 3 experiments. ** Virus titre after 4 hours 
° at 37 o. Initial titre 106•0 p.f.u./ml. Mean of 3 experimen ta. 
(131) . 
Fig4. Kinetics Of Inactivation Of FMDV In Buffers And Bovine 
Secretions At Physiological pH Values. 
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(132) 
(iii) Effect of heat 
Saliva was heated a~ 31°e , 65°C or 10°C and samples were withdrawn 
at ten minute intervals for up to 1 hour. The pH was adjusted to 8.5 
by the addition of HCl (1.0 or O.IN), virus was suspended in the saliva 
samples and the mixtures incubated at 31°e. 
The antiviral factor was .not affected by heating at 650e for 60 
minutes but was partially destroyed after 10 minutes and completely 
destroyed after 20 minutes at 70°C (Table 15). 
Table 15. Effect of heat on the antiviral factor in saliva 
Diluent. Incubation Time of incubation (mins.) 
Temp. (oe) 0 10 20 30 40 50 60 
Saliva 31 3.40* 
-
3.31 
65 3.58 3.50 
70 3.45 1.16 0.98 1.0 
PBS 1.20 
* Reduction in titre, (10g10 p.f.u./ml) occurring when virus at 106•0 
p.f.u./ml was incubated for 4 hours at 37°e and pH 8.5 in PBS or in 
saliva which had been heated at 31. 65, 700e for various times. 
Mean of 3 experiments. 
(iv) Effect of Dialysis. 
Saliva was dialysed against PBS at pH 7.5 or 8.5 overnight at 4°e 
with constant stirring using a saliva, FBS ratio of 1 J 50. The 
inactivation of virus was studied in dialysed and non dialysed saliva 
and in buffer at the same pH. Dialysis at pH 8.5 resulted in the 
removal of the additional antiviral factor while dialysis at pH 7.5 
resulted in the removal of both the pH effect and the additional anti-
viral agent (Table 16). 
Table 16. Effect of dialysis on the antiviral factors in saliva. 
Diluent 
PBS 
Saliva 
Dialysed saliva 
Virus titre 
* 10glO p.f.u./ml after 4 hours at 37°C. 
Concluaiona. 
pH Virua titre 
Mean of 3 experiments. 
The first section of experimental resulta was large~ conoerned with 
the establishment of normal Talues for bovine secretions. The mean and 
range of PH and protein content was determined for teara, nasal seoret-
ions, oral saliva, pharyngeal fluid, faeoes, urine and serum. Value a 
varied between animals and between samples from the same animal but no 
diurnal, daily and seasonal pattern was apparent. Two different diets 
were investigated for their effect on the pH and protein oontent of 
seoretions. An effeot was discernible only in the calile of urine which 
was of a oonsistently lower pH in cattle fed on a diet of hay and concen-
trates than in cattle fed on luoerne coba. 
The major immunoglobulin olasses were identified in a number of 
secretiona. In common with the other breeds of cattle so far investi-
gated, 181 Walil found in all seoretionstogether with an IgGl oomponent 
while IgM was also identified in lachrymal secretion. 
The range of pH stability of the FMDV strains was determined in 
buffer solutions. The pH values for type C Novi1le (pH 7.5 - 8.5) were 
greater than for type 0 Swiss (pH 7.0 - a.o) or type A 119 (pH 7.0 -
8.25). 
The antiviral effeot of normal seoretions was studied in experiments 
which inoorporated the baseline data established for pH and protein 
oontent. No interferon was deteoted in normal seoretions. Comparis-
ons between the normal pH values for seoretions and the range of pH 
stability of the viruses revealed that hydrogen ion oonoentration alone 
oould exert an antiviral effect in some instances. However, although 
the effect was dependent on the virus strain, it was like~ to be of 
only minor significance in protection beoause of the slow rate of viral 
inaotivation. The rate at which FMDV strains lost infeotivity (logl 
hour) in buffers at 37°C was : 
pH type 0 type A type C 
7.5 0.100 0.125 0.100 
8.0 0.375 0.325 0.200 
8.5 0.625 0.575 0.375 
Virus in tears at pH 7.5 or nasal seoretion at pH 8.0 and 37°C lost 
infectivity at rates ver.y similar to those oco~ in buffer. 
Apart from the pH effect an additional, non specifio, antiviral 
factor was discovered in normal bovine saliva or pharyngeal fluid. The 
factor was most aotive against types 0 and A and less so against type C. 
Inactivation rates for virus at pH 8.5 and 37°C were as follows: 
Saliva 
Pharyngeal Fluid 
type 0 
1.075 
1.250 
type A 
1.185 
1.075 
type.;C 
0.700 
0.750 
The factor was concentration dependent, active over the pH range 
of at least 7.5 - 8.5, unaffected by heating at 600 C for I hour, parti-
ally destroyed after 10 minutes and totally destroyed after 20 minutes 
at 700 C and able to be removed by dialysis. The protective capacity 
of this factor was also likely to be small since viral inactivation pro-
ceeded on~ slowly under its influence. 
7.2. Secretions from convalescent animals 
The role of secretions in pathogenesis was investigated in steers 
experimentally infected with FMDV t,ypes 0, A and C. The experiments 
involved short term studies (made between Day 0 and Day 56 post exposure 
to infection) and long term studies (made between 2 months and 5t years 
after infection). Factors investigated were: the acquisition and 
excretion of virus, the development of clinical disease, the induction 
of interferon, the antibody response (neutralising capacity, kinetics 
of neutralisation and type of immunoglobulin), the pH and protein content 
of secretions, the carrier state and the interrelationships between these 
factors. 
A standard method of direct infection was used whereby groups of 
2 - 3 steers were housed in one box with two infected donor pigs. Atter 
2 hours of contact the steers were moved into separate, clean boxes and 
the pigs were slaughtered. 
7.2.1. Short term observations. 
7.2.1.1. The acquisition and secretion of FMDV 
In order to elucidate the comparative .importance of various routes 
of infection and excretion of FMDV, a study was made 0'£ virus excretion 
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following infection by natural routes. Cattle were sampled immediately 
prior to infection on Day 0, at approximately 24 hour intervals for up 
to 12 days and then at 2 - 3 day intervals for up to 56 days post exposure. 
Samples were assayed for infectivity on CTY mono layers in tubes within 
o' 4 hours of collection or after longer periods of storage at -70 0 and 
the identity of a random sample of cultures showing OPE was checked by 
complement fixation. 
The frequenoy of reo overy and the amount of virus in secretions and 
exoretions is given in Table 17 (type A, 119), Table 18 (type 0, Swiss 
1/66), Table 19 (type 0, BFS 1860), Table 20 and P1gure 5 (type 0, 
Noville). 
and 23. 
The development of clinical disease is shown in Tables 22 
The method of exposure was akin to that occurring in the field when 
the diseased animal infects a.stall mate. Exposure resulted in the 
development of generalised disease between 2 and 4 days post infeotion 
but the degree of ohallenge in each oase was unknown. However, compari-
son of the amounts of virus recovered on D~ 1 suggests that the steers 
exposed to type 0, Swiss 1/66 (Table 18) experienced a far greater 
challenge than ~ of the other groups (Tables 17, 19 and 20). Alterna-
tively the Swiss 0 strain might be a more invasive agent. 
Samples may have been contaminated during oollection and those con-
taining minimal amotults of virua at the peak of the syndrome are parti-
cularly suspect in this respect. Nevertheless the pattern of exoretion 
is clear (Fig. 5). Virus was generally detected earliest and to highest 
titre in pharyngeal fluid. Oral saliva and nasal secretion were often 
positive at the same time as pharyngeal fluid but almost always to a 
lower level. Lachrymal and preputial swabs also contained appreoiable 
amounts of virus before the onset of clinical disease. Urine and faeces 
contained little if any virus during this period. Viraemia ensued with-
in 1 - 3 days of exposure and persisted for 3 - 6 days. 
Once the disease was apparent, high levels of FMDV could be detected 
in all the secretions with the exception of urine, from whioh sporadic 
reooveries were made, and faeces which oontained the least amount of 
virus. One steer (JT7l, Table 18) infected with type 0, Swiss 1/66 
showed unusually high levels of virus in urine. Maximum excretion of 
virus occurred during the period 1 - 3 d~s before and after the develop-
ment of vesioles in the nose and mouth with peak levels in saliva and 
pharyngeal fluid at the time of their rupture. Of the 4 virus strains 
examined the 0. Swiss 1/66 strain was exoreted earliest in greatest 
amounts, Exoretion of the other strains followed a similar pattern but 
at a later time (C Noville) or a lower level (0, BFS 1860, A 119). 
Table 21 gives the titre of virus in secretions and exoretions as measured 
in this stu~ together with values from the literature. 
Fluorocarbon was employed to dissooiate possible antigen - antibody 
oomplexes in seoretions during the acute phase of FMD. In some instanoes 
an increased amount of virus was recovered following treatment (details 
in section 7.2.1.6.) 
Clinical signs developed in a charaoteristio manner (Tables 22 and 
23). The febrile response varied, some animals showed little deviation 
of temperature while others were pyrexic for up to 4 d~s. Neither the 
extent and severity of lesions nor the degree of viral exoretion could 
be correlated with the temperature response. It is noteworthy that one 
steer in each group infeoted with types 0 and C remained free of tongue 
lesions despite the development of extensive vesioles elsewhere.in the 
mouth. The frequent involvement of the prepuce is also of interest as 
a feature which has not been commonly recorded. No conclusions could 
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Table 11. Excretion of FllDV type A (119) from steers. 
Animal Sample Days post exposure 
--------------------~--~-------------------No. 0 1 2 3 4 5 6 1 8 9 10 
+ 
HX20 N/S 0.0 Tr ,.0 5.0 5., 4.0 1.5 0.0 Tr 0.0 0.0 
O/S 0.0 1.0 4.8 6.5 7.0 6.5 4.3 2.8 0.0 0.0 0.0 
Ph/F 0.0 1.8 4.5 7.3 6.8 5.0 5.0 ,.5 1.3 1.0 2.0 
F 0.0 0.0 Tr 1.3 2.0 0.0 1.5 0.0· 0.0 0.0 0.0 
U 0.0 0.0 2.0 2.3 0.0 1.8 0.0 0.0 0.0 0.0 
p/S 0.0 Tr 2.8 4.6 5., 2.1 0.0 1.2 0.0 0.0 0.0 
Se 0.0 0.0 1.5 6.0 6.3 5.5 1.8 0.0 0.0 0.0 0.0 
+ 
HX21 N/S 0.0 Tr 0.0 2.8 6.0 5.0 4.8 ,.3 0.0 0.0 0.0 
O/S 0.0 0.0 1.3 4.5 6.8 6.5 5.3 4.0 1.3 0.0 0.0 
Ph/F 0.0 1.0 2.5 3.8 6.5 6.5 6.0 3.5 2.8 1., 2.0 
F 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 
U 0.0 0.0 Tr 1.8 2.5 0.0 Tr 0.0 0.0 
p/S 0.0 1., 1.6 2.6 2., ,.8 4.1 1.; 0.0 0.0 0.0 
Se 0.0 0.0 0.0 ,.5 6.5 5.8 4., 1.; 0.0 0.0 0.0 
Four CTY tubes per dilution. 
Key 
L/S 
Nls 
0/5 
Ph/F 
F 
U 
P/S 
Se 
Sample 
: Lachrymal Swab 
Nasal secretion 
: Oral Saliva 
Pharyngeal Fluid 
Faeces 
Urine 
Preputial Swab 
I Serum 
Lowest dil. tested 
1:2 (approx.) 
1:1 
1:1 
1.1 
1:10 
1:1 
1:5 (approx.) 
1:1 
+ Earliest detection of clinical lesions 
No sample 
Results expressed as 
CTY ID5~sample 
CTY ID v/ml 
CTY ID5V,ml 
CTY ID~~ml 
CTY In ~g 
CTY ID~d:ml 
CTY ID5~ml 
CTY ID5~ml 
Tr Trace of virus (one or two tubes showing CPE at the lowest 
dilution tested. 
0.0 : No virus detected at the lowest dilution tested. 
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Table 18. Excretion of FMDV type 0 (Swiss 1/66) from steers. 
kUma1 S~p1e, ____________ ~D=a~y~s~p~os~t~ex=p=o~sur~e ______________ __ 
No. o 1 2 3 4 5 6 7 8 9 10 
+ 
JT71 LiS 0.0 2.8 4.8 5.3 6.3 2.8 2.8 1.8 0.0 0.0 0.0 
N/S 0.0 4.5 6.8 6.3 4.3 4.3 3.3 0.0 0.0 0.0 0.0 
olS 0.0 5.3 6.8 6.8 5.0 4.8 4.3 0.0 0.0 0.0 0.0 
Ph/F 0.0 6.3 5.8 7.3 4.5 5.3 3.3 2.8 0.0 2.3 3.0 
F 0.0 0.0 2.3 2.3 0.0 2.5 1.8 0.0 0.0 0.0 0.0 
U 0.0 0.0 ;.8 4.3 5.5 4.8 4.0 0.0 0.0 0.0 0.0 
p/S 0.0 2.8 5.6 5.8 4.1 4.6 4.8 0.0 0.0 0.0 0.0 
Se 0.0 4.; 5.8 5.3 4.5 0.0 0.0 0.0 0.0 0.0 0.0 
+ 
JT72 Lis 0.0 Tr 2.3 4.6 6.1 5.3 ;.6 1.8 0.0 0.0 0.0 
JT7; 
N/S 0.0 2.8 4.8 6.3 5.0 4.5 3.3 0.0 0.0 0.0 0.0 
O/S 0.0 5.8 7.3 6.8 6.5 5.; 4.8 Tr 0.0 0.0 0.0 
Ph/F 0.0 6.8 7.8 6.8 5.3 3.0 4.8 2.3 1.8 0.0 '.3 
F 0.0 0.0 2.3 Tr 0.0 0.0 2.; 0.0 0.0 0.0 0.0 
U 0.0 0.0 2.3 ;.8 1.3 0.0 2.0 0.0 0.0 0.0 0.0 
p/S 0.0 1.8 3.6 4.8 2.8 4.3 4.8 0.0 0.0 0.0 0.0 
Se 0.0 1.5 5.; 4.8 4.8 2.0 0.0 0.0 0.0 0.0 0.0 
-+ 
L/S 0~6 5;8 ;:8 4.8 4.; 4.1 5.; 1.6 0.0 0.0 0.0 
N/S 0.0 2.8 5.8 7.3 5.8 3.8 ;.0 0.0 0.0 0.0 0.0 
ols 0.0 4.; 8.; 7.8 5.; 3.8 ;.0 2.8 0.0 0.0 0.0 
Ph/F 0.0 4.8 6.3 5.8 4.8 4.5 4.8 2.8 2.; 1.3 2.8 
F 0.0 0.0 3.0 0.0 1.8 0.0 2.3 0.0 0.0 0.0 0.0 
U 0.0 0.0 2.8 3.8 1.8 0.0 2.3 0.0 0.0 0.0 0.0 
pis 0.0 Tr 4.6 5.8 4.8 4.3 4.8 0.0 0.0 0.0 0.0 
Se 0.0 4.3 6.3 6.8 3.5 0.0 0.0 0.0 0.0 0.0 0.0 
Four CTY tubes used per dilution. Keyes for Table 17. 
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Table 19. Excretion of ~IDV type 0 (BFS 1860) from steers. 
Animal Sample Days post exposure 
No. o 1 2 4 5 6 7 8 9 10 
+ 
ER8 N/S 0.0 0.0 1.5 4.0 5.5 5.0 4.5 2.5 0.0 Tr 0.0 
0/5 0.0 Tr 2.0 4.5 5.5 6.0 5.5 3.0 1.0 0.0 0.0 
Ph/F 0.0 0.0 4.5 4.0 6.0 4.5 4.5 5.0 1.5 1.0 1.5 
F 0.0 0.0 0.0 0.0 Tr 0.0 1.5 0.0 0.0 0.0 0.0 
U 0.0 0.0 0.0 1.0 1.5 1.5 0.0 0.0 0.0 
p/S 0.0 0.0 Tr 1.5 3.5 4.0 4.0 2.5 0.0 0.0 0.0 
Se 0.0 0.0 0.0 1.2 5.2 5.2 2.2 0.0 0.0 0.0 0.0 
+ 
HR9 N/S 0.0 Tr 0.0 1.5 5.0 5.0 4.5 3.0 1.0 0.0 0.0 
O/S 0.0 1.5 2.0 3.5 5.5 6.0 5.5 1.5 0.0 0.0 0.0 
Ph/F 0.0 2.0 5.5 4.0 4.5 4.5 3.5 2.5 1.5 1.0 1.5 
F 0.0 0.0 0.0 Tr 1.5 Tr 0.0 1.5 0.0 0.0 0.0 
U 0.0 0.0 1.0 2.0 0.0 2.5 0.0 0.0 0.0 0.0 
p/S 0.0 0.0 Tr 2.5 4.0 4.5 4.0 1.0 0.0 0.0 0.0 
Se 0.0 0.0 Tr 1.2 4.2 5.2 1.5 0.0 0.0 0.0 0.0 
+ 
HRll N/S 0.0 2.0 4.0 5.0 3.5 2.0 0.0 0.0 0.0 0.0 0.0 
0/5 0.0 3.5 5.8 5.5 6.0 4.0 2.3 0.0 0.0 0.0 0.0 
Ph/F 0.0 6.5 7.0 5.0 4.5 3.5 2.5 2.0 0.0 1.0 1.0 
F 0.0 0.0 1.5 0.0 Tr 0.0 0.0 0.0 0.0 0.0 0.0 
U 0.0 1.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 
p/S 0.0 1.5 3.5 3.5 2.0 0.0 1.0 0.0 0.0 0.0 0.0 
Sa 0.0 3.0 3.0 4.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 
Two CTY tubea used per dilution. Key as for Table 17. 
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Table 20. Excretion of FMDV type C (Noville) from steers. 
Animal Sample Days post exposure 
No. o 1 2 4 5 6 1 8 9 10 
+ 
JS51 1/S 0.0 0.0 1.8 3.8 3.8 5.3 Tr 0.0 0.0 0.0 0.0 
H/S 0.0 1.5 6.3 8.3 6.3 5.8 3.5 3.0 1.3 0.0 0.0 
O/S 0.0 3.8 5.3 8.3 1.0 6.3 4.0 3.3 2.5 Tr 0.0 
Ph/F 0.0 3.8 6.8 7.8 6.3 5.3 5.8 4.3 2.0 2.2 3.2 
F 0.0 0.0 0.0 2.3 0.0 Tr 0.0 0.0 0.0 0.0 0.0 
U 0.0 1.3 2.8 0.0 0.0 Tr 0.0 0.0 0.0 
p/S 0.0 1.8 3.3 1.3 4.8 5.8 5.8 2.3 0.0 0.0 0.0 
Se 0.0 0.0 4.8 6.3 1.8 1.3 0.0 0.0 0.0 0.0 0.0 
+ 
JS59 L/S 0.0 0.0 1.8 4.1 4.1 5.1 2.8 2.3 0.0 0.0 0.0 
N/S 0.0 1.3 5.3 4.8 6.3 6.8 4.5 2.3 0.0 0.0 0.0 
O/S 0.0 2.3 7.8 8.8 1.3 6.3 5.8 4.8 2.8 Tr 0.0 
Ph/F 0.0 3.3 5.0 7.3 8.3 5.3 4.8 3.8 2.8 2.2 2.2 
F 0.0 0.0 0.0 2.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 
U 0.0 0.0 3.3 1.5 0.0 1.5 0.0 0.0 0.0 0.0 
p/S 0.0 0.0 3.8 7.3 5.8 7.0 3.8 2.8 1.8 0.0 0.0 
Se 0.0 0.0 0.0 4.2 6.2 5.2 0.0 0.0 0.0 0.0 0.0 
+ 
JS63 L/S 0.0 0.0 0.0 0.0 2.8 6.1 1.8 0.0 0.0 0.0 0.0 
N/S 0.0 1.3 4.8 5.3 6.8 6.3 6.8 2.3 0.0 0.0 0.0 
O/S 0.0 1.8 4.3 7.0 6.8 6.8 6.8 4.3 3.0 1.3 Tr 
Ph/F 0.0 3.3 5.3 6.3 5.3 7.3 6.3 5.8 1.8 2.2 2.8 
F 0.0 0.0 0.0 1.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 
U 0.0 0.0 2.3 2.5 0.0 0.0 0.0 0.0 
p/S 0.0 0.0 3.5 3.5 3.5 5.1 4.3 3.8 0.0 0.0 0.0 
Se 0.0 0.0 0.0 2.8 "5.3 5.3 0.0 0.0 0.0 0.0 0.0 
Four CTY tubes used per dilution. Key as for Table 17 
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Fig 5. Mean Virus Content Of Samples From Three Steers Infected With 
FMDV Type C Noville By Contact. 
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Table 21. Titre of FMDV in some secretions and excretions of cattle. 
Secretion/ Volume or Virus Max Virus Tota.l Virus Ref. 
Excretion Weight Strain Titre content 
Blood/ 30 1 Al19 105•8/ml 1010., A 
Serum ° Canefa-9 10S.6/ml 1010•1 B 
Various 106.0/ml 1010•5 C 
0, BFS 1860 105•2/ml 109•1 E 
0, Swiss 1/66 106•8/ml lOll., E 
Al19 106•5/ml 1011•0 E 
C Novi11e 101. 8Jml 1012., E 
Lachrymal Unknown o Canefa-2 101.°/8 F 
Secretion 0, Swiss 1/66 106·,/s E 
C Novi11e 106.1/s E 
Nasal Unknown Various 107•7/g C 
Secretion 0, BFS'1860 105.5/ml E 
0, Swiss 1/66 101., /ml E 
Al19 106•O/ml E 
C Novil1e 10S.3/ml E 
Oral 98 - 190 1 Various 10S.0/ml 1013•3 C 
Saliva per day o Israel/63 10S•5/ml 1013•8 G 
0, BFS ls60 106•7/ml 1012 •0 D 
0, BFS ls60 106•O/ml 1011•3 E 
0, Swiss 1/66 101.S /ml 1013•1 E 
A119 101•O/m1 1012 •3 E 
C Noville 10S.8/ml 1014•1 E 
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Secretion/ Volume or Virus Max Virus Total Virus Ref. 
Excretion Weight Strain Titre content 
Phar.yngeal probably as 0, BFS 1860 107•4/ml 1012•7 D 
Fluid saliva 0, BFS 1860 107.O/ml 1012•3 E 
98 - 190 1 0, Swiss 1/66 lO7. S/ ml 1013•1 E 
per day A119 107•31ml 1012•6 E 
.C Noville 10S•3/ml 1013•6 E 
Faeces 14 - 45 kg o Canefa-2 104. 1/ g 10S.7 F 
per day o BFS 1860 102•O/g 106•7 D 
0, Swiss 1/66 103•O/g 107•7 E 
Al19 102 •O/g 106•7 E 
C Novil1e 103.3/g 108•0 E 
Urine 8.8 - 22 1 Al19 104.9/ml 109•2 H 
per day ° M 11 104.6/ml 10
8
•9 H 
0, BFS 1860 102. 5/ ml 106•8 E 
0, Swiss 1/66 10S.5/ml 109•8 E 
Al19 102•5/ml 106•8 E 
C Novi1le 103•3/ml 107•6 E 
Physiological data from Sellers (1971) and Dukes (1970) 
A. 
B. 
C. 
D. 
E. 
F. 
G. 
H. 
Cottral and Bachrach 1968. Titre in mouse ID ~/ml or g. Infected 
by tongue inoculation. Report gives details df types and strains 
of FMDV not listed in the table. . 
Cottral 1969. Titre in mouse ID501ml or g. Infected by tongue 
inoculation. 
Scott et al 1966. Titre in Calf Kidney p.r.u./ml or g. Infected 
by tongue inoculation. Results obtained with 7 types of FMDV but 
report gives only collected figures. 
Sellers et a1 1969. Titre in IB-RS-2 p.f.u./ml or g. Infected 
by indirect contact. 
This Thesis. Titre in CTY ID50 per ml or g. or sample (s). In-fected by direct contact. 
Sutmoller and McVicar 1973. Titre in Calf Kidney p.f.u./ml, g or s. 
Infected by intraconjunctiva1 installation. 
Hyslop 1965a. Remarks as for A •• 
Cottral et al 1968. Remarks as for A •• 
Table 22. Development of clinical disease in cattle exposed to FMDV. 
Virus Days post exposure 
Animal No. 
Al19 
HX20 
2 
10;.8* 
3 
103.8 
UL 
4 
101.4 
LL 
5 
103.4 
RN 
6 7 
10;.2 102.4 
T.G. HP 
HX21 101.0 101.; 
C Novil1e 
JS57 105.2 
RH. LN. M 
ut. LL. T 
JS59 100.8 
Js63 101.2 
* Reotal temperature of. 
Lesion Sites: 
103.4 
UL LL 
T. UP. P 
2F 4F 
104.; 
10;.6 
RE. RH.IN LE 
UL. LL. T HP 
4FP 
106.0 
LN 
UL. LL.HP P 
IF 4F 
104.6 10;.4 
101.6 101.0 
103.4 101.2 
101.8 
RE, LE: Right and left eye (oonjunotivitis) .G: Gum 
DP' Dental Pad 
HP J Hard Palate 
T J Tongue 
Ms Muzzle 
RN, 1M: Right and left nostril 
ut, 11: Upper and lower lip 
1F - 4F: one to 4 feet P J Prepuoe 
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Table 23. Development of clinical disease in cattle exposed to FMDV. 
Virus Days post exposure 
Animal No. 1 2 3 4 5 6 
0, BFS 1860 
HR8 101.4* 101.5 102.6 103.8 103.8 102.0 
1lN LN 
UL p 
4F 
HR9 100.8 101.4 102.8 104.2 101.8 101.4 
UL 11 
G T. P. 
2F 4F 
HR11 101.5 103.8 104.0 102.4 101.4 101.6 
1lN LE LN M 
DP T HP 
4F 
0, Swiss 1/66 
JT11 101.6 104.6 103.8 103.0 102.5 101.5 
RNLN 
UL 11 T P 
3F 4F 
JT12 100.8 102.8 103.6 103.2 101.5 101.4 
RNM LN 
UL 11 G DP 
2F 4F 
JT13 101.4 102.8 103.0 101.5 100.8 101.4 
RN 
UL 11 T 
P ~F 
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be drawn about the origin of virus in urine. However, virus was rarely 
found in urine outside the viraemie phase or in the absence of preputial 
virus, either or both of which might act as a source of urinary FMDV. 
Internal secretions were also examined for virus at post mortem. 
Six steers were slaughtered at 7 day intervals between 7 and 42 days 
after exposure to type 0, Swiss 1/66. All animals developed fully gen-
eralised disease. Prior to slaughter the usual samples were taken while 
after death 42 samples were taken of mucosae, tissues and associated 
lymph nodes throughout the alimentary and respiratory systems. Table 
24 includes only samples from which virus was recovered. No lesions 
were found in the lower respiratory or alimentary tracts, nor was virus 
detected in these regions. From 14 days post exposure, virus persisted 
only in pharyngeal fluid and in oropharyngeal tissues. 
Table 24. Recovery of FMDV in ante and post mortem samples from steers. 
convalescent to type 0, Swiss 1/66. 
Animal Number BRIO BRa BR9 
Days post exposure 7 14 21 
Oral Saliva Tr 
Pharyngeal Fluid 1.5* 2., 1.5 
Tongue Epithelium 2.S 
DSSP 2.5 1.0 1.3 
Pharyngeal Mucosa 1.5 Tr 
Tonsil 3.0 1.0 1.0 
RPLN 1.5 
Oesophageal Mucosa 1.5 
DSSPJ Dorsal surface of the soft palate 
RPLN: Retropharyngeal lymph node 
HRll HR6 HR7 
28 35 42 
1.2 2.3 
1.5 2.2 2.S 
1.5 
* Titre in CTY IDSO per ml or g. 5 tubes per dilution used. 
Tr.: tr~ce of Virus at lowest dilution examined. -J No 7irus detected. 
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7.2.1.2. pH values during infection. 
Inflammation may result in the alteration of normal pH values and 
since FMDV produces an acute inflammatory response and the virus is pH 
labile, the hydrogen ion content of secretions might serve in a defensive 
capacity during infection. Fourteen daily measurements were made of 
the pH values of tears, nasal secretion~oral saliva, pharyngeal fluid, 
faeces, urine and blood from two groups of 3 cattle before, during and 
after clinical disease following exposure to FMDV types 0, Swiss 1/66 
and C Noville. 
Urine alone showed a consistent deviation from the normal range of 
pH with a tendency to become more acid as disease became generalised 
(Fig. 6). The shift was more pronounced after type C infection and the 
lowest value recorded was pH 5.2. Low PH persisted for 2 - 4 days at 
levels known to be inimical to the survival of FMDV infectivity (c.f. 
Fig. ~). Type C virus was recovered once from urine during the acid 
shift (Table 20) but type 0 was recovered on several occasions (Table 16). 
Both viruses were recovered from preputial swabs taken during this period. 
Protein levels during infection. 
The survival of FMDV may be influenced by the amount of protein in 
secretions. At least two effects may be envisaged, a non specific pro-
tective effect or a specific antiviral effect due to neutralising 
antibody. 
Total protein levels were measured by the Lowry method in seoretions 
derived from cattle throughout infection as described in section 1.2.1.2 •• 
Tears, nasal secretion, oral saliva and pharyngeal fluid showed a marginal 
increase in protein content lasting only I - 2 days at the peak of 
Fig 6 . Mean pH Of Bovine Urine During The Course Of F MD. 
pH. 
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clinical disease (Table 25). In many animals the serous, nasal. and 
lachrymal secretions became mucoid or muco-purulent at this time while 
oral sal:i.va and pharyngeal fluid tended to become more viscid. These 
changes might explain the increased protein levels which are found. 
Interferon levels during infection. 
IF occurs in secretions during the course of a number of viral 
diseases and in some instances it is known to exert an antiviTal effect. 
The IF response of cattle to infection with FMDV was therefore investi-
gate~. Fourteen daily sample sets were taken from 4 groups of cattle 
before, during and after clinical disease caused by FMDV types 0, Swiss 
1/66, 0, BFS 1860, Al19 and C Noville. After overnight acidification 
at pH 2.0 to destroy FMDV, samples were brought to a neutral pH and 
assayed for IF by measuring their capaCity to inhibit CPE in Calf Kidney 
tube cultures challenged with Vesicular Stomatitis Virus. Results are 
shown in tables 26, 27, 28 and 29 ~d Fig. 7. In general IF was detec-
ted only during the development of clinical lesions. In some instances 
the appearance of IF apparently preceeded the development of vesicles 
by 24 hours but it is possible that undetected lesions were present in 
such areas as the nasopharynx at the earlier time. 
The maximum time of detection of IF in any single animal or secret-
ion was 4 days but IF was more commonly present for only 2 or 3 days. 
Greatest amounts of IF were found in tears, nasal secretion and serum, 
smaller amounts occurred in oral saliva and pharyngeal fluid while none 
was detected in faecal suspension or urine. The lower levels in oral 
and phar,yngeal secretion may merely reflect their dilution with saliva 
which forms the major constituent of these fluids. Types Al19 and C 
Noville induced more IF than type O. BFS 1860 and type 0, Swiss 1/66 
induced least, a fact which cvrre1ates to some extent with the amounts 
(151) 
of virus recovered from secretions (c.f. Tables 17 - 20). 
Table 25. Mean protein content of secretions during FMD. 
Virus Sample Days post exposure 
Animal No. 0 1 2 3 4 ,5 6 
+ + 
0, Swiss 1/66 L/S 406* 510 906 950 800 566 450 
N/S 567 483 915 1060 641 412 485 
JT 11, 72, 73 O/S 164 155 710 302 210 154 368 
Pb./F 298 360 961 214 354 400 210 
U 45 16 10 24 4 60 45 
Se 6430 6510 6610 6580 6490 6610 6520 
+ + 
C Noville L/S 520 413 613 852 981 964 565 
N/S 612 704 621 900 1010 1040 600 
JS 51, 59, 63 O/S 196 251 316 588 140 216 230 
Fh/P 309 264 '338 682 840 506 310 
u 22 53!. 12A lOA 43 40A 6A 
Se 6550 6610 6420 6560 6610 6530 6490 
*: Protein content mg/1OO ml. 
+: Earliest detection of clinical lesions 
Values are the mean of 3 samples from individual steers on each day. 
As Mean of only 2 samples 
Sample abbreviations as in Table 11. 
· (152) 
Table 26. Interferon in bovine secretions during infection with FMDV 
type 0 (Swiss 1/66). 
Animal No. Sample Days post exposure 
0 1 2 3 4 5 6 
+ 
JT1l L/S 0.5 1., 
N/S 0.8 1.8 
O/S 0.5 
Ph/F .. 0.8 0.8 
Se 1.0 1.0 
+ 
JT12 L/S 0.8 1.3 
H/S 0.8 0.8 2.1 
O/S 0.5 0.5 
Ph/F 0.8 0.5 
Se 1.3 0.8 
+ 
JT13 L/S i 0.3 1.5 
N/S 0.5 2.0 0.8 
O/S 0.3 0.5 
Ph/F 0.5 0.5 
Se 1.0 1.3 
IF titre expressed as log units per 0.5 m1 of secretion. 
+: Earliest detection of clinical lesions 
-: No IF detected 
Otherwise Key as for Table 17. 
(153) 
Table 21. Interferon in bovine secretions during infection with ~IDV 
type 0 (BFS 1860). 
Animal Sample Days post exposure 
No. ,0 1 2 3 4 5 6 1 
+ 
BR8 N/S 1.2 2., 0.5 
o/s 0.5 1., 0.3 
Ph/F 0.5 1.0 1.0 
Se 0.5 2.0 1.3 
+ 
HR9 N/S 1.5 2.0 
O/S 0.3 0.8 0.5 
Ph/F 0.5 1.2 0.8 
Se 1.0 0.5 
+ 
BRll N/S 2.0 2.3 
O/S 0.8 1.0 
Ph/F 1.0 0.3 
Se 0.3 0.8 1.2 
Key as for Table 11. 
Table 28. Interferon in bovine secretions during infection with FMDV 
type A (119). 
Anjmal Sample Days post exposure 
No. ',0 1 2 3 4 5 6 7 
+ 
HX20 N/S 1.5 2.6 
O/S 0.8 1.5 0.3 
Ph/F 0.3 1.0 1.2 
Se 1.5 1.5 0.3 
+ 
HX21 ];l/S 2.6 1.8 0.5 
0/5 1.2 1.0 
Ph/F 0.8 1.2 
Se 1.0 1.2 
Key as for Table 17. 
Table 29. IF in bovine secretions during infection with FMDV 
type C (Noville). 
Animal Sample Days post exposure 
No. 0 1 2 3 4 5 6 
+ 
JS57 L/S o.} 1.5 2.0 0.5 
N/S 0.8 2.3 1.5 1.0 
0/5 1.0 1.3 0.5 
Ph/F .0.3 0.7 1.0 0.8 
Se 0.3 1.7 1.5 
+ 
JS59 L/S 1.3 1.0 1.5 
N/S 0.5 0.8 2.2 1.8 
O/S 1.0 1·5 0.8 0.3 
Ph/F 0.5 1.2 1.5 0.3 
Se 0.5 2.0 0.8 
+ 
JS63 L/S 1.5 
N/S 1.2 2.3 0.5 
o/s 0.3 0.8 1.2 0.3 
Ph/F 0.5 1.0 0.5 1.2 
Se 2.3 1.8 
Key as for Tabl~ 17. 
7 
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Fig 7 . Interferon In Bovine Secretions During The Course Of F MD. 
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a). Development of neutralising antibody. 
Antibody has been found in secretions after a number of viral 
infections and in some instances an important protective role has been 
assigned to it. Preljrnjnary reports indicated that secretory antibody 
was produced after infection with FUn but detailed information was lack-
ing. A close study was made of the humoral and secretory neutralising 
antibody response in groups of steers which developed generalised disease 
after exposure to FMDV types 01 (Swiss 1/66) and (BFS 1860), A (119) and 
C (Noville). Sets of secretion samples were obtained for the first 10 
days and then at weekly intervals for up to 6 weeks post infection. 
Saliva and pharyngeal fluid were dialysed overnight against PBS at 
pH 7.5 to remove the adverse alkaline pH effect and the additional anti-
viral factor. Tears, nasal secretion, saliva and pharyngeal fluid were 
tested undiluted, serum and post mortem mucus at a dilution of 1110 and 
urine and faecal suspension after concentration by a factor of 10 - 100 
times. All secretions were heated at 56°C for 30 minutes prior to 
measurement of the homologous neutralisation index in suckling mice and 
the specificity of neutralisation was detected by testing the heterologous 
neutralising capacity of selected samples. 
The neutralising antibody response was similar for the 4 strains of 
FMDV examined. Initial development during the first 10 days after 
infection is shown in Tables 30 to 33 and the subsequent pattern during 
the first six weeks is shown in Tables 34 to 37. The antibody response 
to type C Noville is also depicted in Fig. 8. Neutralising antibody 
was detectable in secretion within 3 - 6 d~s (mean 5 days) of exposure. 
Antibody attained a peak 21 - 28 days after exposure and persisted at 
(158) 
declining levels for at least 6 weeks. Long term studies are presented 
in section 7.2.2. Levels in external secretions were almost always well 
below those found concurrently in serum and antibody was often detected 
in serum one day earlier than in secretions, even when humoral antibody 
was sought at a dilution of 1:10. The development of antibody was more 
closely related to time after exposure virus than to time after develop-
ment of lesions and in one animal (HR9, Table 31) antibody was detected 
at the same time as lesions. 
The amount of antibody was greatest in serum. Of the external 
secretions, nasal contained most antibody - slightly more than lachrymal, 
while antibody was found at a lower level and in approximately equal 
amounts in oral saliva and pharyngeal fluid. Very little antibody could 
be detected in urine or faecal suspension collected 28 days after infect-
ion, even when concentrated up to 100 times. Heterologous neutralising 
activity was confined to the early part of the response and was not 
detectable 3 weeks after exposure to virus. Representative cross neutral-
isation results are given in Table 38. 
The development and decline of antibody in mucus samples obtained 
at post mortem from the lower respiratory and alimentary tracts (Table 39) 
resembled that of ante mortem secretions. Antibody occurred in appreci-
able amounts in mucus and although the levels were alw~s below those 
found in serum they were sufficient to raise doubts about the apparent 
lack of antibody in faecal suspension. 
The influence of infection on the additional non specific antiviral 
factor in oral saliva and phar,yngeal fluid was also investigated. Se-
quential undialysed samples were brought to pH 7.5 by the addition of 
acid and examined in heterologous neutralisation tests. The factor 
remained constant throughout the course of disease and convalescence. 
(159) 
Table 30. Neutra1ising antibody in bovine secretions following 
infection with FMDV type 01 (Swiss 1/66). Day 0 - 10. 
Animal Sample Days post exposure 
No. 0 1 2 3 4 5 6 7 8 9 10 
+ 
JT71 L/S 0.2* 0.0 0.4 0.0 0.0 1.0 1.6 1.6 1.4 1.8 2.2 
N/S 0.0 0.2 0.0 0.0 0.4 1.8 2·4 1.8 2.0 2.0 2.4 
O/S(D) 0.4 0.0 0.2 0.0 0.2 0.8 1.0 2.0 1.8 2.0 2.0 
Ph/F(D) 0.2 0.2 0.0 . 0.4 0.4 1.0 1.4 1.8 1.6 1.8 2.0 
Se 0.0 0.4 0.2 0.6 1.2 2.6 2.2 2.8 2.8 ;.0 ,.8 
+ 
JT72 L/S 0.0 0.0 0.0 0.2 0.2 0.8 1.0 1.8 2.0 1.6 1.8 
N/S 0.4 0.0 0.2 0.0 0.0 1.2 2.4 2.6 2.0 2.4 2.8 
olsen) 0.2 0.0 0.0 0.4 0.0 0.6 1.2 1.8 1.6 2.0 2.2 
Ph/F(n) 0.4 0.2 0.0 0.0 0.2 0.0 1.0 2.0 1.8 1.8 2.4 
Se . 0.2 0.0 0.4 0.2 0.0 2.0 2.8 3.4 2.8 ,.0 3.2 
+ 
JT73 L/S 0.2 0.0 0.2 0.2 '0.0 0.4 1.4 1.8 1.6 1.6 2.0 
N/S 0.0 0.2 0.0 0.0 0.2 1.2 2.4 2.6 2.4 2.6 ,.0 
olsen) 0.4 0.2 0.4 0.0 0.4 0.2 0.8 2.2 1.8 2.0 1.8 
Ph/F(D) 0.0 0.4 0.0 0.2 0.0 0.4 1.0 2.2 1.4 1.8 2.4 
Se 0.0 0.2 0.0 0.2 1.0 2.0 2.4 2.8 2.6 ,.0 2.8 
* Mouse neutralisation index per 0.0, m1 of sample 
(D) z Dialysed 
0.0: No antibody detected at the lowest dilution tested 
Key otherwise as Table 17 
Note 1. Antibody could not be detected in urine or faeces even after 
concentration. See text. 
(160) 
Table 31. Neutralising antibody in bovine secretions following infect-
ion with FMDV type 01 (BFS 1860). Day 0 - 10 
Animal Sample Days post exposure 
No. 0 1 2 3 4 5 6 7 8 9 10 
+ 
BR8 N/S 0.0 0.2 0.2 0.0 0.4 0.8 1.0 1.6 2.0 2.0 2.4 
O/S(D) 0.4 0.0 0.2 0.0 0.0 0.4 0.6 1.2 1.6 1.6 1.8 
Ph/F(D) 0.1 0.2 0.0 0.2 0.4 0.4 0.8 0.8 1.2 1.8 1.6 
Se 0.0 0.2 0.0 0.4 0.4 0.8 1.4 2.4 2.8 2.6 3.2 
+ 
HR9 N/S 0.0 0.0 0.0 0.2 0.8 0.4 1.2 1.6 1.8 2.0 2.6 
O/S(D) 0.2 0.2 0.0 0.2 0.2 0.0 0.6 1.0 1.2 1.4 1.6 
Ph/F(D) 0.0 0.0 0.4 0.2 0.0 0.2 0.6 1.0 1.0 1.6 1.8 
Se 0.2 0.4 0.4 0.0 1.0 1.2 2.0 1.8 2.4 ,.0 ,.6 
+ 
HR11 N/S 0.0 0.2 0.0 0.8 1.0 1.0 1.4 1.8 1.6 2.0 2.6 
O/S(D) 0.2 0.2 0.4 0.4 0.6 0.6 1.0 1.6 2.0 1.8 2.0 
Ph/F(D) 0.0 0.2 0.0 0.0 0.6 0.8 0.8 1., 1.8 1.6 1.8 
Se 0.2 0.0 0.4 0.4 1.2 1.8 2.4 2.4 2.8 3.0 2.8 
Key as for previous tables. 
(161) 
Table 32. Neutralising antibody in bovine secretions following infect-
ion with FMDV type A (119). Day 0 - 10. 
Animal Sample Days post exposure 
No. 0 1 2 3 4 5 6 7 8 9 10 
+ 
HX20 li/S 0.2 0.0 0.2 0.4 0.2 0.6 0.8 1.6 1.2 1.4 1.6 
O/S(D) 0.0 0.4 0.2 0.0 0.2 0.4 0.6 1.0 0.8 1.0 1.2 
Ph/F(D) 0.4 0.0 0.0 0.0 0.4 0.2 0.8 1.2 1.0 0.8 1.2 
Se 0.4 0.0 0.2 .0.2 0.2 1.4 2.0 2.6 2.8 ,.2 3.0 
+ 
HX2l H/S 0.2 0.2 0.4 0.0 0.6, 1.0 1.2 1.8 1.8 1.6 2.0 
O/S(D) 0.2 0.2 0.0 0.0 0.4 0.8 1.0 1.4 1.0 1.2 1.4 
Ph/F(D) 0.0 0.0 0.2 0.2 0.0 0.6 1.2 1.2 1.2 1.4 1.6 
Se 0.4 0.2 0.2 0.2 0.2 1.4 2.2 2.0 2.2 ,.0 2.8 
Key as for previous tables. 
(162) 
Table 33. Neutralising antibody in bovine secretions following infect-
ion with FMDV type C (Noville). Day 0 - 10. 
Animal Sample Days post exposure 
No. 0 1 2 3 4 5 6 1 8 9 10 
+ 
JS57 L/S 0.2 0.2 0.0 0.0 0.2 0.8 1.0 1.0 1.6 1.4 1.6 
N/S 0.2 0.0 0.4 0.2 0.2 1.0 2.4 2.4 2.4 2.6 2.4 
O/S(D) 0.4 0.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.0 1.6 
Ph/F(D) 0.0 0.0 0.4 '0.0 0.0 0.8 1.0 1.2 1.2 1.4 1.6 
Se 0.0 0.4 0.0 0.6 0.4 1.8 2.2 2.8 2.8 3.2 3.0 
+ 
JS59 L/S 0.0 0.2 0.4 0.0 0.4 0.6 0.6 l.2 1.8 2.0 2.2 
N/S 0.4 0.2 0.2 0.2 0.2 0.6 0.6 2.0 2.4 2.4 2.6 
O/S(D) 0.2 0.0 0.0 0.4 1.0 1.2 0.8 1.2 1.4 1.6 2.2 
Ph/F(D) 0.2 0.2 0.2 0.0 0.4 1.6 1.0 1.2 1.2 1.0 2.8 
Se 0.0 0.4 0.2 0.0 0.6 1.8 2.4 2.4 2.6 2.4 2.8 
+ 
JS63 L/S 0.4 0.2 0.0 0.0 0.4 0.8 1.0 1.0 1.0 1.4 1.8 
N/S 0.4 0.2 0.4 0.2 0.4 0.8 1.2 1.4 2.2 1.8 2.4 
O/S(D) 0.4 0.0 0.0 0.2 0.6 1.2 1.0 1.0 1.2 1.4 1.6 
Ph/F(D) 0.0 0.0 0.2 0·4 0.0 1.4 0.8 1.0 1.2 1.6 1.4 
Se 0.2 0.4 0.2 0.4 0.0 1.0 1.6 2.6 2.8 2.6 3.0 
Key as for previous tables. 
(163) 
Table 34. Neutralising antibody in the secretions of cattle following 
infection with FMDV type 01 (Swiss 1/66). Week 0 - 6. 
Animal Sample Days post exposure 
No. 0 7 14 21 28 35 42 
JT11 L/S 0.2 1.6 2.0 2.6 2.6 1.8 0.8 
N/S 0.0 1.8 2.4 3.0 3.6 2.4 2.6 
O/SeD) 0.4 2.0 1.8 2.4 2.2 2.0 1.0 
Ph/FeD) 0.2 1.8 . 1.6 2.0 2.0 2.0 1.2 
Se 0.0 2.8 3.8 4.6 4.4 4.6 3.8 
JT12 L/S 0.0 1.8 1.8 2.4 2.8 1.4 1.2 
N/S 0.4 2.6 2.6 3.0 2.6 1.8 2.2 
O/SeD) 0.2 1.8 2.0 2.4 2.0 1.0 1.2 
Ph/FeD) 0.4 2.0 2.4 2.6 2.2 1.4 1.0 
Se 0.2 3.4 4.0 5.0 5·2 4.8 4.4 
JT13 L/S 0.2 1.8 1'.8 2.0 2.0 1.4 1.0 
N/S 0.0 2.6 2.8 2.4 1.8 1.4 
O/S(D) 0.4 2.2 2.0 2.2 2.0 2.2 1.0 
Ph/FeD) 0.0 2.2 1.6 1.8 2.0 1.6 0.8 
Sa 0.0 2.8 3.0 4.2 3.4 3.4 3.6 
Key as tor previous tables 
(164) 
Table 35. Neutralising antibody in the secretions of cattle following 
infection with ~IDV type 01 (BFS 1860). Week 0 - 6. 
Animal Sample Days post exposure 
No. 0 7 14 21 28 35 42 
HRIO N/S 0.0 1.5 
O/S(D) 0.2 1.0 
Ph/F(D) 0.0 1.4 
Se 0.4 1.8 
HR8 N/S 0.0 1.6 3.; 
O/S(D) 0.4 1.2 2.4 
Ph/FeD) 0.2 0.8 2·3 
Se 0.0 2.4- 4.1 
HR9 N/S 0.0 1.6 2.6 ;.4 
O/S(D) 0.2 1.0 1.8 1.9 
Ph/FeD) 0.0 1.0 1.2 2.2 . 
I 
Se 0.2 1.8 3.8 4.5 
HR11 N/S 0.0 1.8 2.8 2.1 ;.; 
O/S(D) 0.2 1.6 1.5 1.2 1.9 
Ph/F(D) 0.0 1.3 1.1 2.4 
Se 0.2 2.4 ;.6 3.1 4.4 
HR6 N/S 4.1 3.1 3.; 2.8 
O/S(D) 2.0 2.2 0.9 1.1 
Ph/FeD) 1.9 1.8 1.8 1.2 
Se 4.8 4.5 4.; 3.8 
lffi7 N/S 3.4 3.; 3.1 2.6 1.7 
O/S(D) 1.6 2.2 1.1 0.9 1.0 
Ph/FeD) 2.1 1.8 1.7 1.4 0.9 
Se 3.0 4.5 4., ,.4 3.0 
(165) 
Table 36. Neutralising antibody in the secretions of cattle following 
infection with FMDV type A (119). Week 0 - 6. 
Animal Sample Days post exposure 
No. 0 1 14 21 28 35 42 
EX20 N/S 0.2 1.6 2.2 3.0 3.2 2.8 2.0 
O/S(D) 0.0 1.0 1.4 2.2 2.0 1.4 0.4 
Ph/FeD) 0.4 1.2 1.8 1.8 2.2 1.6 0.6 
Se 0.4 2.6 3.8 4.6 3.4 3.0 3.0 
HX21 N/S 0.2 1.8 2.0 2.6 3.0 2.6 1.8 
olsen) 0.2 1.4 1.6 1.8 2.0 1.6 0.6 
Ph/F(D) 0.0 1.2 1.8 2.2 1.4 1.0 0.4 
Se 0.4 2.0 4.2 4.6 4.2 3.6 3.2 
Key as for previous tables. 
(166) 
Table 37. Neutra1ising antibody in the secretions of cattle following 
infection with FMDV type C (Noville). Week 0 - 6. 
Animal Sample Days post exposure 
No. 0 7 14 21 28 35 42 
JS57 L/S 0.2 1.0 3.8 4.2 4.0 2.2 1.8 
N/S 0.2 2.4 3.4 4.6 4.2 3.8 3.0 
O/S(D) 0.4 1.0 2.4 2.8 2.2 0.8 1.2 
Ph/F(D) 0.0 1.2 . 2.6 3.0 1.8 1.0 1.0 
Se 0.0 2.8 5.6 5.6 5.2 4.8 4.2 
JS59 L/S 0.0 1.2 4.0 4.8 4.4 4.0 1.8 
N/S 0.4 2.0 4.0 4.8 4.4 4.0 2.8 
O/S(D) 0.2 1.2 1.8 2.6 2.6 1.8 1.2 
Ph/F(D) 0.2 1.2 2.0 ,.0 2.4 1.2 0.8 
Se 0.0 2.4 5.2 5.6 5.4 4.6 4.8 
JS63 L/S 0.4 1.0 3.4 3.6 3.8 3.0 1.2 
N/S 0.4 1.4 3.8 4.6 4.2 3.6 3.2 
O/S(D) 0.4 1.0 2.4 2.8 2.0 0.8 0.8 
Ph/FeD) 0.0 1.0 1.6 2.2 1.8 1.2 0.4 
Se 0.2 2.6 4.2 5.6 5.6 4.8 4.0 
Key as for previous tables. 
Fig 8. Mean Neutralising Anti body Response In Bovine Secretions 
Following Infection With F MDV Type C Noville. 
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Table 38. Homologous and heterologous neutralisation by bovine 
secretion following infection with FMDV type C (Noville). 
Sample Days post exposure 
0 7 14 21 
L/S 0.2/0.0 1.0/0.4 3.6/2.4 4.2/0.2 
N/S 0.2/0~2· 2.0/1.2 . 3.4/1.6 4.4/0.4 
O/S(D) 0.4/0.2 1.0/0.4 2.4/0.8 2.6/0.4 
Ph/FeD) 0.0/0.2 1.2/0.6 2.2/1.0 2.8/0.2 
Se 0.2/0.0 2.4/1.6 4.8/1.2 5.6/1.0 
Results expressed as the Neutralisation Index (NI) per 0.03 ml of 
undiluted sample or, in the case of serum, of sample at 1.10 dilution. 
Numerator : Homologous N.l. against C Noville 
Denomenator Heterologous N.l. against 0 Swiss 1/66. 
Table 39. Neutralising antibody in the secretion of cattle following 
infection with mlDV type 01 (BFS 1860). Post mortem 
samples. 
Animal Number ERlO ER8 HR9 HRl1 HR6 HR'T 
Days post exposure 7 14 21 28 35 42 
Tracheal Mucus 0.5* 1.2 1.5 1.7 0.8 0.8 
:Bronchial Mucus 0.8 1.5 1.0 1.4 1.1 0.5 
Broncho-alveolar 
Washings 1.0 2.4 2.0 2.2 1.2 1.0 
Abomasal Mucus 0.5 0.8 1.2 1.0 0.8 0.8 
Small Intestinal 
Mucus 0.6 1.2 1.8 1.4 0.5 I 0.8 
Caecal Mucus 0.5 1.0 1.2 1.2 0.6 0.6 
Colonic Mucus 0.8 0.8 1.0 1.4 0.8 0.8 
Serum 1.8 4.1 4.5 4.4 3.8 3.0 
* Mouse Neutralisation Index per 0.03 ml of sample 
All samples apart from broncho-a1veo1ar washings tested at a dilution 
of 1 : 10. 
(170) 
b) Immunoglobulin type. 
Convalescent sera, secretions and fractions separated from them by 
column chromatography were investigated with regard to immunoglobulin 
type by means of neutralisation tests, reduotive oleavage prooedures, 
absorption with speoifio antisera and immunOdiffusion or immunoeleotro-
phoresis tests using antiserum speoific for bovine globulin classes and 
oonoentrated homologous FMDV as diagnostic reagents. Since results were 
essentially similar for all the viruses investigated, only those obtained 
with type C will be reported. 
The chromatographio separation of proteins by gel filtration from 
the seoretions of a steer 21 days convalescent is shown in Fig. 9. The 
elution pattern resembles that of seoretions from normal animals (of Fig. 
1) and of other samples taken between 7 and 42 days post infeotion. 
Similar remarks apply to the results of anion exohange chromatography. 
F.MD infeotion does not therefore oause ohanges in the proteins if seoret-
ions which are deteotable by the chromatographio methods employed although 
it may cause a transient rise in total secretory protein at the height 
of clinical disease (section 7.2.1.3.). 
Figure 9 illustrates the distribution of neutralising aotivity in 
the isolated fractions and oomparison of the elution profiles for protein 
and neutralisation gave an indication of the immunoglobulin types invol-
ved. Closer identification was provided by the results of immunodiffus-
ion (Plate 10), immunoeleotrophoresis (Plates 5 - 9), reductive cleavage 
(Table 40) and absorption (Table 41) tests. The composite data showed 
that the speoific neutralising activity of oonvalesoent bovine secretions 
was associated with protein molecules possessing the oharaoteristics of 
immunoglobulins. In serum the neutrslising activity corresponded with 
the first and second peaks eluted in gel filtration. As reported by 
(171) 
other workers, the neutralising activity during the first 14 d~s was 
linked mainly with the I~~ class of antibody, being highly susceptible 
to disulphide bond reduction, showing typical electrophoretic mobility 
and being largely removed by absorption with antiserum to 19U. A 
gradual change over to IgG (both IgGl and IgG2 subclasses) occurred 
during the period 14 - 21 days post infection with neutralisation becom-
ing increasingly resistant to mercaptoethanol, showing characteristic 
gamma electrophoretic mobili~y and reacting with antiserum to 19G. 
Long term neutralising capacity resided almost entirely in the 19G class. 
In tears, nasal secretions, oral saliva and pharyngeal fluid, early 
antibody was of the IgA class with some activity in IgM molecules 
(particularly in lachrymal secretion). 19A was mainly eluted from sec-
retions in the area between the first and second peaks of the gel filt-
ration profile for serum and showed a sensitivity to mercaptoethanol 
which was intermediate to that of IgM and IgG. Again the molecules 
displayed a characteristic electrophoretic mobility and gave specific 
precipitin reactions with antiserum to IgA. Neutralising capacity per-
sisted in the IgA class of antibody and was also detected in the IgGl 
subclass from 10 days after exposure to infection, particularly in oral 
saliva and pharyngeal fluid. 
c). Kinetics of neutralisation. 
The rate at which virus was neutralised by antibody in serum or sec-
retions was examined using samples obtained 21 - 28 days after exposure 
to FMD. Saliva and pharyngeal fluid were dialysed prior to testing. 
Samples were incubated at 37°C and pH 7.5 with homologous virus at 106•0 
p.f.u. per ml and aliquots withdrawn at 20 minute intervals were assayed. 
for residual virus in tissue culture monolayers. The results were simi-
lar for the 4 virus strains although neutralisation appeared to proceed 
· (172) 
slightly faster and to a greater degree with the C Noville system than 
with the other strains. The type C virus may have elicited antibody of 
higher avidity or, alternatively, the virus itself may be more susceptible 
to neutralisation. However the quantitative aspects of the experiments 
were not sufficiently well defined to allow any conclusions to be drawn. 
Representative results are shown in Figure 10. In 20 minutes incubation 
90 - 99% of virus was neutralised by homologous antibody. A fraction of 
o 
virus escaped neutralisation and persisted for at least 4 hours at 37 C. 
When similar experiments were carried out in nasal secretion at pH 8.0 or 
in undialysed oral saliva and pharyngeal fluid at pH 8.5 the residual, 
non neutralised fraction was usually totally inactivated after 4 hours 
o 
at 37 C, probably by means of pH and thermal inactivation in these alka-
line secretions together with the action of the additional non specific 
antiviral factor. 
7.2.1.6. Dissociation of antibody-antigen complexes. 
Antigen-antibody complexes might be expected to form in many secret-
ions during the acute phase of FMD especially at the time when viral ex-
cretion is decreasing while antibody levels are increasing. Fluorocarbon 
treatment has been successfully employed in the reactivation of FMDV from 
neutralised complexes (Brown and Cartwright 1960, Sutmo1ler and Cottral 
1967c etc.) and the technique was applied to the secretions of 3 steers 
collected during the first 10 days after exposure to type C virus. 
Attempts to reactivate virus did not produce clear cut results 
(Table 42). In some samples an increase in viral titre followed dissoci-
ation but in others the titre was unaltered or reduced after treatment. 
Furthermore, the results varied independently of the virus titre in un-
treated samples. Despite the unpredictable nature of the results three 
features were apparent. Firstly, fluorocarbon treatment consistently 
(113) 
failed to increase the titre of virus in samples taken during the first 
three days of exposure although large amounts were shed in the secretions 
at that time (see Table 11). Secondly, reactivation was principally 
achieved in samples taken between 5 and 1 days after exposure at the time 
when antibody was developing. Thirdly, in only one instance (Steer Js63, 
Serum, Day 1) did dissociation result in the recover.y of virus from a 
sample which had been negative prior to treatment. The first and second 
observations indicated that neutralising antibody did playa part in 
limiting the excretion of infective virus. The third observation sug-
gested that virus is recoverable from complexes for a rather short time 
and that the disappearance of virus from all secretions (except pharyngeal 
fluid) is mediated to some extent by antibody but also by other antiviral 
agencies. 
Long term observations. 
Two groups of steers were followed for extended periods of time 
after infection with F.MD to determine the perSistence of antibody and 
virus in secretions. The first group was sampled at approximate~ 
monthly intervals during 11 months of convalescence after infection with 
type 0 (BFS 1860) and the second group at irregular intervals during the 
period 4 - 5i years after infection with type A (119). Samples were 
treated with fluorocarbon in an attempt to increase virus recovery by 
the dissociation of possible antibody-antigen complexes. 
No virus was recovered in six samplings from the 8 steers infeoted 
with type A virus. These animals had carried virus for as long as 105 
weeks after infeotion (Brooksby 1967). One month after infection of 
steers with type 0, the virus could not be detected in tears, nasal sec-
retion, oral saliva, faeces, urine or serum from 3 animals but was recov-
ered from pharyngeal fluid for up to 4 months post infeotion (Table 43). 
(114) 
Fluorocarbon treatment resulted in little if any increase in viral 
recovery. 
Serum neutralising antibody persisted at high levels in both groups 
and showed only a gradual decline ~ years post infection. Nasal and 
lachrymal antibody also persisted at low levels. Antibody in oral 
saliva and pharyngeal fluid declined below detectable levels 2 - 3 months 
after infection with type 0 but was still demonstrable in concentrated 
secretions (xlO - 100) for as long as 11 months after type 0 and 5i years 
after type A infection (Tables 44 and 45). It is of interest that levels 
of antibody and virus declined in pharyngeal fluid at about the same time 
(see Tables 43 and 44). 
Fig 9. Gel Filtration Profiles For Protein Content And Neutralising 
Activity Of Convalescent Bovine Secretions. 
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4 
Immunodiffusion patterns for normal and convalescent 
bovine secretions. 
Details overleaf. 
Key for PLATE 10. 
Central wells 1. Lachrymal secretion.xlO. 
2. Nasal secretion. 
3. Oral saliva/pharyngeal fluid xl00. 
4. Serum. 
Left hand pattern - samples taken before infection. 
Right hand pattern - samples taken 21 days after infection. 
Peripheral wells A. 
B. 
C. 
D. 
E. 
F. 
Homologous concentrated FMDV. 
Antiserum to 1, 2, 3 or 4. 
Antiserum to IgM. 
Antiserum to 19A. 
Antiserum to IgGl' 
Antiserum to IgG2' 
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Table 40. Effect of reductive cleavage on the neutralising capaci~ 
of whole and fractionated convalescent bovine secretions. 
(?~V type C Noville) 
Sample Days post exposure 
7 14 21 42 
Lachrymal Sec. 1.0/0.2* 3.6/1.8 4.0/2.8 1.0/0.e 
Nasal Sec. 1.6/1.0 3.6/2.e 4.4/3. 2 2.e/2.0 
Oral Saliva o.e/o.e . 2.0/1.6 2.4/1.0 o.e/o.e 
Pharyngeal Fl. 1.0/0.6 2.2/1.e 2.e/1.0 0.e/0.6 
Serum 2.2/0.6 4.6/1.4 5.4/5.0 4.2/4.4 
IgM 
-/- 3.0/0.2 -/- -/-
Ig! 
-/- -/- 3.6/2.4 -/-
IgGl -/- -/- 4.8/4.2 -/-
IsG2 -/- -/- 5.0/4.6 -/-
Results expressed as the neutralisation index per 0.03 ml of sample. 
Samples tested at a dilution of I:} apart from serum whioh was tested 
at 1:30. 
-/- : Not tested 
* Numerator a Neutralisation Index of non reduced sample 
Denomenator Neutralisation Index of reduoed sample. 
(179) 
Table 41. Effect of immunoglobulin absorption on the neutralising 
capacity of whole and fractionated convalescent bovine 
secretions. (FMDV type C Noville). 
Sample Absorbed with:- Days post exposure 
7 14 21 42 
Lachrymal Secretion anti L/S 96* 98 100 98 
(L/S) anti IgM 58 45 32 10 
antiIgA 69 75 70 75 
anti IgGi 10 15 18 20 
anti IgG2 0 2 0 4 
Nasal Secretion anti N/S 100 94 90 98 
(N/S) anti IgM 11 12 15 2 
anti 19A 74 76 60 79 
anti IgGl 22 18 25 30 
anti IgG2 5 2 3 5 
Oral Saliva anti O/S 96 96 97 96 
(O/S) anti IgM 2 3 5 0 
anti IgA 80 75 68 77 
anti IgGl 12 15 20 26 
anti 19G2 6 3 0 4 
Pharyngeal Fluid anti Ph/F 98 97 100 100 
(Ph/F) anti 19M 4 a 2 0 
anti IgA 76 70 70 65 
anti laG1 39 25 22 31 
anti IgG2 2 4 8 3 
continued overleaf. 
(180) 
Sample Absorbed with:- Days post exposure 
1 14 21 42 
Serum (Se) anti Se 100* 100 98 100 
anti IgM 82 10 21 4 
antilgA 5 2 10 13 
anti IgGl 15 26 81 95 
anti IgG2 11 15 13 86 
IgM anti IgM 91 
antiIgA 10 
anti IgGl 3 
anti IgG2 5 
19A anti IgM 15 
anti IgA 89 
anti IgGl 4 
anti IgG2 2 
IgGl anti IgM 6 
anti 19A 2 
anti 19G1 100 
anti 19G2 21 
IgG2 anti IgM 5 
anti 19A 5 
anti 19G1 35 
anti IgG2 98 
* Reduction in the Neutralisation Index of sample after absorption with 
specific antiserum expressed as a percentage of the original unadsorbed 
value. 
- : not tested. 
(181) 
Fig 10 . Kinetics Of Neutralisation Of F M DV By Convalescent 
Bovine Secretions. 
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Table 42. Effect of fluorocarbon dissociation on the titre of virus 
in secretions from cattle infected with FMDV. 
Animal 
No. 
JS57 
JS59 
JS63 
+ 
* 
Type C Noville. Day 3 - 10. 
Sample Days post exposure 
3 4 5 6 7 8 9 10 
+ 
L/S 0.4* 
N/S 1.0 1.2 0.8 
O/S 1~5 0.4 
Fh/F 1.2 0.8 
Se 0.8 1.0 
+ 
L/S 1.0 0.8 
N/S 1.5 . 0.4 
O/S 1.8 1.8 1.0 
Ph/F 0.6 1.4 0.8 0.6 
Sa 1.0 1.4 0.4 
+ 
L/S 1.0 0.4 
N/S 1.5 0.6 
O/S 0.4 1.8 0.6 0.8 
P4/F .. -. 1.3 1.5 0.4 
Se 1.2 0.8 0.8 
Earliest detection of lesions. 
Increase in virus titre (C.T.Y. ID50 per ml) after treatment 
with fluorocarbon. 
No increase in virus titre. 
Note: Severa+ samples lost titre after treatment with fluorocarbon. 
Key otherwise as for previous tables. 
(183) 
Table 43. Persistence of virus in pharyngeal fluid samples following 
infection with F1IDV type 01 (BFS 1860). 
Month post Animal Number 
Infection ** JE36 JE37 JE38 
1 0.7* 2.0 1.2 
2 1.2 1.5 1.0 
3 1.5 0.0 1.5 
4 1.3 0.0 0.7 
5 Tr 0.0 0.0 
6 - 11 0.0 0.0 0.0 
* CTY ID50 per ml of sample 
** Animals sampled at approximately monthly intervals 
0.0 = No virus detected in undiluted sample 
Tr = One or two tubes showing CPE at 10-0 dilution. 
(184) 
Table 44. Neutralising antibody in bovine secretions following infection 
with type 01 (BFS 1860). Month 1 - 11. 
Animal Sample Months post exposure** 
No. 1 2 3 4 5 6 7 8 9 10 11 
JE36 L/S 1.2 1.0 1.4 1.0 1.2 0.8 
N/S 3.6 2.0 1.2 1.4 1.6 1.8 2.2 1.6 1.4 1.2 
O/S(D) 1:1 1.2 0.4 0.2 NT NT NT NT NT NT NT 
O/S(D) zlO 1.8 1.4 1.4 1.0 0.8 1.0 1.2 0.8 1.0 1.0 
Ph/F(D) 1:1 0.8 0.6 0.0 NT NT NT NT NT NT NT 
Ph/F(D) xl0 1.6 1.6 1.0 1.0 1.0 1.2 1.4 1.2 0.8 1.0 
Se 4.6 '3.8 3.4 3.6 3.8 3.6 4.0 ,.6 ,.0 ,.2 
JE37 L/S 1.0 1.4 1.2 1.2 1.0 0.6 
N/S 3.0 2.8 2.0 2.2 1.4 1.0 1.6 1.2 1.0 1.0 
O/S(D) 1:1 0.8 0.2 0.4 NT NT NT NT NT NT NT 
O/S(D) xlO 2.0 1.0 1.4 1.6 1.0 1.4 1.0 1.2 1.4 0.8 
Ph/F(D) 1:1 1.6 0.0 0.4 . NT NT NT NT NT NT NT 
Ph/F(D) z10 2.2 1.2 1.6 1.2 1.6 1.2 0.8 1.4 1.0 1.0 
Se 4.9 ,.2 ,.6 ,.6 4.0 ,.8 ,.6 ,.2 ,.0 2.8 
JE38 L/S 1.0 1.2 1.4 0.8 1.0 1.0 
N/S 3.2 2.8 1.4 1.0 1.2 1.4 1.6 1.4 1.0 1.0 
olsen) 1:1 1.4 0.6 0.0 NT NT NT NT NT NT NT 
olsen) xlO 2.0 1.2 1.4 1.6 1.0 1.4 0.8 1.2 1.4 0.8 
Ph/F(D) 1:1 1.2 0.2 NT NT NT NT 
Ph/F(D) xl0 1.8 1.0 0.8 1.4 1.0 1.0 
Se 3.8 3.8 3.0 4.2 3.8 308 4.0 3.6 3.8 3.4 
** Animals sampled at approximately monthly intervals. 
Dialysed saliva and pharyngeal fluid tested undiluted or after xlO cone. 
NT: not tested 
Key otherwise as for Table ,0 etc •• 
Note: Pharyngeal fluid samples from steer JE38 are incomplete because the 
animal often regurgitated perSistently during sampling. 
Table 45. Neutralising antibody levels in bovine secretions following 
infection with FMDV type A (119). 4 - 5t years. 
Sample and Dilution Months post infection 
49 66 
Lachrymal Secretion 1:1 1.0* 0.8 
(0.6 - 1.5) (0.4 - 1.2) 
Nasal Secretion 1:1 1.4 .1.2 
(0.6 - 2.0) (0.6 - 1.8) 
Oral Saliva x50 1.0 1.0 
(0.4 - 1.8) (0.4 - 1.6) 
Pharyngeal Fluid x50 1.2 0.8 
(0.4 - 1.8) (0.4 - 1.4) 
Serum 1:10 2.8 2.6 
(2.4 - 3.2) (2.3 - 3.2) 
* Geometrio mean (and range) of Neutralisation Indices per 0.03 ml of 
secretion tested at the specified dilution. 
Eight steers in the group. 
~186) 
Conclusions. 
Cattle exposed to simulated natural infection with 4 strains of EM] 
by direct contact with donor pigs developed generalised disease, lesions 
being first detected between 2 - 4 days after exposure. The method of 
infection entailed a number of intrinsic variables, e.g. the known dif-
ference in aerosol excretion between strains of FMDV (Donaldson et al 
1970), the probable differences in excretion by individual donor pigs 
and the relative positions of donors and recipients in the loose box 
during exposure. These variables may explain in part the different 
amounts of virus recovered from various groups 24 hours after exposure 
(considerably more was recovered from recipients of FMDV type 01 Swiss) 
and the different rate at which disease developed within groups (lesions 
were detected in one steer, BRll, on Day 2 and in two other steers, HR8 
and HR9, on Day 4 after exposure to FMDV type 0 BFS 1860). Important 
determinants of susceptibility may reside in individual recipients. 
The fact that steer BRll succumbed '48 hours earlier than box mates may 
have been due to a particularly high degree of susceptibility rather 
than to the acquisition of a larger dose of challenge virus. However 
differences between individual animals in respect of the amount of virus 
recovered and the rate at which lesions developed could not be related 
to the pH value, the total protein content or the level of natural anti-
viral factors in secretions at the time of infection. 
Interferon was present in the secretions of all animals between 2 -
4 days after exposure to virus and was usually detected for 2 or , days 
(maximum 4 days). Most IF was induced in response to types A and C, 
less to type 0 viruses and in all secretions the presence of IF showed 
a good correlation with the time of development of lesions and a poor 
correlation with time after exposure to infection. 
(187) 
Neutralising antibody was detected in secretions 3 - 6 days (mean 
5 days) after exposure to virus, its development being more closely 
related to the time after exposure to virus than with the time of develop-
ment of lesions. Antibody levels were similar for all 4 strains of 
virus although slightly more was produced in response to type C infection. 
Peak levels were reached between 21 and 28 days post infection and the 
levels in external secretions were always lo~er than those found in serum. 
Antibody was found in order of decreasing concentration in nasal secret-
ion, tears, saliva and pharyngeal fluid. Mucus from the lower respira-
tory tract and alimentary tFact at post mortem also possessed neutralising 
capacity. No antibody was detected in urine or faecal suspension despite 
concentration of the samples. 
Infection produced a transient rise in the total protein content of 
secretions COinciding with the height of clinical disease but very little 
alteration of pH was observed, except in urine which became more acid. 
The distribution of protein in secretions was unaltered as assessed by 
column chromatography but specific neutralising antibody developed in 
the immunoglobulin fractions. The neutralising capacity of various 
secretions was associated with different immunoglobulins; in serum 
initially with IgM and later with IgGl and IgG2' in tears initially with 
IgM and IgA and later with IgA and IgGl and in oral saliva and pharyngeal 
fluid with IgA and later with IgA and IgGl. 
The temporal relationship between virus excretion, clinical disease, 
IF induction and antibody production was examined for each secretion. 
Figure 11, for example, shows a graphical representation of this relation-
ship for bovine nasal secretion following infection with type C virus. 
In general IF was detected at the height of the syndrome and antibody 
was detected 1 - 3 days later. Viral excretion declined from its peak 
as IF was induced and decreased markedly in the face ~f rising antibody 
(188) , 
Fig 11 . Relationships Between Virus Excretion I Interferon And 
Antibody In Bovine Secretions During Infection With F M DV . 
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levels. Evidence for a casual relationship between rising antibody and 
declining virus was provided b~ the fact that fluorocarbon treatment 
resulted in an increased viral recovery from some samples (Table 42;, 
particularly those taken during the period immediately after the peak 
of clinical disease and viral excretion. This effect was by no means 
universal and for the most part the data admits of association rather 
than proof. 
From the tenth day after infection virus was detectable only in 
pharyngeal fluid samples. Neutralising antibody was detectable for at 
least 5t years after infection in serum (at high levels)~ in nasal 
secretion and tears (at lower levels) and in oral saliva and pharyngeal 
fluid (in low levels detectable only after concentration procedures had 
been applie~ 
7.3. Secretions from Passively Immunised Animals 
Studies in convalescent animals (section 1.2.) showed that specific 
neutralising antibody appeared in bovine secretions after exposure to 
FhlDV. The antibody could have originated by overspill from serum, by 
local production in peripheral situations or by a combination of these. 
Passive immunisation was employed to investigate the possibility of anti-
body attaining the secretions by simple transudation or by selective 
transfer from serum. Secretions from 3 steers were sampled before 
immunisation, at 2 hourly intervals for 8 hours and then daily for 21 
days after the intravenous application of concentrated bovine antiserum 
to FMDV type 0 BFS 1860. The total protein content and the neutralising 
capacity of samples was measured but in the light of the negative find-
ings in respect of pH in convalescent animals, the hydrogen ion content 
was not studied. 
_ (190) 
After immunisation one of the three steers (JC67) showed clear clini-
cal signs of immediate hypersensitivity with tachypnoea, shivering, 
defecation, urination, lachrymation and salivation, swelling of the eye-
lids and submaxillary oedema. 
Protein levels following passive immunisation. 
No changes attributable- to immunisation were detected in the total 
protein content of serum or secretions sampled during the first 72 hours 
after the passive transfer of concentrated antiserum. 
Neutralising antibody following passive immunisation. 
Humoral antibody declined slowly after immunisation showing a half 
life of 18 days (range 16 - 21 days). Antibody was detected in sec-
retions within 2 hours of passive immunisation and was measurable in 
nasal secretion for 3 - 4 days and in oral saliva and pharyngeal fluid 
concentrated by a factor of 10 for 2 - 3 days after immunisation. The 
highest levels of secretory antibody were found in samples taken 2 hours 
after immunisation from the steer which showed anaphylaxis but hy 4 hours 
the levels were similar in all animals. Individual results are shown 
in Table 46 and mean results are displayed in ~gure 12. Neutralising 
antibody in secretions was principally of the IsGl class. 
Conclusions. 
At face value the findings support the concept that serum may act 
as a source of secretory antibody in the bovine species, but the results 
must be qualified in at least two respects. a) One animal showed 
striking signs of immediate hypersensitivity which were reflected in high 
levels of antibody (but not in total protein levels) ~arlY secretion 
(191) 
samples. It is possible that subclinical vascular lesions occurred in 
the other steers with increased capillary permeability allowing an ab-
normal escape of antibody into the secretions. b) The finding that 
the neutralising activity of secretions was associated chiefly with 
immunoglobulin of the IgGl class must be set against the fact that the 
immune serum had been derived from cattle 28 days convalescent to F.MD 
when the neutraliaing capacity is known to reside chiefly in that class. 
The absence of antibody of the IgM or 19A classes was not therefore sur-
prising. 
Despite these shortcomings the experiment proved that serum antibody 
could attain the external secretions in certain situations. The idea 
of the overspill mechanism was supported by the fact that antibody was 
detectable in secretions when the serum had a neutralisation index of 
around 2.5 but could not be demonstrated (at least in saliva) when serum 
antibody levels fell below that threshold. The results also indicated 
a degree of selectivity in the transfer since the antiserum contained 
both IgGl and IgG2 molecules whereas IgGl predominated in the secretions 
after immunisation. 
7.4. Secretions from Actively Immunised Animals 
The serum neutralising antibody response to potent, inactivated FMD 
vaccine is well established but very little is known about secretory 
antibody following Vaccination. Antibody levels were therefore measured 
in serum and secretions collected from cattle vaccinated once, twice or 
three times with conventional inactivated type C Noville vaccine given 
by the subcutaneous route. Total protein and interferon levels were 
also measured. One group of ; steers was used and samples of serum, 
lachrymal and nasal secretion, oral saliva and pharyngeal fluid were 
taken before each vaccination, daily for 10 d~s and at weekly or monthly 
(192) 
Table 46. Neutralising antibody levels in the secretions of cattle 
following passive immunisation. (Antiserum to FMDV 
t~pe 0 BFS 1860). 
Animal Sample Time post immunisation 
No. Hours Days 
0 2 4 6 8 1 2 3 4 
JC70+ N/S 0.2* 2.0 1.2 0.8 1.0 0.8 0.6 0.8 0.4 
o/S 0.0 1.0 1.0 0.8 0.8 0.6 0.4 0.6 0.2 
Ph/F 0.2 1.2 0.8 1.0 0.8 0.4 0.2 0.4 0.0 
Se 0.4 2.6 2.6 2.4 2.6 2.4 2.0 2.0 1.8 
JC7l N/S 0.0 1.0 1.0 1.2 1.0 1.0 0.8 0.4 0.2 
o/S 0.2 0.6 0.8 0.8 1.0 0.8 0.4 0.6 0.0 
Ph/F 0.2 0.8 0.8 1.0 0.8 0.6 0.8 0.0 0.2 
Se 0.2 2.8 2.4 2.8 2.6 2.6 2.2 1.8 1.8 
JC72 N/S 0.4 1.2 1.2 0.8 1.0 1.0 0.8 0.6 0.2 
0/5 0.0 0.8 0.8 1.0 0.8 1.0 0.8 0.6 0.2 
Ph/F 0.0 0.6 0.8 0.6 0.8 0.6 0.6 0.4 0.2 
Se 0.2 3.0 2.8 3.2 2.6 2.4 2.0 1.8 1.6 
N/S Nasal Secretion 1:1 
O/S Oral Saliva Dialysed xlO 
Ph/F Pharyngeal Fluid Dialysed xlO 
Se Serum 1: 10 
* Homologous Neutralisation Index per 0.03 ml 
+ Animal showed clinical signs of anapnylaxis. See Text. 
(193) .. 
Fig 12. Neutralising Antibody Response In Bovine Secretions 
Following Passive Immunisation (Mean Of Three Steers) 
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intervals thereafter •. 
7.4.1. Total Protein and Interferon levels. 
No changes attributable to vaccination were detected in the total 
protein content of serum or secretions. Interferon was not detected 
in samples taken during the first 72 hours after vaccination or revaccin-
ation. 
Neutralising Antibody Response. 
Primary vaccination engendered a normal humoral response with anti-
body being first detected after 5 days and reaching a peak at about 21 
days. Antibody was found in tears and nasal secretion at low levels 
but not in dialysed oral saliva or pharyngeal fluid even when these sec-
retions were concentrated as much as a hundredfold. Serum antibody 
levIes had declined to about 2.0 (Neutralisation Index per 0.03 ml at 
>J 
1:10 dilution) and nasal and lachrymal antibody had fallen to baseline 
levels when the animals were revaccinated 35 days after the initial 
immunisation. 
After secondary vaccination a typical anamnestic response ensued 
in serum and antibody also became evident in external secretions. Serum 
antibody levels were invariably greater than those found in secretions 
and more antibody was found in fluids from the eyes and nose than in those 
from the mouth or pharynx. Serum antibody showed a gradual decline of 
about 2 logs (Neutralisation Index) over 12 months of sampling but 2.5 -
3.0 logs of neutralising activity remained. Antibody was detectable in 
tears for 6 - 8 weeks, in nasal secretion for 8 - 12 weeks and in oral 
saliva or pharyngeal fluid for 4 - 5 weeks after revaccination. In 
salivary secretions antibody was initially detectabl~ in unconcentrated 
(195) 
dialysed fluid but later it was necessary to concentrate by 50 - 100 fold. 
Approximately one year after secondary immunisation the steers were 
vaccinated for a third time. Serum antibody rose rapidly to levels as 
high as those seen in convalescent animals (cf Table 31 and Fig. 8) and 
high levels of activity were also demonstrated in all the secretions in 
the order: nasal secretion, tears, oral saliva and phar,yngeal fluid. 
Sampling continued for only 14 days after tertiary vaccination at which 
time antibody levels were still rising in each location. The pattern 
of neutralistng antibody response followed repeated vaccination is shown 
in Fig. 13 •• 
Immunoglobulin type. 
Pooled s~ples collected at weekly intervals after each vaccination 
were examined by gel diffusion, anion exchange chromatography, immuno-
diffusion, immunoelectrophoresis and adsorption procedures to determine 
the immunoglobulin type responsible for neutralisation. 
The early IgM response in serum was replaced by IgG and antibody 
of the IgGl and 1802 classes was responsible for most of the humoral 
neutralising activity from 28 d~B after primary vaccination to 14 days 
after tertiary vaccination. In the secretions of animals once or twice 
vaccinated neutralisation was principally associated with antibody of 
the IgGl class (with traces of IgM in early samples, particularly of " 
tears). However, in samples derived from steers 14 days after the third 
vaccination neutralisation was associated not only with the 180 fraction 
but also with the 19A class (Table 41). 
Conclusions. 
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Fig 13. Neutralising Antibody Response In Bovine Secretions 
Following Repeated Vaccination. 
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Table 47. Effect of I~~oglobulin absorption on the neutra1ising 
capacity of secretions from vaccinated cattle. 
Sample Absorbed Days post vaccination 
(and dilution) with* 0 1 Vacc 0 2 Vacc 0 3 Vacc 
14 21 7 28 7 14 
Serum (1:10) IgM* 92** 18 6 ;3 0 3 
IgA 3 9 2 5 13 15 
IgG1 10 91 88 96 100 100 
IgG2 12 85 100 92 95 96 
Lachrymal IgM 49 15 5 16 12 18 
Secretion IgA 12 13 86 80 19 43 
(1:2) IgG1 2 81 97 100 91 98 
IgG2 4 14 10 13 18 10 
Nasal IgM 10 8 2 6 4 4 
Secretion IgA. 5 6 3 4 2 49 
(1:1) IgGl 65 100 96 100 96 100 
IgG2 13 16 11 10 13 15 
Oral IgM 5 2 0 3 
Saliva IgA 3 5 10 36 
(x10 dialysed) IgGl 94 90 100 96 
IgG2 15 13 19 12 
Pharyngeal IgM 0 3 5 5 
Fluid IgA 5 8 15 32 
(x10 dialysed) IgGl 81 100 91 100 
IgG2 13 16 15 14 
*: Sample absorbed with antiserum against the specified immunoglobulin 
class. 
**: Reduction in the Neutralisation Index of sample after absorption 
with specific ahtiserum expressed as a % of the original unabsorbed 
value. 
-: not tested. 
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The amount of antibody detectable in the external secretions of 
cattle immunised by the subcutaneous application of inactivated ~ID 
vaccine was dependant upon the number of times that the animals had been 
vaccinated. After a single vaccination neutralising antibody was de-
tected for a brief period in small amounts in tears and nasal secretions 
but not in oral saliva or pharyngeal fluid even after these fluids had 
been concentrated. Serum antibody was plentiful. When animals were 
revaccinated 35 d~s later antibody became apparent in all the external 
secretions. Secretory antibody levels were always below those found 
concurrently in serum and greater amounts were detected in tears and 
nasal secretion than in oral sa~iva and pharyngeal fluid. High levels 
of serum antibody persisted for at least 12 months after secondary 
vaccination. Secretory antibody, however, declined more rapidly and 
was longest detected in nasal secretion (12 weeks). After one or two 
doses of vaccine antibody in all secretions was principally of the IgGl 
class. 
A third vaccination, 12 months after the second, resulted in in-
creased antibody in all samples to levels above those elicited by one 
or two doses and comparable with the amounts seen in convalescent animals 
(cf Figs. 8 and 13). An interesting alteration occurred in the distribu-
tion of neutralising activity in secretions following the third vaccina-
tion since an Ig! component was demonstrated in addition to IgGl. 
Vaccination did not give rise to detectable IF in serum or secretion 
nor did it produce changes in the total protein content or the distribut-
ion of protein classes which were measurable by the technique employed. 
The fact that antibody could be recovered from secretions after sub-
cutaneous vaccination with killed virus confirmed the possible involve-
ment of the secretory immune system in the protection of cattle 
vaccinated by this route. 
7.5. Secretions from Immunised and Challenged Animals 
Recovered animals are highly immune to a second challenge by homo-
logous FMDV. Furthermore, complete clinical protection against FMD is 
readily conferred upon cattle by subcutaneous vaccination wit.h conven-
tional inactivated vaccines. The immunity does not extend to the 
pharyngeal region however and vaccinated animals frequently become 
asymptomatic carriers of virus after challenge. Studies already des~ 
cribed showed that neutralising antibody could be detected in bovine 
secretions during convalescence (Section 1.2.) and after passive (Section 
7.3.) or active (Section 1.4.) immunisation. The final series of 
experiments was conducted to investigate the role of secretory antibody 
in the protection of cattle against FMD. Local immunity was studied 
after a) vaccination or b) infection. Immunit,y was assessed according 
to the degree of protection afforded against cl~ical disease, the amount 
of viral shedding in secretions and the development of the carrier state. 
Animals challenged after vaccination. 
Eight groups of 3 steers were vaccinated and revaccinated by the 
subcutaneous route using an inactivated type C Noville vaccine applied 
at varying intervals before exposure to challenge with homologous FMDV. 
Table 48 shows the schedule of vaccination. Samples of pharyngeal fluid, 
tears, nasal secretion and serum were collected for antibody assay before 
vaccination and at weekly intervals thereafter until the time of challenge. 
Oral saliva was not sampled since previous work had shown (Sections 1.2, 
7.3~ and 7.4) that antibody levels in saliva were indistinguishable from 
those in pharyngeal fluid. 
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Animals were exposed to infection by holding 3 steers for one hour 
in a loose box immediately after it had been vacated by 6 donor pigs 
infected with FLIDV 48 hours previously. The amount of virus in the box 
was replenished by reintroducing the donor pigs for one hour before the 
infection of the next group of cattle. Recipient groups were returned 
to their original uninfected box and the donors were slaughtered after 
the final exposure period. 
Steers were examined and sampled daily for ten days and then at 
irregular intervals for up to 42 days after exposure. Oral saliva, 
faeces and preputial swabs were taken in addition to these secretions 
sampled before exposure and all were examined for the presence and amount 
of virus. 
7.5.1.1. Antibody levels at the time of exposure. 
The vaccination schedule resulted in widely different levels of 
neutralising antibody in secretion at the time of exposure. Group mean 
neutralisation indices varied between 0.1 - 3.6 for tears, 0.3 - 4.3 for 
nasal secretion, 0.0 - 2.6 for pharyngeal fluid and 0.0 - 5.4 for serum 
(Table 49). The response to vaccination resembled that already described 
(Section 7.4.) except for group 2 in which antibody could not be detected 
7 d~ys after primary vaccination. 
Clinical protection 
Groups 1 and 2 succumbed with fully generalised disease. There 
was a total absence of clinical signs in groups 3 - 8 and no significant 
temperature response was detected in these animals. 
Excretion of virus. 
Table 48. 
Group 
1 
2 
3 
4 
5 
6 
7 
8 
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Schedule of vaccination prior to homologous challenge with 
Fl.lDV type C If oville. 
Status 
Vacc. xl 
Vacc. x2 
Vacc. x3 
Days vaccinated before exposure 
First Vacc. 
o 
7 
14 
21, 
28 
35 
42 
414 
Second Vacc. Third Vacc. 
o 
7 
14 
379 14 
Three steers were included in each group. 
(202) 
Table 49. Group mean Neutralising antibody levels at the time of 
exposure to maov type C Noville. 
Group 
1 
2 
3 
4 
5 
6 
1 
8 
Status 
Lis 
Vacc. xl 0.1* 
0.3 
1.8 
1.1 
Vacc. x2 1.1 
Vacc. x3 3.6 
Secretion 
Nls l?h/F 
0.3 0.0 
0.5 0.0 
1.6 0.2 
1.9 0.0 
1.2 
2.6 
Se 
0.1 
0.2 
2.2 
2.8 
2.8 
* Homologous mouse neutralisation index per 0.03 mI. Geometric mean 
of results derived from 3 animals. 
Lis Lachrymal secretion 112 
N/s Nasal secretion 1:1 
Ph/F Pharyngeal Fluid Dia1ysed.xlO cone. 
Se Serum 1:10 
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The frequency of recovery of virus in samples taken daily from 
each group between Days 1 and 11 after exposure is given in Table 50. 
Viral excretion in animals vaccinated once on the day of exposure or 
seven days previously closely resembled that seen in non vaccinated 
animals (of Table 20). However, excretion was almost completely in-
hibited in all situations excepting pharyngeal fluid in cattle vaccina-
ted one or more times at least 14 days before challenge. The sporadic 
recovery of virus from sites other than the pharynx and the small amount 
of virus involved (equal or less than 1.5 CTY ID50 per sample) were com-
mensurate with contamination during sampling rather than with true 
infection. 
Pharyngeal fluid from group 3 contained virus as often and at the 
same level as samples from groups 1 and 2. However, viral recovery from 
this secretion was somewhat less frequent in groups 4 - 7 and strikingly 
less in group 8. Pharyngeal virus was confined to a single animal in 
this froup and recoveries were made on only 3 occasions during the first 
10 days of sampling and ; out of 10 subsequent samples taken at intervals 
during the period 10 - 42 days post exposure. 
Detection of Interferon. 
Interferon was not detected in serum or secretion samples taken 
during the first 48 hours after exposure to virus. 
Recovery of virus at post mortem. 
The marked reduction in the amount of virus recoverable in pharyngeal 
fluid samples from thrice vaccinated steers in group 8 was investigated 
further when the animals were slaughtered 42 days after challenge. 
Tissue f=om the dorsal and ventral surfaces of the soft palate, pharyngeal 
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Table 50. Recovery of virus from vaccinated cattle during the first 
ten days after exposure to FLIDV type C Noville. 
Group 
1 
2 
3 
4 
5 
6 
7 
8 
LiS 
15* 
18 
3 
0 
o 
o 
1 
o 
N/s ols 
25 27 
21 25 
0 2 
0 1 
2 o 
o o 
o 2 
o o 
Sample 
Ph/F 
26 
24 
29 
19 
16 
17 
19 
3 
P 
20 
21 
3 
1 
o 
o 
o 
o 
F Se 
4 10 
9 9 
0 0 
0 0 
1 o 
o o 
o o 
o o 
* Number of times that virus was recovered from 30 samples (3 cattle 
sampled daily for 10 days). Infectivity assay performed in CTY tube 
cultures. 
Lis Lachrymal Secretion 1:2 P Preputial Swab 1:5 
N/s Nasal Secretion 1:1 F Faeces 1:10 
o/s Oral Saliva 1:1 Se Serum 1:1 
Ph/F Pharyngeal Fluid 1:1 
wall and tonsil were obtained at post mortem, processed and examined for 
FMDV by inoculation onto CTY monolayer cultures. Although no virus 
could be demonstrated in fluid samples taken immediately prior to slaugh-
ter, type C virus was recovered from the pharngeal tissues of all 3 
animals. Virus was recovered in amounts of 1.0 - 1.7 CTY ID50 per gram 
of tissue, and only in samples from the dorsal surface of the soft palate. 
7.5.2. Animals challenged after infection. 
The experiment described in section 7.5.2. was performed conjointly 
with Mr. J.A. Mann of this Institute. 
Eight steers were challenged with homologous virus approximately 
~ years after infection with FMDV type Al19. The animals had been 
asymptomatic carriers of virus for as long as 105 weeks during the initial 
convalescence (see Section 7.2.2.) but no virus was detected in 6 samples 
taken during the period 4 - ~ years post infection. The steers were 
housed in pairs and challenge:was effected by the intradermal inoculation 
of 105•0 Bovine Tongue ID50 over 10 sites on the lingual dorsum of one 
animal in each pair. Two normal steers were treated in the same way 
to act as challenge controls. Secretions were sampled before reexposure 
to infection and for as long aJr8 days after as previously described 
(Section 7.5.1.). 
7.5.2.1. Antibody levels at the time of exposure. 
Table 45 gives the mean and range of neutralisation indices in the 
secretions of the convalescent steers at the time of reexposure to virus, 
66 months after primary infection. The antibody levels and immuno-
globulin types have been discussed in section 7.2.2 •• 
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Clinical protection. 
Clinical disease in convalescent steers was confined to the tongue 
inoculation sites, some of which showed mild, non progressive lesions 
of an erosive nature along the track of the needle reminiscent of the 
effect often noted after the intradermolingual inoculation of attenuated 
strains of FMDV. Control animals succumbed with generalised disease. 
Excretion of virus. 
Virus was not detected in tears, nasal secretion, oral saliva, 
pharyngeal fluid, preputial swabs, faeces or serum sampled during the 
first 10 days after reexposure or in pharyngeal fluid obtained on 6 
occasions during the period 10 - 28 days after challenge. Virus was 
readily detectable in the secretion of control animals where excretion 
conformed to the pattern previously established (Section 1.2.1.1. and 
Table 11). 
Recovery of virus at post mortem. 
Convalescent steers were slaughtered 26 - 28 d~s after reexposure 
to FMDV and tissue samples from the dorsal and ventral surface of the 
soft palate, the wall of the pharynx and the tonsils were processed and 
examined for infective virus. Virus was not detected, even after fluoro-
carbon treatment had been applied to the samples. 
Antibody response after reexposure. 
Although both control animals developed generalised disease the 
absence of detectable virus in the secretions of animals after reexposure 
called into question the adequacy of the challenge procedure, particularly 
(2°7) 
for the non inoculated member of each convalescent pair. Proof of 
adequate exposure was sought by examining the neutralising antibody 
response to challenge. Table 51 shows the differences in the neutral-
isation index of serum and secretions measured immediately prior to re-
exposure and again 10 days later. Two interesting features are apparent. 
All 4 inoculated and 2 non inoculated steers showed a rise in serum 
antibody but no such increase occurred in the other 2 non inoculated 
steers infected by contact (FE54 & FE75). However, in one of these (FE54) 
there was evidence of a rise in the neutralising capacity of external 
secretions in the absence of a humoral response. 
The results showed that 1 of 8 steers were exposed to antigen in 
sufficient concentration to stimulate an increase in neutralising anti-
body while one animal exposed by contact infection may not have received 
an adequate challenge. The results also indicate a possible dissociat-
ion between the local and humoral responses in the production of neutral-
ising antibody following challenge by contact. 
Conclusions. 
Various schedules of single, double and triple vaccination gave rise, 
as planned, to a wide range of antibody level at the time of exposure 
to infection. At one extreme steers vaccinated once on the d~ of 
exposure or 7 days previously were without detectable antibody while at 
the other, steers vaccinated for the third time 14 days before exposure 
exhibited antibody levels comparable with those of convalescent animals. 
As in previous experiments serum antibody was detectable earlier and at-
tained higher levels than secretory antibody and all levels increased 
with repeated vaccination. 
In convalescent animals serum antibody showed higher levels than 
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Table 51. The neutra1ising antibody response in serum and secretions 
after reexposure of steers to F.1I'IDV type Al19. 
Box Animal 
No. 
1 FE5l 
FE53 
2 FE56 
FE75 
3 FE50 
FE54 
4 FE74 
FE55 
Method of 
Infection* 
Tongue 
Contact 
Tongue 
Contact 
Tongue 
Contact 
Tongue 
Contact 
Se 
2.0** 
1.2 
1.9 
0.0 
2.0 
0.2 
1.6 
2.2 
I 
Sample 
L/S 
1.0 
1.0 
0.8 
0.2 
1.2 
0.8 
1.0 
N/S Ph/F 
1.4 0.8 
1.2 0.8 
1.0 
0.0 0.2 
1.6 1.2 
1.2 0.8 
1.6 1.2 
1.8 1.4 
* Steers were infected by intradermal inoculation of the tongue or by 
direct contact with the inoculated animal. 
** Rise in homologous neutralisation Index of the sample between Day 0 
and D~ 10 post challenge (N.r. per 0.03 ml). 
Se Serum 1:10 
L/S Lachrymal Secretion 1:2 
Nls Nasal Secretion 1:1 
Ph/F Phar.yngeal Fluid Dialysed 1:1. 
secretorJ antibody_ However, 1 of 8 convalescent steers reexposed to 
homologous challenge proved to be a notable exception in that antibody 
levels rose in secretions but not in serum. 
Animals which had been vaccinated one or more times at least 14 days 
before exposure were immune to the development of clinical lesions, 
resisting challenge which produced severe generalised FMD within 3 days 
of exposure in steers vaccinated on the day of exposure or 7 days pre-
viously. The susceptibility of the latter group was unexpected since 
earlier work in this field had shown that cattle vaccinated as early as 
2 - 3 days before exposure could be protected against clinical disease 
(Graves et al 1968, Garland, Burrows and Greig unpublished). 
Convalescent animals showed only mild local lesions following homo-
logous challenge ~ years after primary infection. 
Viral excretion in vaccinated but non immune animals was essentially 
similar to that already established in normal cattle. Vaooination pro-
cedures which produced clinical protection were also associated with the 
virtual elimination of viral shedding in all secretions other than 
Pharyngea~luid. The sporadic recovery of virus from sites other than 
the pharynx and the small amounts involved (1.5 CTY ID50) were oommensur-
ate with contamination during sampling rather than with true infection 
and excretion. 
One or two doses of vaccine failed to prevent the acquisition of 
the carrier state although there were indications of a slight reduction 
in the frequency of viral recovery after a second vaccination. However, 
a highly significant reduction was observed in the recovery of carrier 
virus from animals vaccinated three times. In sampling during the period 
o - 42 days ~ust exposure pharyngeal virus was detected in only 1 of 3 
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steers in this group and on only 6 of 20 occasions. The next lowest 
frequency, found in animals twice vaccinated at exposure, gave corres-
ponding figures of 3/3 and 15/20. Nevertheless all 3 steers were found 
to be harbouring virus at post mortem. Three doses of vaccine therefore 
failed to prevent the acquisition of the carrier state but did succeed 
in producing a dramatic reduction in the excretion of virus in pharyngeal 
fluid. 
Virus was not detected in the secretions of convalescent steers 
after reexposure to homologous challenge. The animals did not become 
carriers and no virus could be recovered from pharyngeal predilection 
sites at post mortem. Immunity engendered by previous infection may 
therefore be sufficient to prevent the acquisition of the carrier state. 
Neutra1ising antibody in secretions after one or two vaccinations 
was principally of the IgG1 class and was associated with resistance to 
infection in all superficial sites except the pharynx. In the secret-" 
ions of convalescent or thrice vaccinated animals neutra1ising antibody 
was associated with IgGl and also with IgA. Increased pharyngeal 
immunity as shown by reduced viral excretion in thrice vaccinated animals 
or by the ability of convalescent animals to resist pharyngeal infection 
was therefore associated with the presence of IgA antibo~ in secretions 
at the time of exposure. 
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DISCUSSION 
In natural infection of cattle with FMD the initial encounter 
between virus particle and susceptible cell may occur at one of several 
portals including the conjunctiva, nasal passages, oral cavity, pharynx 
and lower respiratory tract. A common feature of these sites is the 
presence of a film of secretion which bathes the outer mucosal and 
epithelial surfaces. These secretions ~ play an important part in 
the defence of the animal against invading pathogens including viruses 
as indicated by early work on mucoantibody and coproantibody in 
influenza and poliomelitis. More recently the discovery of the inter-
ferons and the partial elucidation of the secretory antibody system 
have given fresh impetus to the study of local immunity. Since primary 
sites of FMD infection are in superficial locations and since prelimin-
ary reports have shown the presence of antibody in bovine secretions 
after infection with the virus, close study of local immunity seemed 
appropriate. 
This study began with an investigation of the physiological proper-
ties of normal bovine secretions to determine their influence on the 
process of infection with FMDV. Techniques and equipment were devised 
for the collection of large amounts of seoretion. The total protein 
content, pH range, Ig class and antiviral activity of tears, nasal 
secretion, oral saliva and pharyngeal fluid were examined in samples 
from 101 normal steers. 
The total protein content of the secretions of Red Devon cattle 
fell within those quoted for other breeds (Table 10). Levels in 
sequential samples varied less than the widely divergent values reported 
by Butler et al (1972a) or Duncan et al (197~. Their work differs in 
respect of breed, sex and physiological status since it concerned lac tat-
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ing cattle of the Holstein-Friesian breed. The variability in dairy 
cattle would however be unlikely to influence suscept.ibili ty to mlID to 
any marked extent. 
The type and distribution of immunoglobulins in the secretions of 
Red Devon steers (Table 12) was similar to that described for other 
breeds of cattle. IgA predominated, IgGl was also commonly found and 
IgM occurred in certain secretions, notably in tears. The origin of 
local Ig in cattle has not been fully elucidated. In man various 
sources are accepted e.g. salivary Ig may be derived from a) the major 
and minor salivary glands, b) serum via transudation, c) crevicular 
fluid and d) local production by plasma cells (Dayton et al 1969). 
Mach and Pahud (1971) have shown the synthesis of secretory IgA by 
bovine parotid and submaxillary glands in vitro and paramucosal cells 
containing IgA have been demonstrated in the lower gut, lungs, nasal 
mucosa, oral phar,ynx, parotid and lachrymal glands (Porter and Noakes 
1970, Butler et al 1971, Mach and Pahud 1971, Hurliman and Darling 1971). 
Passive immunisation in cattle using radioactively labelled IgGl and 
IgG2 have shown some selectivity in the transport of IgGl into aliment-
ary, respiratory and occular fluids (Curtain 1971, Sullivan et al 1969, 
Pedersen and Nansen 1972). Evidence from passive immunisation studies 
must be interpreted with caution, since the results depend not only on 
the constituents of the transferred serum but also on the integrit,y of 
the reoipient vascular system. Nevertheless the results obtained in 
this thesis (Section 7.3.) lend support to the view that some secretory 
antibody can be acoounted for by overspill from serum. The results of 
active immunisation and infection studies discussed below indicate that 
secretory Ig can also be derived from other sources. 
The pH of secretions was measured in the animal or as soon as possible 
after collection and normal values established (Table 5). The pH may 
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have altered during collection. For example, carbon dioxide may have 
escaped from blood while it was expressed from the syringe or from nasal 
secretions during recovery from tampons. However, the figures for blood 
compare reasonably well with the theoretical values derived using the 
Henderson - Hasselbach equation (Altman and Dittmer 1961). Moreover 
the pH value of nasal secretion collected by means of a pasteur pipette 
as it accumulated in the nares differed little from that of fluid 
expressed from tampons, Dif~erences between values quoted in this 
thesis and those obtaining in the animal are therefore likely to be small. 
The effect of hydrogen ion concentration on FMDV is well known 
(Bachrach et al 1957, Mussgay 1959). Several authors have commented 
on the antiviral activity of alkaline pH in oro-pharyngeal secretions 
(Van Bekkum et al 1966, Hedger 1968, Burrows 1966, 1972) but there have 
been no detailed studies of pH inactivation in natural bovine secretions. 
The limits of pH stability of the 4 virus strains were first investigated 
in buffers (Fig. 3b). Comparison of the range of pH stability with 
the pH value of secretions (table 5 and Fig. 3a) showed that nasal 
secretion and more especially oral saliva and pharyngeal fluid were 
sufficiently alkaline to cause damage to capsid protein while urine could 
be suffiCiently acid to disrupt the virion exposing the nucleic acid to 
unfavourable pH and to the action of ubiquitous nucleases. 
Inactivation of virus in normal tears and nasal fluid at 37°0 and 
under physiological conditions of pH and protein content proceeded at 
a slow rate similar to inactivation in buffer and commensurate with 
thermal inactivation. In oral saliva and pharyngeal fluid virus was 
inactivated at a rate greater than that attributable to pH alone (Fig. 4). 
The additional antiviral factor was effective against 3 types of FMDV, 
concentration dependant, active over the pH range 7.5 - 8.5, unaffected 
by heatir~ at 60°C for 1 hour, partially destroyed after 10 minutes and 
totally destroyed after 20 minutes at 100 C and removable by dialysis. 
Concurrent work at this Institute on the aerosol stability of FMDV 
type 01 BFS 1860 has shown the virus to be more unstable when suspended 
in bovine salivary fluid than when suspended in cell culture fluid, milk, 
faeces or nasal secretion (Donaldson 1912, 1913, Barlow and Donaldson 
1913). Inactivation was caused by an undefined organic molecule which 
was dialysable and sensitive to heating at 10°C but ~ot at 60oC. It 
is probable that the factor causing inac~ivation of type 01 BFS 1860 in 
aerosols of bovine salivary fluid is the same factor causing inactivation 
of types 01 BFS 1860, 01 Swiss 1/66, Al19 and C Noville in oral saliva 
and pharyngeal fluid in this study. 
No amylase or protease has been reported in bovine saliva and the 
secretion is apparently devoid of peroxidase and lysosyme which exist 
in the saliva of other species (Bailey and Balch 1961a and b, Hyslop 
1965a, Kay 1966, Phillipson 1910).' Nevertheless the additional factor 
might be a dialysable enzyme or an enzyme-coenzyme system and although 
the addition of some inhibitors (mercuric chloride, sodium azide and 
iodoacetamide) or a chelating agent (ethylene-diaminetetra acetic acid) 
had no effect on its capacity to inactivate FMDV in aerosols (Barlow and 
Donaldson 1913) or in suspensions (Garland unpublished data) the results 
do not preclude this possibility. 
Secretions were obtained from 101 individual steers, many sampled 
repeatedly, and the additional antiviral factor was detected 1n all 
samples of oral saliva and pharyngeal fluid tested. Other workers have 
stated that normal bovine saliva possessed no antiviral activity (Hyslop 
1965a, Figueroa et al 1913) or made no mention of such activity (Kaaden 
and Matheaus 1970). These reports are difficult to reconcile with the 
invariable occurrence of the factor in th~ present study but might be 
explained by the use of different breeds of cattle, assay of activity 
in different systems and the focus of attention on antibody rather than 
on other factors. 
The fact that type C Noville was more resistant to alkaline pH and 
to the additional antiviral factor than were types 01 Swiss or Al19 
(Section 7.1.3. and Fig. 3b) illustrates the important differences which 
may exist between types and strains of FMDV in this respect. 
The maximum rate of viral inactivation due to the combined agencies 
of temperature, alkaline pH and the additional non specific factor in 
salivary secretion was 1.25 log units per hour. This value was deter-
mined from in vitro kinetic studies and may well be lower than the rate 
in vivo since it makes no allowance for the continuous admixture of 
fresh secretion which occurs in the animal. The flow rate of parotid 
saliva varies from 2.0 mllminute in the resting steer to 30 - 50 mll 
minute during feeding and the lactating cow may secrete 98 - 190 litres 
of mixed saliva per day, the volume depending to seme extent on the diet 
(Bailey 1961, Bailey and Balch 1961a and b). The importance of the 
natural non specific, antiviral factors must be considered in relation 
to the rate of infection of cells with FMDV. Experiments in tissue 
culture gave a half time of penetration of cells by FMDV of 30 seconds 
at 37°C (Thorne 1962) and current work in organ culture on the infection 
of tissue from the pharyngeal region of the calf has shown that cells 
may become infected with FUnV during an exposure time of 5 seconds 
(Garland and Hamblin, unpublished data). Even allowing for the pro-
digious secretion of saliva in the cow with its diluting and washing 
effect and the fresh addition of viral inhibitors, it is probable that 
the natural antiviral factors in bovine secretions are of limited pro-
tective value since viral inactivation proceeds only slowly under their 
influence. Indeed, the incidence of disease, the rate at which lesions 
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developed and the severity of the syndrome in normal cattle showed no 
correlation with the presence or amount of non specific antiviral factors 
in secretions. It should be noted, however, that a severe challenge 
was employed and it is possible that the non specific factors might 
assume a more significant role in animals exposed to minimal amounts of 
virus. 
Cattle vary in their susceptibility to FMDV. Variations in sever-
ity of clinical disease is usually apparent in any group of infected ., 
animals and titration of a viral suspension by a standard method of 
intradermolingual inoculation will give different results in different 
individuals (Henderson 1949). Variations in natural secretory anti-
viral factors may contribute to the differing susceptibility but since 
the secretions of all the cattle examined contained similar antiviral 
activity this possibility could not be tested. 
, 
A related topic concerns the transmission of FMDV between carrier 
and susceptible cattle. Transmission experiments have had little 
success although epidemiological evidence strongly suggests that such 
spread does occur. The event is rare and probably requires a combin-
ation of special circumstances, one of which might be a deficiency of 
non specific antiviral factors. An animal with such a deficiency could 
play the part of the super receiver or super excretor of virus as en-
visaged by Schulman and Kilbourne (196,) and others in the spread of 
influenza. 
An extensive survey was carried out to investigate the occurrence 
of variations and abnormalities in the pH value, protein content, Ig 
class and antiviral activity of bovine secretions (Sections 7.1.1. - 7. 
Samples taken from cattle at 4 hourly intervals over a 24 hour 
period, at daily intervals over a week or at monthly intervals over a 
year showed only minor variations. Samples from 101 individual animals 
all contained the additional antiviral factor. Interferon in any 
measurable amount was consistently absent. Secretions bathing the 
predilection sites showed very little fluctuation. Two different diets 
caused changes only in the pH of urine. On the other hand rare defici-
ency states are known, e.g. Nansen (1912) has recently reported on the 
existence of specific dyscriases of IgG in Red Danish cattle and other 
immunological abnormalities ~e likely to emerge. It is possible that 
abnormalities of secretory antiviral factors may be involved in both 
the varying susceptibility of cattle to FMDV and in the sporadic trans-
mission of ?JDV from the carrier animal but the present studies show 
that such abnormalities are uncommon. 
The occurrence, nature and significance of induced antiviral factors 
in secretions was next examined during the course of infection of steers 
with F.MDV. Viral excretion, clinical symptoms, interferon induction, 
secretory antibody production and the relationship between them were 
studied in cattle infected by exposure to virus excreted from donor pigs •. 
The method was chosen because it combined a natural route of infection 
with a high degree of efficiency. It does however have the inherent 
disadvantage of not allowing precise measurement of the challenge dose. 
All normal steers exposed to FMDV developed generalised disease, 
lesions being first detected within 2 - 4 days of exposure (Tables 22 
and 23). No correlation could be drawn between the rate at which lesions 
developed, the severity of the syndrome and the amount of viral excretion 
on the one hand and the amount of natural antiviral activity in secret-
ions at exposure on the other. The different rates at which individual 
animals became clinically ill may have been related to inequalities in 
the challenge dose and/or to differences in one or more of the many de-
terminants of host susceptibility. 
(21S) 
Pathogenesis of disease is dependant upon a multifactorial complex 
with four principal interrelated components; the virus, the environment, 
the host and the chance which combines them. Each component comprises 
a number of elements, many poorly understood. Viral factors include 
those of type, subtype, strain, history, resistance to inactivation, 
virulence, dose and method of presentation. Environmental factors in-
clude those of season, metereology and husbandry. Host factors include 
species, breed, sex, age, nutritional plane, physiological condition, 
intercurrent infection, disease history, vaccinal status and the presence 
and development of specific and non specific host defences. (the latter 
have already been discussed in Section 5.1.4.). In the present study 
an attempt has been made to investigate some important factors in the 
pathogenesis of FMD but the existence and potential of many other deter-
minants of resistance of susceptibility must also be borne in mind. 
A cautious interpretation of viral infection and excretion was 
necessary. The method of challenge was likely to result in the deposit-
ion of virus in all superficial sites so that the early recovery of 
virus from an area might be due to residual contamination rather than 
true infection and multiplication. Similarly, as infection developed, 
virus shed from active sites of multiplication might well contaminate 
other regions in the same animal or in box mates. With the onset of 
viraemia infectivity would become widely disseminated in tissues and 
possibly in secretions and thus the origin and significance of virus 
recovered in samples at that time would be in doubt. These considera-
tions apply to all the challenged animals but steers exposed to type 01 
Swiss illustrate the effect of overwhelming infection particularly well 
since 24 hours after exposure virus was recovered from all sites other 
than faeces and urine (Table IS). Challenge with the other strains 
appears to have been less severe (Tables 17, 19 and 20) and in one 
animal (Steer BRS, Table 19) the secretions were virtually devoid of 
virus at the first sampling, one day after exposure. Despite these 
difficulties it is possible to discern a pattern of infection based on 
the relative amounts of virus in concurrent samples, the time at which 
virus appeared and the development and distribution of lesions in each 
situation. 
The results (Tables 11 - 20 and Fig. 5) confirm the primary involve-
ment of the pharynx since virus was recovered most consistently in 
secretions from this area, often earlier and almost always to higher 
titre than in samples from other regions. Several other workers have 
shown that FMDV was recoverable from pharyngeal fluid for several days 
before other secretions became infected and before the development of 
lesions following the exposure of cattle to aerosols (Burrows 1968a, 
et al 1911, Sellers et al 1968? 1969), intramammar.y instillation 
(Burrows et al 1911) or intravenous inoculation (Mann and Garland, un-
published data). Examination of upper respirator.y and alimentar,y 
tract tissues from cattle slaughtered during the prodromal period 
confirmed the involvement of the pharynx (Burrows 1912, Garland unpub-
lished data). The suggestion that nasal mucosa might be a site of 
primary infection (Korn 1951) has received less ~ttention but in one 
report samples from this area were much less frequently infected than 
pharyngeal tissues in the early stages of the disease\(Burrows 1912). 
Sutmoller and McVicar (1913) showed that primar,y infection of the 
bovine conjunctiva could occur and that virus spread to pharyngeal fluid 
within minutes or hours of conjunctival instillation. In these studies 
samples were taken from only some of the natural secretions in each case 
whereas in the current work comprehensive samples were obtained. 
Appreciable amounts of virus were recovered in samples from the 
eyes, nostrils and mouth as well as from the pharynx during the prodromal 
period showing that early foci might also develop in these situations. 
(220) 
One novel finding was the frequent presence of virus in preputial swabs 
at the first sampling 24 hours post exposure. The rising titre of 
successive samples and the subsequent development of lesions indicates 
a true infection of the prepuce (e.g. Steer HX21, Tables 17 and 22) 
which must therefore be considered as another focus of primary infection 
in the steer. Since steers spend much of their time in a recumbent 
position it is possible that low grade trauma caused by the pressure of 
the ventral abdomen on the floor of the box might predispose to infection 
of the prepuce in the same way that mild mechanical damage is known to 
exacerbate tongue lesions in cattle or pad lesions in the guinea pig 
(see literature review Section 5.1.2.). 
Many aspects of the excretion of FLIDV have been investigated. Most 
workers, however, have been concerned with a limited number of secretions, 
many have used artificial methods of infection and employed assay systems 
of low sensitivity for FMDV. The present study provides a detailed 
, 
account of viral excretion for 4 strains of FMDV in all the secretions 
of steers following simulated natural infection as measured in CTY tissue 
culture, the most sensitive assay system currently available. (Snowdon 
1966, Donaldson et a1 1970). In general the results accord well with 
previous reports. Useful aomparisons may be made between the present 
findings and those of other workers who have approached the topic from 
different standpoints. Two examples follow. 
Scott et al (1966) followed the excretion of virus in Hereford steers 
infected with FMDV by intramuscular or intradermo1ingual inoculation and 
were able to recover virus in CK mono layers from nasal secretion for up 
to 6 days and from saliva for up to 9 days after the detection of lesions. 
Their work differs from the present stu~ nat only in methods of infect-
ion and assay but also in emphasis since it was concerned more with the 
limits of viral persistenc~ in lesion material (vesicle epithelium from 
(221) 
the muzzle, mouth and feet) than with the overall pattern of excretion. 
The method of infection has an obvious influence on the rate of develop-
ment of disease, the distribution of lesions and the shedding of vi1~s 
during the incubation period but comparison of samples common to both 
reports indicates that it has little bearing on the excretion of virus 
after the appearance of lesions. 
Viral excretion has also been studied in cattle following indirect 
contact 
. a 
infection at this Institute (Burrows 1968, 1972, et al 1971, 
Sellers b et al 1968, 1969). Animals were housed in the same compound 
as infected donors but at some distance from them and in different boxes. 
Infection therefore differed from that in the current experiments in that 
cattle were usually exposed to lower doses of virus presented principally 
by the airborne route. The emphasis of this work was on the detection 
of early sites of viral multiplication and on excretion during the pro-
dromal period. Sampling was normally discontinued at the onset of 
clinical lesions. Disease was characterised by a longer incubation 
period (5 - 10 days) than that normally found after infection by direct 
contact (2 - 4 days in this study) and by the recovery of virus from 
various sites for several days before the appearance of disease. In 
particular pharyngeal fluid contained virus for as long as 9 days (range 
o - 9 days) before the development of lesions. 
In this thesis the topic of viral excretion was approached from 
another related standpoint with two main aims in view. Firstly, to 
provide a comprehensive survey of excretion in the external secretions 
of steers throughout the course of. the disease and secondly, to furnish 
a yardstick with which to measure the efficiency of antiviral substances 
in the secretions. The methods used and the results obtained in pursuing 
these ends occupy a somewhat intermediate .position between the two types 
of approach discussed above and may be used to relate these and similar 
(222) 
observations. 
Virus was found in~all the natural secretions ruld excretions in 
increasing amounts during the prodromal period and excretion reached a 
peak immediately before, during and after the formation and rupture of 
vesicles. Viraemia occurred at about the same time and lasted for 3 -
5 days. Urine and faeces contained the least amounts of virus and 
recovery from these excretions was intermittent. Virus persisted in 
the pharJ~geal fluid of all animals for more than 10 d~s and the longest 
periods for which virus was recovered from other secretions werel tears 
7 days, nasal secretion 9 days, oral saliva at least 10 d~s (9 days in 
most animals), faeces and urine 7 days, preputial swabs 8 days, and 
serum 7 days. 
The airborne excretion of FMDV was not measured but there can be 
no doubt that infected secretions provide a source of virus for aerosols. 
Expired air could be contaminated during passage through the mouth, nose 
and pharynx, particularly when lesions are present in these areas. 
Aerosols might be created during mastication, sneezing, snorting, bellow-
ing, coughing, lowing and the smacking movements of the tongue often 
seen during the clinical phase of FMD. In the case of pigs, at least, 
the virus appeared to originate from expired air rather than from other 
sources of viral excretion (Sellers et al 1970, 1973). However, other 
sources of virus are available such as milk, urine and faeces which may 
be voided with splashing and aerosol formation. Data is available on 
the airborne dissemination of all the viruses used in this thesis except 
strain Al19. The maximum amount of virus in secretion was recovered 
from cattle at the time when lesions first appeared which also corres-
ponds with the peak of aerosol excretion (Sellers and Parker 19691 
Donaldson et al 1970). 
The total output of virus in any secretion or excretion may be 
related to its volume and values may be calculated to show the maximum 
theoretical content in each case (Sellers 1971 and Table 21). These 
figures eophasise the potential hazards but provide only a rough guide 
to actual excretion since they make no allowance for other effects of 
the disease such as increased salivation, reduced faecal output or low 
urinary pH. 
The persistence of virus in pharyngeal fluid for extended periods 
of time after exposure provided further confirmation of the carrier state 
in FUn. The possibility of virus survival in other areas of the conval-
escent animal has received less attention but assay of 42 representative 
tissues from all areas of the respiratory and alimentary tract of 6 
steers at post mortem revealed the presence of virus ~nly in samples from 
the pharyngeal region (Table 24). 
There have been no reports of:IF production in domestic animals 
after natural infection with FMDV. IF has been detected in cattle 
after the inoculation of the viruses of Newcastle disease (NDV), vaccinia 
a 
and parainfluenza type 3 (PI-3) (Rosenquist and Loan 1969b, Ahl and 
Straub 1972) and infectious pustular vdlvovaginitis (IPV) (Ahl and Straub 
1972). The viruses differ greatly in their capacity to stimulate IF 
with NDV (a non replicating agent in cattle) being a very potent inducer 
and PI-3 (a natural bovine pathogen) being a poor inducer (Trueblood and 
Manjara 1972). The peak IF response in cattle may occur 12 hours after 
inoculation (NDV), at 2 days (IPV) or 5 days (IBR) after infection and 
IF may be detected for 2 days (NDV), 7 - 14 days (IBR) or 9 days (IPV) 
after inoculation. The amount may vary widely between locations in the 
animal, thus nasal and vaginal secretion contained 6 or 10 times more 
IF than did serum after infection with IBR or IPV viruses respectively 
and IF was detected for much longer periods in the exteI"nal secretions 
(Abl and Straub 1972). 
IF was detected in the current study following clinical infection 
hut not after vaccination or vaccination and subsequent exposure of 
immune anioals. The appearance of IF was strictly confined to the 
period of maximum viral multiplication which in turn coincided with the 
full expression of clinical disease (Tables 26 - 29). IF was commonly 
.. 
detected for only 2 or 3 days (maximum 4 days). Nasal secretion con-
tained most IF followed by serum and tears, considerably less was found 
in oral saliva and pharyngeal fluid and none in urine and faecal suspen-
sion. The low levels seen in salivar.y fluids may merely reflect the 
dilution of IF in these secretions and the same factor may be involved 
in the apparent absence of IF in pharyngeal fluid during the carrier 
state. On the other hand, chronic residence of virus in the pharynx 
might be associated with the hyporeactive state which may develop in 
cells under repeated viral stimUlation (Ho and Kono 1965, DeClerq and 
Yerigan 1970) resulting in the production of less IF. This possibility 
is supported to some extent by the work of Phillipson and Dinter (1963) 
who were able to demonstrate IF in persistently infected CK cultures 
during the first 10 days but not dUring the 20th to 40th day of chronic 
infection with FMDV. 
Since the initial report by Hyslop (l965a) several workers have 
mentioned the presence of specific neutraliaing antibody or antiviral 
substances in the secretions of cattle convalescent to FUn (see Section 
5. 2.). These reports have been of a preliminary nature and apart from 
the weekly sampling of nasal fluid and saliva in calves for one month 
following infection (Figueroa et sl 1973) and the association of the 
neutralising capacity of concentrated, 6 week convalescent, bovine saliva 
with an immunoglobulin analogous to human secretory IgA (Kaaden and 
Matthaeus 1910) few details are available of the way in which antibody 
(225) . 
develops ~~d persists in secretions or the class of Ig involved. 
Daily sampling of all secretions for 10 days after exposure revealed 
that antibody was detectable within 3 - 5 days of exposure in all in-
fected animals (Section 7.2.1., Tables 30 - 33 and Fig. a). Peak levels 
were reached within 21 - 28 d~s (Tables 34 - 37) and antibody persisted 
for at least ~ years after infection (Tables 44 &45). Serum antibody 
levels were above those found in the external secretions in all but one 
animal (Section 7.5.2.5., Table 51) and were usually demonstrable at a 
dilution of 1:10. Nasal secretion and tears contained the most secret-
ory antibody, normally demonstrable in Unconcentrated fluid at the height 
of the response, while oral saliva and pharyngeal fluid contained least 
and neutralising antibody was often detectable only after concentration 
of the fluid by as much as a hundred fold~ Blood sampling therefore 
continues as the method of choice for diagnostic and epidemiological 
purposes. 
Detailed observations on the development of lesions, the excretion 
of virus, the induction of IF and the production of antibody in acute 
FUD provided a clear picture of the temporal and quantitative relation-
ship between these factors (Fig. 11). The appearance of IF showed a 
good correlation with the time of development of lesions whereas the 
appearance of antibody was better correlated with the time elapsing after 
exposure to virus. In general virus declined in secretions after the 
appearance of IF and the development of antibody was attended by a marked 
decreqse in the amount of recoverable virus. These observations are 
in accordance with the hypothesis that IF, which is induced early in the 
course of the disease, may serve to limit the multiplication of virus in 
primary foci and to localise the spread of lesions while antibody, which 
appears slightly later, acts to neutralise virus, promote resolution, 
rid the host of infection (ex~ept in the phar,ynx) and provide lasting 
(226) 
iCll1'.1.1'1.i ty against infection. 
The observations show that such interrelationships could exist and 
some supporting evidence for the role of antibody is provided by the 
results of dissociation procedures (Table 42). However, it must be 
emphasised that the correspondence of factors in time means that a sig-
nificant interaction is possible but does not in itself prove any teleo-
logical effect. The difficu~ty in separating the defensive roles. of 
secretory and humoral factors has already been discussed (Section 5.2.) 
and the possible involvement of cell mediated immunity and other pro-
tective mechanisms as yet unrecognised should be borne in mind. 
FUn has been controlled in many countries by means of prophylactic 
vaccina.tion. With few exceptions animals are immunised by means of 
inactivated antigen with adjuvant given by the subcutaneous route. 
Having studied secretory antibody following infection, the investigation 
turned to the question of what part, if any, was played by such antibody 
in the immunity of animals which have been vaccinated according to 
current practice. 
Neutralising antibody was detected in serum but, apart from a trans-
ient, low level response in lachrymal and nasal secretion, very little 
antibody was detected in secretions following a single dose of vaccine. 
Levels rose in serum and secretions after a seoond and third application 
of vaccine (Section 5.3., Fig. 13) but secretory antibody was always 
found in lower amounts than humoral antibody. 
Parenteral application of inactivated viral vaccines has generally 
given rise to low levels of antibody in seoretions, despite the suooess-
ful stimulation of serum antibody. The ourrent results are in general 
accordance with those seen in man following subcutaneous vaccination with 
dead influenza viruses (Waldman et al 1968, 1969, 1972b, 1973, Mann et al 
1968, Kasel et al 1969, Alford 1969 and Downie 1970, 1973) and para-
influenza virus type 1 (Smith et al 1966, Chanock et al 1967) or intra-
muscular vaccination with rhinovirus (Perkins et al 1969). Experiments 
in cattle using parainfluenza type 3 virus gave similar results (Morein 
1970, 1972) and Figueroa et al (1973) have recently reported on the 
failure to detect secretory antibody in 6 calves sampled weekly for one 
month after a single subcutaneous dose of inactivated ~IDV vaccine. 
These findings are at odds with those of Ryslop (1965a) who reported the 
presence of antibody in unconcentrated saliva samples taken from 5/6 
steers 4 weeks after primary subcutaneous vaccination. 
In the current studies repeated application of inactivated vaccine 
by the subcutaneous route gave rise to increasing levels of secretory 
antibody. The variable appearance and low level of secretory antibody 
evoked by subcutaneous vaccination with inactivated influenza viruses 
has been noted by several workers as has the tendency for repeated doses 
to produce greater amounts of antibody in secretions (Waldman 1968, 1969 
and Downie 1913). Duncan and Thomson (1970) recorded that the first 
of several sequential doses of killed Pasturella haemolytica vaccine gave 
rise to serum antibody in calves whereas nasal antibody was detected only 
after the fourth dose. Morein (1972) using an inactivated PI-3 vaccine 
in cattle found humoral but not nasal antibody after a single subcutan-
eous injection but secretory antibody was detected after a second dose 
of vaccine given 2 - 3 weeks later. 
The discovery that subcutaneous vaccination in man often failed to 
confer clinical immunity led to the pursuit of other methods of vaccinat-
ion including the use of attenuated strains and the aerosol route, both 
of which produced more consistent results in terms of secretory antibody 
levels, inhibition of viral excretion and protection against clinical 
(228) 
disease (see Literature Review Section 5. 2.). MOwat (personal communi-
cation) was not able to immunise cattle by exposing them to an aerosol 
of inactivated FMDV vaccine. Nevertheless the fact that the immunity 
conferred by vaccination does not extend to the pharyngeal region pro-
vides an incentive for further investigation of alternative methods of 
vaccination. 
Neutralising antibody in the serum and secretions of steers follow-
ing infection and active or passive immunisation were characterised by 
means of column chromatography (Fig. 1 and 2), immunodiffusion (Plate 10), 
immunoelectrophoresis (Plates 5 - 9), reductive cleavage (Table 40) and 
specific absorption of immunoglobulins (Tables 41 and 47). Distinct 
differences were observed between the Ig classes in secretions from 
convalescent animals (principally 19A with some 19G1)' passively immunised 
animals (IgGl) and actively immunised animals (IgGl after the first and 
second doses of vaccine with an 19A component appearing after the third 
dose). Comparisons between serum and secretions in respect of the ttme 
of development of antibody, the levels attained and the 19 classes in-
volved suggest that at least two mechanisms may be involved in the pro-
duction of local antibody. These are discussed under A and B below. 
(A). Since antibody levels in serum were always greater than those 
in secretions the outward diffusion of Ig from serum to secretions was 
feasible. Evidence for the spillover mechanism was provided by the 
detection of antibody in secretions after passive immunisation (evidence 
which must be viewed with reservations - see Section 7.3.) and after 
active immunisation, together with the fact that antibody was not found 
in secretions until the level in serum exceeded a neutralisation index 
of around 2.5. The observation that serum contained neutralising anti-
body of the IgM, IgG! and IgG2 classes whereas the activity of secretions 
was associated principally with IeGl suggested the existence of selective 
(229) 
rather than siDple diffusion. 
(B). Neutralislng activity associated with 19A was detected in 
the secretions of animals following infection or after a third subcut-
aneous application of inactivated vaccine. According to the results 
of absorption procedures, serum contained less neutralising IgA than did 
secretions so that the molecule is unlikely to have been of humoral 
origin. 19A may well have been produced locally and such a source is 
known to exist in the bovine (Butler et al 1971). The production of 
antibody in this system may depend on the penetration of antigen in suf-
ficient mass to prime the immunocompetent cells of theparamucosal tissues, 
an event which is readily envisaged in the diseased animal. Possible 
explanation of the observations in vaccinated animals might be that 
either: a) after repeated vaccination sufficient antigen eventually 
reaches the paramucosal tissues perhaps in macrophages, and stimulates 
the production and release of detectable IgA or b) lymphocytes primed 
for the production of IgA elsewhere in the body finally settle out in 
peripheral situations and there secrete IgA. 
The current studies provide indications of the origin of Ig classes 
in secretions after FMDV infection or vaccination. It would be of 
interest to determine the amount of each Ig class in different situations 
by a technique such as radial immunodiffusion (Mancini et a1 1965). 
In the final section of the work an attempt was made to aBBess the 
importance of local antibody in the immunity engendered by vaccination 
or infection. Without the availability of naturally occurring dysgamma-
globulinaemic animals such as assessment is problematical because of the 
extreme difficulty in disentangling the role of secretory antibody from 
that of serum antibody and other host defences. 
(230) 
The expericental approach was to create groups of steers with widely 
different levels of secretory antibody at the time of challenge and to 
examine the relationships between antibody level, clinical protection, 
acquisition and excretion of virus (in sites other than the pharynx) 
and the carrier state after exposure to FMDV. The schedule of vaccinat-
ion (Table 48) did evoke a wide range of neutral ising antibody levels 
at the time of challenge (Tabl~ 49) but antibody was not detected in the 
serum of the group vaccinated once, 1 days before exposure. The reason 
for this unexpected failure is unknown but it m$Y be that the vaccine 
lost petency before being used in these animals. Previous experiments 
(Graves et al 1968, Garland, Burrows and Greig unpublished data) had 
shown that cattle could be protected within 3 - 4 days of vaccination 
with inactivated antigen applied parenterally so that the capacity of 
one or more doses of baccine to engender clinical protection when applied 
at least 14 days before challenge in these studies was as expected. 
There was no gradation in the'reoovery of virus from samples other 
than pharyngeal fluid since the frequency (Table 50) and amount of virus 
either resembled that seen in fully susceptible cattle (groups vaccinated 
on Day 0 and Day 1 before exposure) or was almost totally eliminated by 
immunisation (all other groups). If a threshold of immunity exists for 
eaoh site, other than the phar,ynx, it had already been exceeded by the 
time that animals had been vaccinated for 14 days. The observations 
confirm and extend the observations of Sellers et al (1969a) who compared 
viral excretions in steers 19 days vaccinated at the time of exposure 
and bulls unvaccinated at exposure when a similar reduction was demonst-
rated in the reoovery of virus from immunised oattle. In future experi-
ments it might be possible to create animals of intermediate immunity by 
vaccinsting closer to the time of exposure. 
When thrice vaccinate~ .~imals were exposed to t.ype C virus a strik-
(231) 
ing decrease followed in the recovery of infectivity from all samples 
including pharyngeal fluid and virus was detected in this secretion in 
only I of 3 animals. Virus was, however, recovered from the tissues 
of all three steers at post mortem (Section 7.5.1.4.). When 6 convales-
cent steers were reexposed to homologous type All9 virus ~ years after 
the initial infection no virus was recovered during ante mortem or post 
mortem sampling (Section 7.5.2.). It is of interest that IgA antibody 
was present in the secretions of both groups of steers which exhibited 
a modification of the carrier state. 
This thesis has been concerned with the study of natural and induced 
factors inhibitory to foot and mouth disease virus in bovine secretions. 
The results indicate that in the normal course of events natural secret-
ory factors are of minor significance in the early phase of the disease 
and that secretory abnormalities are uncommon. Induced factors do appear 
to have a bearing on the course of infection since interferon and neut-
ralising antibody were invariably detected in secretions as infected 
animals began to recover and virus excretion diminished. Secretory 
antibody may be particularly important in highly immune animals. Thus 
the marked reduction in viral excretion from animals exposed to virus 
after repeated vaccination and the total absence of excretion from even 
long term convalescent cattle after reexposure to virus showed a close 
correlation with the presence of neutralising antibody of the IgA class 
in secretions. 
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